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by
Malgorzata Kolotylo-Kulkarni
Florida International University, 2019
Miami, Florida
Professor Monica Chiarini Tremblay, Co-Major Professor
Professor George M. Marakas, Co-Major Professor
Decision support research has largely focused on the mechanics of tool design, with less attention
paid to the way the alternatives are presented to the user - that is, the format of the output, how the
decision tool design can play a role in it, and the output content (characteristics). Furthermore, little
research has examined specific decision contexts and user’s cognitive aspects pertinent to the
choice task, and their role during an online purchase. This study addresses these issues by
investigating the impact of output format and content of a non-compensatory (NC) tool and a
customization-based tool on user’s decision quality in the context of a health insurance purchase.
It also examines the moderating role of context (perceived risk) and user’s decision approach (price
heuristics) – both salient in a health plan choice.
Drawing from risk perception, decoy effect, price order effect, and options framing, this research
carries out 2 studies: 2x3x2 full factorial between subjects experiments. Study 1 examines the effect
of NC Descending (price High-Low) choice sets with asymmetrically dominated alternatives, while
Study 2 examines NC Descending, NC Ascending, and customization-based tools. Both studies
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also investigate the roles of perceived risk (high vs low), and user’s decision approach (price
heuristics-driven strong vs weak).
Results of Study 1 demonstrate that output content characterized by price anchoring differentially
affects user’s decision quality; and Study 2 indicate that by subjecting the user to reference
dependence, usage of NC Descending tool can have a negative impact on decision quality (highest
price paid), and usage of NC Ascending and Financial tool have a positive impact (lower price
paid). These dynamics change for users under different levels of perceived risk and with disparate
decision approaches. Usage of a customization-based tool, as per the design delineated here,
mitigates the negative impact of NC Descending, and further lowers, the influence of NC
Ascending tools, by enforcing cost-utility analysis, adopting base-level reference point, and
enabling more flexible item composition.
The study contributes to: a) information systems, by uncovering detailed dynamics of the
interactions between information delivery and the user; and b) boundaries of reference dependence,
thus, loss aversion.
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1 MOTIVATION
1.1 Motivation, Research Problem, & Research Questions
In 2017 over 1.6 billion consumers around the world purchased products online (Online
shopping and e-commerce worldwide, 2017) and sales reached 2.3 trillion USD. Although
e-commerce sales have so far largely involved product purchases, online service sales have
been on the rise: constituting only 3.8 % of all Internet-based sales, but gradually increasing
(by 11.8 % from 2013 to 2014) (U.S. Department of Commerce, 2016). (Celent, 2007).
One of such service items is constituted by health insurance which post Affordable Care
Act reform, has been under strong consumerization process (Russell, 2014) and, thus, an
increasing number of consumers purchase their healthcare coverage online, using decision
tools provided by Health Marketplaces and private broker websites. Consumers frequently
find it challenging to process health plan options and overspend online (Abaluck, Gruber,
& NBER, 2016; Zhou & Zhang, 2012). Their ability to choose low-cost health plans which
meet their needs depends on many elements such as policy-related (e.g. the number of
available options) (Zhou & Zhang, 2012), presentation format (e.g. price format display)
(Andrew J. Barnes, Hanoch, Wood, Liu, & Rice, 2012), and individual factors such as
one’s level of comprehension of health insurance (Andrew J. Barnes, Hanoch, & Rice,
2015).
Many of the tools available to the consumers share design features with commonly used
product recommendation agents (RAs) (Xiao & Benbasat, 2007, 2014), by for instance,
enabling the user to sort through available plans and filter them based on specific attributes,
according to the user’s preferences.
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Health insurance purchase decisions are not however, parallel to other types of purchases.
They are highly complex, consumers often adopt price heuristics during the decision
making process (Ericson & Starc, 2012) and are sometimes made in peculiar
circumstances, such as under high perceived risk (or, for instance, enforced by legislature).
Although when choosing health insurance, consumers are largely driven by minimization
of cost (Ericson & Starc, 2012), paradoxically, as a result, they often end up losing money
(Heiss, Leive, McFadden, & Winter, 2013). Arguably, a number of various factors can
affect consumers’ ultimate (such as paying a higher deductible) – as well as immediate
(paying a higher premium) - consequences of the choice of a particular health plan, and
online decision tool design may be one of them. Consumers’ need for coverage alongside
their increasing reliance on online decision tools to make their purchase choices, calls for
an investigation of the impact that the usage of these tools has on consumers’ decision
quality. It is imperative that we examine whether online decision tools are indeed
supportive of such decisions, and under what conditions they would enable the user to
reach varying degrees of decision quality. For instance, in the circumstances where the user
is focused on price, is it conceivable that information delivery formats of e-commerce
platforms related to price can exert differential – potentially negative - impact on users’
decision quality? Is it conceivable that such effects can vary in different circumstances?
Although our dependability on online decision tools is growing, the impact of these
systems, and, thus, our capacity to develop improved ones, is still not yet fully known.
Early research concerning decision support systems analyzed decision tools from the
perspective of their potential to improve such aspects as decision quality (Todd &
Benbasat, 1992), efficiency (Silver, 1991), and accuracy-effort tradeoff (Chenoweth,
2

Dowling, & St. Louis, 2004). However, the outcomes of these investigations vary partially
because of contextual differences among tasks and conditions (Song, Jones, &
Gudigantala, 2007; Todd & Benbasat, 1992). Research has so far attempted to reconcile
these differences, by, for instance considering the intricacies of the similarity between the
tool’s decision making process and the consumer (Aksoy, Bloom, Lurie, & Cooil, 2006),
or by taking into account differential impact of user’s expertise with the product on the
effect of task transparency on preferences and product evaluation (Kramer, 2007).
However, the impact of online decision tools on user’s decision performance remains
inconclusive.
Extant decision support literature has extensively examined the effects of tool design (Song
et al., 2007; Tan, Teo, & Benbasat, 2010), choice set size (Kamis, Koufaris, & Stern, 2008)
and the interaction between them (Kamis et al., 2008) on user’s purchase behavior. The
majority of this research has focused on purchase intention, with little papers examining
specifically user’s decision quality (Song et al., 2007; Tan et al., 2010).
Furthermore, extant research has noted that the effectiveness of decision tools is contingent
upon a number of factors, such as user’s characteristics (e.g. domain knowledge), product
characteristics (type and complexity), elements associated with the interaction between the
user and the tool, as well as characteristics of the decision tools (with regards to the type
of the tool, its input, process, and output it generates) (Xiao & Benbasat, 2007). Despite an
extensive body of research on decision tools, calls for research have been raised to
investigate the role of the different elements related to the user and the decision tool
characteristics, in the impact of online decision tool usage on user’s decision quality, as a
number of such elements have been overlooked (Xiao & Benbasat, 2007, 2014).
3

Furthermore, scant research exists examining the characteristics of the alternatives
provided by the decision tool to the user, and even more so, very little investigations have
been done into the characteristics of the options as well as the way in which they are
presented by different tool designs – output content and output format (Xiao & Benbasat,
2007, 2014) – which, this paper, refers to as information delivery (literature review is
shown in Table 1). Minority of papers investigating output content include studies such as
(Senecal, 2003) who examined the effect of product cross-recommendations on user’s
purchase intention and showed that users are more likely to purchase the alternative when
it is recommended. Research focusing on output format is slightly greater in number and
generally differentiates between presenting the information in a sorted vs. non-sorted
fashion (Xiao & Benbasat, 2007, 2014).
Additionally, although the role of contextual elements in the effectiveness of online
decision tools has been recognized, recent studies which have examined it, also didn’t focus
on its effect in the impact of decision tools on user’s decision quality (Lee & Benbasat,
2011).
Sorting the available items by a category of choice (for instance relevance, average
customer reviews, newest arrivals, or price) constitutes one of the most common design
features of online decision tools, included in virtually every recommendation agent. Using
this feature results in presenting the alternatives in an ordered fashion, depending on the
attribute the user has decided to sort the options on. This feature is based on (or, more
explicitly, constitutes an application of) the most fundamental type of non-compensatory
decision strategies, which is lexicographic-by-attribute strategy. Non-compensatory
strategies are analogous to heuristics, whereby a high value of one attribute does not
4

compensate for a low value of a different attribute (J. W. Payne, Bettman, & Johnson, 1993;
Song et al., 2007).
Scholarship has noted that under different conditions, the reliance on the tool could yield
different results and calls for further research have been raised (Tan et al., 2010). Although
each decision is contextual, IS literature has so far not paid sufficient attention to the
different decision contexts (circumstances/ environments) in which the user can find
themselves in, which can influence their preferences and decision strategies, thus,
potentially, impacting the effectiveness of the decision tool. Limited literature in this area
includes decision context studied by (Lee & Benbasat, 2011) who examined the differential
effect of the user being in a loss or gain situation and showed that in loss conditions the
decision tool can negatively impact attribute trade-off difficulty, and, furthermore, the
negative effect perceived effort on decision tool usage intention is weaker under loss
conditions. Although the widespread adoption of online decision tools has triggered a
rather extensive body of research investigating their effect on user’s decision performance
(Haubl & Trifts, 2000; Song et al., 2007; Tan et al., 2010; Xu, Benbasat, & Cenfetelli,
2014), very sparse number of studies attempted to investigate the alignment of a decision
tool and the contextual dynamics of decision processes that is, under what conditions an
online decision tool would indeed be helpful to the user.
Furthermore, although decision strategy has been investigated as a factor influencing the
impact of an online decision tool on user’s decision quality (Aksoy et al., 2006), little
research exists that studies the role of user’s decision strategy when making online
purchases and how that can differ as context, salient to the nature of the decision, changes.

5

Differing dynamics between the decision tool and the user’s decision strategy can have
varying effects on their decision quality, which requires further investigation.
In order to address the above-mentioned insufficiencies in research, this paper focuses on
output characteristics (content and format) and examines the conditions under which they
can positively or negatively impact user’s decision quality. This study examines a singleattribute non-compensatory (NC) tool design, specifically, one of the possible attributes
based on which the user may sort the alternatives, that is, price - sorting either in ascending
Low-High (here referred to as NC ascending) or descending High-Low (here referred to as
NC descending) fashion. It investigates the effect of information delivery in the form of
output characteristics that can occur in an NC decision tool and output format embedded
in the design of NC tool and considers whether, and if so, under what conditions, such
output characteristics may negatively impact user’s decision quality. Empirical evidence
touching upon the effects of price order and price characteristics on consumer’s choice is
available in price presentation order (Suk, Lee, & Lichtenstein, 2012) and price anchoring
(Ariely, Loewenstein, & Prelec, 2003). However, this research has not paid sufficient
attention and has not sufficiently examined these mechanisms in varying conditions
(decision contexts) that could impact user’s preferences and decision strategies, and thus,
change the dynamic of price order and price anchoring effects.
This study further proposes an alternative tool design, which could potentially mitigate the
negative impact of certain output characteristics in non-compensatory tool design.
Moreover, this study extends this investigation by examining the role of user’s decision
quality and decision context in the relationship between the decision tools and user’s
decision.
6

Therefore, the main objectives of this study are to:
•

investigate mechanisms embedded in information delivery in the form of output
characteristics: output content and output format of a non-compensatory tool,
which may potentially drive the user to overspend in an online environment in
different decision contexts (peculiar to the decision type), thus negatively
impacting their decision quality

•

identify alternate online environment features which could potentially mitigate this
negative effect

•

inspect how the effectiveness of these mechanisms may differ for different users

By focusing on the health insurance context, the following research questions are proposed:
1. How can the design of an online decision tool affect user’s purchase decision?
2. How can such an effect be mitigated?
3. Which consumers are particularly vulnerable to this effect?
Particularly:
4. What is the effect of non-compensatory online decision tool usage on buyer’s
decision quality?
5. What is the effect of a customization-based online decision tool usage on buyer’s
decision quality?
6. How will these effects vary for consumers under different levels of perceived risk
and who differ in the decision approach they undertake?
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To address the above-mentioned research questions, this study builds upon the findings of
prior research concerning:
•

non-compensatory and compensatory decision rules

•

online decision tools: recommendation agents and customization-based tools

•

decision under risk: particularly risk perception, availability heuristic, and
simulation heuristic,

•

reference dependence and loss aversion

•

behavioral pricing: decoy effect, price-order effect, and options framing

Specifically, this study examines the effect of usage of a non-compensatory tool and argues
that using a non-compensatory tool can have a negative effect on user’s decision quality,
as a user making a purchase choice with a non-compensatory tool presenting the
alternatives according to price in a descending fashion will pay a higher price than with
non-compensatory tool ascending. It is further proposed that using a customization- based
tool, which enforces cost-utility analysis, results in positive decision quality, as the tool
design adopts a base-level reference point, and enables item customization, which
ultimately lets the user spend less on their item. It is further argued here that characteristics
of the output in the form of price anchoring can differentially influence user’s decision
quality.
This study also investigates the effect of user’s decision approach and how it can moderate
the relationship between decision tool usage and user’s decision quality. Specifically, it
examines how user’s price-heuristics - oriented decision approach affects their usage of a
8

non-compensatory and customization-based tools, whereby the price paid by the users who
are strongly driven by cost will not differ regardless of the tool being used. The decision
tools will have a differential effect on users’ decision quality for users weakly driven by
price heuristics. Judgment error evoked by information presentation thus plays a role, but
it further depends on user’s decision approach.
It further analyzes the impact of contextual factors associated with the decision
environment of the user by looking at how, depending on the circumstances, for instance,
for users under high perceived risk, the effect of the decision tools will be different than
for users under low perceived risk. It is argued that decision context plays a role in the
salience of the attributes of the options, thus affecting the effect of the decision tools on
user’s choices.
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2 LITERATURE REVIEW
2.1 Information delivery: Output Format & Output Content
If we are to consider a decision tool and its usage, there are at minimum four core elements,
including three process-related factors, which would need to be recognized and examined.
Those elements include: a) the type of the decision tool (the way in which the tool is
designed to process the decision, e.g. filtering method); as well as (at process-level) b)
input (e.g. information related to user’s preferences for the choice), c) process
(characteristics of the tool informing the user about the progress such as time left to
complete the search of potential alternatives meeting user’s criteria), and d) output (the
ultimate presentation of the available options) (Xiao & Benbasat, 2007, 2014).
It is the latter element – the output – that provides the information to the user about the
item alternatives which are available, hence, delivers the required information, and it
constitutes a vital part of the tool, as it is here, where the user chooses an option for them.
It can be related to the way the decision tool is designed and its complexity level, for
instance a single attribute non-compensatory tool will generate an output as a sorted list,
but not necessarily so: a more sophisticated tool based on compensatory design may also
provide the output as a list (or in other ways, such as columns facilitating comparison of
options).
In any case, the output of a decision tool can be characterized by two features: 1) the format,
and 2) the content of the output (Xiao & Benbasat, 2007, 2014). The format of the output
pertains to such elements as the way in which the alternatives are presented, that is, whether
they are sorted or non-sorted, or to the number of options presented in a single page (Xiao
& Benbasat, 2007, 2014). The content of the output relates to the actual characteristics of
10

the alternatives being displayed such as their ratings (Xiao & Benbasat, 2007, 2014), the
attributes included, or prices offered. The characteristics of the alternatives can refer to any
attribute (price, color, dimensions, etc.) and may be random, for instance when the decision
aid belongs to an independent merchant (and offers items from various providers) or may
be, in one way or another, related – if the items are, e.g., from a single vendor.
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Literature investigating the effects of usage of information delivery on decision quality.
Information
delivery:
NC tool vs. tool
Output
Independent
Dependent
Paper
Setting
type
format vs
Variables
Variables
Output
content

(Tan et
al.,
2010)

• Washing
machines
• mini
audio
systems
purchase

(Song et
al.,
2007)

Apartment
rental

• Noncompensatory
(single attribute based
support),
• Noncompensatory
(multiple attribute based
support),
• Compensatory
based

• Noncompensatory
• Compensatory

Output
format

Output
format

• Decision tools
(non-compensatory
and compensatory)
• Attribute load

• Decision tools
(non-compensatory
and compensatory)
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Findings

Single-attribute –
based decision
support yields
higher decision
quality and higher
• Decision
perceived decision
quality
quality than
• Perceived
multiple-attribute –
decision
based decision
quality
support when
• Decision time
attribute load is
• Perceived
low. Perceived
system
decision quality is
quality
lower using singleattribute based tool
than multipleattribute based tool
when attribute load
is high.
Non-compensatory
• Perceived
decision support is
effort
perceived as less

(Aksoy
et al.,
2006)

• Compensatory
with ordered
output
Cell phones
• Compensatory
with unordered
output

• Output
format
• Output
content

• Ranked list of
options with
similarity HighLow
• Perceived decision
strategy similarity
High -Low
• Output ordered vs
unordered
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• Perceived
accuracy
• Perceived
effectiveness
• Consistency
with user
preferences
• Satisfaction
• Objective
decision
quality
• Subjective
decision
quality
• Perceived
benefits of
using the
agent
• perceived
costs of using
the tool
• information
search
• Conformity
to output
• Website
satisfaction
• Repurchase
intention

accurate and yields
decisions less
consistent with
user’s preferences.

Decision strategy
or attribute
similarity between
the user and the
decision tool yields
higher
dissimilarity.
Dissimilarity yields
no difference
between choosing
from an ordered or
unordered set.

• Intention to
recommend
website

(Diehl,
2005)

Birthday
e-cards

(Diehl,
Kornish,
&
Postcards
Lynch
Jr.,
2003)

Noncompensatory

• Noncompensatory
ordered
• Noncompensatory
random

• Output
format
• Output
content

• Output
format
• Output
content

• Search costs
• Item recipient
• Number of
recommendations
• Ordered output

• Decision
Quality
• Selectivity

• Sorted list ordered
(ordered by quality
or expected net
price) vs random
• Choice set size
• Order of recipient
• Price of the
• Sequence of search
chosen card
• Order of recipient • Quality of
the chosen
• Trial (1 vs. 2)
card
• Sorted list ordered
vs random
• Relative
importance of
price in the reward
function
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Making the choice
from a list of
options sorted from
best to worst
encourages
consideration of
more options and
reduces user’s
selectivity resulting
in lower decision
quality
Users pay a lower
price when output
is ordered than
when it is
unordered. In
ordered searches,
price is marginally
lower if output is
large than if it is
small. With ordered
search and large
choice set, quality
of chosen item is
higher.
Multiple uses of
ordered output

• Order of search

decreases the price
paid even further.
If quality is more
important than
price, price is
higher when output
is ordered than
random. If quality
and price are
equally important
or if price is more
important than
quality, price paid
is lower in an
ordered set.

Table 1 Literature examining the effects of information delivery on decision quality.
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A very common output format constitutes a sorted list which can be generated by a singleattribute non-compensatory tool. Such sorting fashion may be based on different factors,
such as average customer review, featured, or price high-low and low-high. When the
output is sorted by price, for instance, the alternatives are presented in a top-down fashion
starting either from the most to the least expensive alternative – or vice versa.
Although the alternatives are generally organized by increasing or decreasing cost, such an
output may still vary in terms drops or gains in price, and, furthermore, by the attributes
included by those options. Thus, output content further adds to the information delivery.

2.2 Decision context
Decision context carries a number of meanings and, in the extant literature, has been
defined in many ways: as characteristics of the situation that the user is at or the
characteristics of the choice set1.
Situational factors – elements such as the circumstances that individuals find themselves
in or the framing of the decision problem frequently influence individuals’ decision making processes (Das & Teng, 2001; Daniel Kahneman & Tversky, 1979; March &
Shapira, 1987; Schoemaker, 1990). For instance, individuals tend to be more risk averse in
gain situations and more seeking in loss situations (A. Tversky & Kahneman, 1991), and,
furthermore, a particular decision maker can behave differently in terms of risk taking

In this paper the term ‘choice set’ and ‘consideration set’ are used interchangeably, as the choice sets used
in the experiment also serve as consideration sets for the user.
1
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depending on how they consider their situation – positive or negative (that is, higher or
lower the reference point that is of interest) (Bateman & Zeithaml, 1989a, 1989b).
Decisional context can also impact individual’s preferences, whereby preferences can be
formed at the time of making the decision (J. W. Payne et al., 1993). It has been also
recently proposed that decision makers don’t even necessarily engage in value assessment
but, depending on the context of the choice (defined as characteristics of the alternatives
available) they can learn choice strategies distinctive to the choice set (Amir & Levav,
2008).
In any case, however decision context is defined, it can impact the decision - making
process of the user and ultimately, the choice that make.
In this paper, decision context is defined as the level of perceived health risk evoked by a
real-life situation and personal risk factors. Individuals can often exhibit an increased risk
perception for a medical outcome, which can influence their preferences and decisionmaking process, thus a choice between a person with higher vs. lower risk perception, will
differ. Experiencing an increased perceived risk can impact one’s anticipated health
services needs and, via their willingness to mitigate the possible consequences of the
medical condition and the need to utilize different health services, impact the extent of
coverage and/or the price (premium or deductible).

2.3 Decision approach
Decision strategy constitutes a series of actions taken up in order to convert decision
maker’s initial (original) knowledge into a concluding (final) state of knowledge, whereby
the individual feels that his decision problem has been settled (Riedl, Brandstätter, &
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Roithmayr, 2008). From a theoretical standpoint decision strategies differ from information
search behavior, but consociate with them in a number of cases (Takemura, 2014).
Decision strategy used by the individual in his choice will involve elements of information
search (for instance evaluation of the options available resembles assessment of
information collected).
Features which differentiate various choice strategies include aspects such as: a) amount
of information processed (e.g. the DM may or may not consider all attributes); b) the way
in which the information is evaluated (assessment may be done alternative-wise, that is,
considering the values of attributes one option at a time, or attribute-wise, whereby the DM
studies the values of a single attribute across alternatives before taking another attribute
into account); c) consistency of amount of information processed across attributes and d)
alternatives; e) method of exclusion of undesired alternatives; f) employment of attribute
weights or lack thereof; g) employment of a threshold for acceptable value level or lack
thereof; h) method of dealing with conflicting values of attributes of a single option; i)
extent of application of quantitative and qualitative reasoning for the purpose of alternative
evaluation (Hastie & Dawes, 2001; Riedl et al., 2008).
Decision makers adapt their approaches to processing the available options and information
on them to facilitate the decision process depending on the task structure or given situation
(Gigerenzer, 2001; Simon, 1956). Decision strategies are not stable and can change across
contexts (Russo & Dosher, 1983), with changes in aspects of the decision task such as
complexity level (Swait & Adamowicz, 2001), or environmental structures (Mata,
Schooler, & Rieskamp, 2007). One of the aspects that can affect individual’s decision
making approach is objective (motivation), as it has the potential to influence one’s focus
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on different aspects of the choice/ available alternatives (Carstensen, Isaacowitz, &
Charles, 1999; Lockenhoff & Carstensesn, 2007).
For instance, consumers who are highly price conscious exhibit preferences for low prices
and, thus, consider the available options with a focus on the cost (Lichtenstein, Ridgway,
& Netemeyer, 1993). Those consumers seek products and services that meet their needs
while relying on price (Lichtenstein et al., 1993). Price consciousness may be defined as
the extent to which an individual ‘focuses exclusively on paying a low price’ (Lichtenstein,
Bloch, & Black, 1988; Lichtenstein et al., 1993). It can be a personal characteristic, but
also it may be a generally observed trend among the consumers in a particular choice
context or item, for instance it has been noted that consumers frequently are driven by price
when choosing health insurance for purchase (Abaluck & Gruber, 2011; Ericson & Starc,
2012).
In this paper, decision approach is defined as decision maker’s tendency to focus solely on
price during a particular purchase choice task.

2.4 Online decision tools
Decision aids (both IT- and non-IT- based) may be used to support the choice process and
help achieve a better quality decision (Shim et al., 2002). A number of decision support
tools are web-based and encompass individual features and capabilities, such as
recommender systems (Haubl & Trifts, 2000) or constitute software or applications
designed fully as decision aids (Bharati & Chaudhury, 2004).
The most essential feature of a decision tool is the mechanism supporting generation of the
evoked set based on user’s evaluation criteria. Online RAs design components that sustain
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this process are mostly grounded on the support of compensatory, non-compensatory, or
hybrid decision strategy types (Xiao & Benbasat, 2007). Compensatory and noncompensatory decision rules are driven by DM’s preferences and the importance he assigns
to particular choice attributes, but they differ in the way they handle these preferences.
The majority of online decision tools for multiattribute alternative evaluation are based on
these information - processing practices, enabling the user to assess options using these
different approaches.

2.4.1 Non-compensatory decision rules
Non-compensatory rule is alike a heuristic, whereby the DM does not face value conflicts,
but evaluates the options based on a cut-off point of the most substantial attribute(s), and
disregards the other attributes (Bettman, Luce, & Payne, 1998; Hogarth, 1987). This
strategy eliminates unneeded options and facilitates the choice process by reducing
cognitive effort. Two main ways in which non-compensatory strategies are carried out
include single-attribute and multiple-attribute screening (John W Payne, Bettman, &
Johnson, 1993).

2.4.2 Non-compensatory decision tools
Non-compensatory designs for option assessment usually involve features such as: filtering
by a particular attribute (e.g. showing only a subset of alternatives – only those which meet
the desired level of a certain attribute), sorting facility (e.g. sort by price, by customer
review, etc.), or choosing a desired/acceptable threshold for a given attribute.
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Non-compensatory online tools (NC tools) have so far been studied from the perspective
of information overload (Song et al., 2007; Tan et al., 2010; Xu et al., 2014), yet little
attention has been paid to the contextual factors surrounding the decision process, which
may possibly play a role in the effectiveness of these tools in terms of user’s decision
quality. (Song et al., 2007) showed that non-compensatory – based tools are inferior to
compensatory-based tools with respect to user’s perception of their accuracy, effectiveness,
effort involved, satisfactoriness, as well as coherence with user’s preferences. (Tan et al.,
2010) compared the effects of decision tools in high and low attribute load conditions and
found that usage of single attribute non-compensatory tools results in higher decision time,
lower perceived decision quality when attribute load is high, and is associated with lower
perceived system quality than usage of multiple-attribute – based tools.
Furthermore, presenting alternatives in a sorted order from the most advantageous to least
advantageous may still result in lower decision quality, as user’s evaluation of other items
is associated with a reduced average quality of examined items and user’s selectivity is
decreased (due to concentration on lower quality items) (Diehl, 2005). (Diehl et al., 2003)
studied how ordering of item recommendations based on item quality influences
consumers’ choices when price and quality are and are not correlated. They found that,
when there is a positive price-quality relationship assumed, presenting the user with
alternatives ordered by quality can result in higher or lower prices paid depending on the
relative importance of price in utility function, such that: a) when importance of price is
greater than the slope of quality on price, then users pay lower prices; and b) when
importance of price is less than the slope of quality on price, then users tend to pay higher
prices (Diehl et al., 2003). Accordingly, users choose higher quality items if the relative
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importance of quality is greater than the slope of price on quality, and will choose lower
quality items if quality importance is less than the slope of price on quality (Diehl et al.,
2003). It has been further shown that, when price and quality are not correlated, users will
choose a lower priced item when presented with alternatives in an ordered fashion rather
than unordered, as the ordered presentation provides them with better options on top of the
list, and the top items are close substitutes in terms of quality (Diehl et al., 2003).
(Dellaert & Haubl, 2005) for example, investigated these types of tools in terms of their
ability to present items in the order of their anticipated appeal to the user, and compared
user’s decision process when assisted by the tool and user’s choices when unassisted. They
showed that users provided with recommendations evaluate alternatives in ‘choice mode’,
that is, they focus on evaluating utility and picking the best option out of the ones presented
with (Dellaert & Haubl, 2005). When making the choice when provided with
recommendations, users compare an item to others, previously identified items in the set;
and, further, when evaluating items of greater variability, users tend to search less than
with no recommendations (Dellaert & Haubl, 2005).
Research shows that in contradistinction to presenting the user with options in a random
fashion, choosing from alternatives sorted according to user’s preferences results in higher
decision quality (Diehl, 2005) and lower prices paid (Diehl, 2005). It has also been shown
that when provided with item recommendations in an ordered fashion (although with a
decision tool based on a WADD strategy) is positively related to user’s objective decision
quality when user’s attribute weight and decision tool’s attribute weight are similar, as
compared to an unordered fashion (Aksoy et al., 2006).
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2.4.3 Customization - based online decision tools
Customization-based decision tools provide decision support by enabling the user to
construct the product and services according to the user’s preferences and needs (Ives &
Piccoli, 2003; Kamis et al., 2008). The tools display specific attributes and metrics
characterizing the attributes and permit the user to construct the product or service by
picking and choosing the parameters to custom design the item. The tools can provide the
user with specific attributes or attribute packages (sets of attributes) for the user to arrange
to their liking. Usage of customization-based tools is associated with greater perceived
usefulness and perceived enjoyment experienced by the users (Kamis et al., 2008). Those
types of decision tools also perform better in terms of supporting complex decision tasks
in the sense that they alleviate the decline in perceived ease of use and perceived control
which users experience with non-customization-based tools when task complexity
increases (Kamis et al., 2008).

2.5 Presentation Bias
In the online environment, research has discussed the issue of bias in usage of search
engines (sometimes referred to as presentation bias) (Bar-Ilan, Keenoy, Levene, & Yaari,
2009). Scholarship has examined users’ tendencies in their utilization of search engines
and showed that individuals are generally biased towards top results, yet sometimes they
look into lower ranked records (Keane, O’Brien, & Smyth, 2008). The boundaries of this
phenomenon still remain inconclusive. On the one hand, presentation bias was shown to
be substantial by (Bar-Ilan et al., 2009) who showed that users value the ranking of the
record and consider it the most important factor determining the quality of the record. On
the other hand, research has found evidence indicating that record position is not the only
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factor that plays a role here and with less applicable results positioned on the bottom of the
search results, users pay more attention and consideration into the process of evaluation of
the results (Lorigo et al., 2008).

2.6 Prospect theory
Prospect theory (Daniel Kahneman & Tversky, 1979; Amos Tversky & Kahneman, 1992)
constitutes a theory of choice across risky alternatives with known outcome probabilities,
and was proposed to be more aligned with human cognition which expected utility theory
does not take into account. The theory was advanced on the basis of findings that: a)
individuals prefer certain gains to uncertain ones of an equivalent assumed magnitude; and
b) favor uncertain losses over certain ones of an equivalent assumed magnitude (Daniel
Kahneman & Tversky, 1979; A. Tversky & Kahneman, 1986; Amos Tversky &
Kahneman, 1992). The theory is concerned with the way decision maker makes their choice
(rather than the final outcome of the decision) and posits that they approach the alternatives
from a standpoint/reference – concerning income and wealth level.
Prospect theory delineates decision process as occurring in two phases: editing and
evaluation (Daniel Kahneman & Tversky, 1979). In the first stage, the decision maker
chooses which outcomes they perceive to be equivalent, establishes a reference level, and
then deems greater outcomes as gains and lesser ones as losses. The objective of this phase
is to mitigate framing and isolation effects. During the second stage, the individual acts as
if they were computing decision utility and picks the option exhibiting highest utility
(value). The corresponding formula delineating the second phase may be represented as
follows:
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𝑉 = ∑𝑛𝑖=1 𝜋(𝑝𝑖 )𝑣(𝑥𝑖 ) , where
V – overall expected utility value of the outcomes
x1, x2, x3, …, xn – potential outcomes
p1, p2, p3, …, pn – probabilities of corresponding potential outcomes
v – value function of an outcome
Here the individual makes their choice with reference to changes in income – represented
as possible either gains or losses – which occur relative to the reference level rather than
the actual level itself. That is, if gain increases, then the gain considered from the reference
point, will diminish in value; and if loss increases, then the loss considered from its
reference point, will lessen in negative value. Since more weight are assigned to losses than
gains: the marginal gain in value derived from a gain in income level is less than the
marginal loss in value derived from income (wealth) loss of an equivalent magnitude
(Figure 1 Value function of losses and gains).
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Figure 1 Function of gains and losses.

Because value is ascribed to losses and gains, rather than actual outcomes, the value
function (Figure 1) is defined on alterations from the reference level. Prospect theory posits
that depending on the contextual scenario individuals may involve in two types of risktaking behavior: risk seeking and risk aversion, each one delineated via the value function.
The function is concave for gains (indicating risk aversiveness), and convex for losses
(indicating risk seeking). The function is also normally steeper for losses than for gains,
signifying loss aversive nature of decision makers.
Due to the relationship between the concavity-convexity shape of the function and the fact
that low probabilities tend to be overweighed, the two risk attitudes indeed occur in a fourfold pattern. Individuals are inclined to be more risk averse when gains are of moderate(fear of disappointment), or losses of small- (fear of loss) probability; they also tend to take
up a risk seeking approach when losses are of moderate- (hope to circumvent loss) or gains
of small- (hope of a great gain) probability.
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The main advantages of prospect theory over expected utility theory include: 1)
demonstration that individuals prefer uncertain losses revises the explanation regarding
insurance demand; and 2) consideration of alterations in utility levels done from a reference
point constitutes a more useful clarification of consumer behavior (Nyman, 2003).

2.6.1 Loss Aversion
Loss aversion constitutes the disparity between one’s appraisement of gains and losses
(Daniel Kahneman & Tversky, 1984). That is, it is decision makers’ preference to evade a
potential loss than to obtain a corresponding gain. Loss aversion has been defined as the
influence of a changing reference level on indifference curves (A. Tversky & Kahneman,
1991). Whenever an alternative is evaluated against the reference standard, it is judged
with regards to the advantages and disadvantages it brings. Furthermore, when considering
pairs of alternatives, discrepancies between disadvantages are of greater impact
(psychological difference to the decision maker) than equivalent variations between
advantages (Daniel Kahneman, 1992).
In scenarios where the reference level is constituted by status quo, disadvantages of an
alternative to the status quo resonate with the individual more heavily than its advantages,
causing a bias towards maintenance of the status quo (Samuelson & Zeckhauser, 1988).

2.6.2 Reference Dependence
Reference dependence theory posits that decision maker’s choice depends on a reference
point (level) (A. Tversky & Kahneman, 1991). The position of the reference standard
impacts the evaluation of an outcome as either as a gain or loss. Due to the differences in
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assessment of gains and losses the appraisal of an outcome will influence decision maker’s
preferences (Daniel Kahneman, 1992). The individual considers the possible change as
either a gain and an advantage, or as a loss and a disadvantage; whereby losses influence
one’s preferences and choices more heavily than gains.
Although reference dependence and anchoring bias are similar in their effects, and are
frequently used synonymously; reference dependence deals with gains and losses valued
asymmetrically, whereas anchoring impacts one’s judgment of an object in a more general
context (Daniel Kahneman, 1992).

2.6.3 Framing Effects
A framing effect constitutes a cognitive bias which arises when equivalent depictions of a
choice problem direct decision makers towards systematically diverse choices (A. Tversky
& Kahneman, 1981). Framing effects have been extensively studied in terms of their
potential to undermine classical rationality approach and considered to support incoherence
in decision processes.
Hitherto, literature has identified and demonstrated three major types of framing effects:
1) attribute framing effects; 2) goal framing effects; 3) risky choice framing effects (Levin,
Schneider, & Gaeth, 1998). These effects differ in terms of their operationalizations, their
distinctive outcomes, and hypothesized underlying mechanisms (Levin et al., 1998).
Attribute framing is characterized by a different (positive or negative) valence of a single
attribute (positively described items tend to be evaluated more favorably by individuals)
(Levin et al., 1998). Goal framing involves adoption of a persuasive message which focuses
on either positive or negative consequences of a particular behavior (persuasive effect of a
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negatively-framed message is rooted in human loss aversion) (Levin et al., 1998). Last, but
not least, risky choice framing effects entail different risk approaches of decision makers,
that is risk seeking or risk aversion, depending on whether the decision problem is framed
positively (in terms of gain or success rate) or negatively (in terms of loss or failure rate)
(Levin et al., 1998; A. Tversky & Kahneman, 1981).

2.7 Anchoring
Anchoring constitutes a type of cognitive bias whereby an individual strongly depends on
the first piece of information he is provided with (that is, the anchor) when making a choice
(Amos Tversky & Kahneman, 1974). The individual considers that piece of information a
reference point which influences his assessment of further options. In the classic
experiment the subjects were asked to estimate a multiplication of figures 1 to 8: once in
ascending and once in descending order (Amos Tversky & Kahneman, 1974). The
estimations were significantly higher for the descending sets than ascending sets.
Anchoring effect thus pertains to scenarios whereby the decision maker’s estimation or
judgment of a possible outcome is influenced by a stimulus, often unrelated or
uninformative (Amos Tversky & Kahneman, 1992).
Individuals judgment may be impacted even by context-irrelevant cues and a variety of
types of anchors: numerical as well as non-numerical. Physical stimuli, such as line length,
object’s (such as pennies) weight or music loudness may also be accompanied by
anchoring. Individuals, when asked to reconstruct the magnitudes of these stimuli, judge
their estimates differently; when exposed to a small anchor (short length, light object or
quiet music), they generate lower estimates (LeBoeuf & Shafir, 2006). Non-numeric
anchors may skew numeric assessment (Oppenheimer, LeBoeuf, & Brewer, 2008), for
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instance subjects asked to estimate the length of the Mississippi River, and shown a longer
line beforehand, expressed greater evaluations.

2.8 Relative pricing
Research has uncovered a number of ways in which different formats of price presentation
and the ways in which alternatives are presented to the user with regards to their pricing,
can influence decision maker’s choice.

2.8.1 Decoy Effect
Alternatives in choice sets can exhibit various types of relationships and those different
relationships can exert various effects on decision maker’s preferences and choices. This
mechanism has been coined in the literature as the ‘decoy effect’ (Doyle, O’Connor,
Reynolds, & Bottomley, 1999; Huber, Payne, & Puto, 1982; Zhang & Zhang, 2007). There
are three types of decoys which can be differentiated: asymmetrically dominated decoy
(Heath & Chatterjee, 1995; Huber et al., 1982); a phantom decoy (Highhouse, 1996); and
a compromise decoy (Simonson, 1989). Phantom decoys dominate the target but are
presented to the decision maker as currently unavailable (Highhouse, 1996); compromise
decoys constitute alternatives which influence decision makers’ choices towards
intermediate options rather than extreme ones (Pettibone, 2012; Simonson, 1989).
When alternatives of higher price are also of higher quality, the choice set is set to be
symmetrically dominated. It is possible, however, for a choice set to include an option
which is asymmetrically dominated (superior in certain attributes such as cost, but lower
in other attributes) – the decoy - this option guides the decision maker to refocus their
attention to a different alternative – the target – which is high in all the attributes (Huber
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et al., 1982). The other option in the choice set are lower in attributes of the items (Huber
et al., 1982). When faced with such a choice set, the decision maker is expected to choose
the target option, as it constitutes value to them.

2.8.2 Options framing and price-order effect
2.8.2.1 Options framing
Consumer purchase decisions vary depending on how item choices are presented to them.
Decision makers who are provided with attributes enabling them to customize the item
ultimately purchase a different number of attributes and pay a different total price for the
item when they begin the customization process with a basic (single) attribute than when
they begin the process with a fully customized item (consisting of all possible attributes)
and then subtract the attributes from it (C. W. Park, Jun, & Macinnis, 2000). This effect
has been coined as options framing effect (Biswas & Grau, 2008; C. W. Park et al., 2000).
Two particular types of option framing have been studied: additive (starting from the base
model and adding ancillary options to it, each one at a given cost) and subtractive (starting
from the full model and taking out options from it) (Biswas, 2009; Biswas & Grau, 2008;
C. W. Park et al., 2000; Peng, Xia, Ruan, & Pu, 2016). When provided with an additive
option framing, each addition of an option constitutes a gain, but a loss in monetary
sacrifice, whereas when making the choice in subtractive option framing, each deduction
of an option constitutes a loss in utility, but a gain in cost (A. Tversky & Kahneman, 1991).
Considering losses carry a heavier weight to an individual than gains, in the former
condition consumers ultimately choose less options and pay a total lower price than in the
latter condition.
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2.8.2.2 Price order effect
In a similar fashion to options framing, price – order effect, whereby prices are presented
gradually increasing or decreasing (without options being explicit and provided to the
individual to customize) also demonstrates differential choices for consumers (Suk et al.,
2012). When provided with a price list starting from the highest to the lowest, individuals
tend to purchase more expensive items, than when presented with a price list in an
ascending order (Suk et al., 2012).

2.9 Debiasing
Debiasing refers to approaches, techniques, and methods aimed at minimizing, or
eradicating the effects of cognitive biases (Fischhoff, 1982). It can be done by providing
the decision maker with warning messages and explanations of bias, or training them on
task execution (Fischhoff, 1982).
Due to the profound impact of the anchoring effect on human judgment, extant research
has attempted to debias it – or find alleviating mechanisms - in various contexts, such as
estimation of productivity - in software engineering (Haugen, 2006; Mair, Shepperd, &
Jorgensen, 2014; Ralph, 2011; Shepperd, Mair, & Jorgensen, 2018), integration of
sequential information in intelligence work (Wickens, Ketels, Healy, Buck-Gengler, &
Bourne, 2010), assessment of weather conditions by pilots (Walmsley & Gilbey, 2017),
health-related and medical judgments (Lau & Coiera, 2009; Ludolph, Allam, & Schulz,
2016; Mumma & Wilson, 1995) as well as numeric estimates (Block & Harper, 1991; G.B.
Chapman & Johnson, 1994; Hoch & Schkade, 1996; Smith & Windschitl, 2015; Welsh,
Begg, & Bratvold, 2007), and specifically, price evaluation (George, Duffy, & Ahuja,
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2000), item value estimations (Gretchen B. Chapman & Johnson, 1999) and offer values
in market negotiations (Galinsky & Mussweiler, 2001; Ritov, 1996; Whyte & Sebenius,
1997).
These studies use a variety of approaches to address anchoring mitigation, and in addition
to particular methods or tools used for debiasing, research has attempted to investigate
boundary effects of anchoring and tried to utilize that knowledge to minimize its effect,
also in the context of numerical assessments (G.B. Chapman & Johnson, 1994).
Extant attempts to alleviate the anchoring effect with a decision support system or
information presentation, are scarce.
(George et al., 2000) designed and developed a decision tool to support user’s decision
making for house price evaluations. The tool included basic information about and photos
of the house to be appraised, information on other houses (available for sale or recently
sold), pricing advice and clues (factors that influence property appraisal value such as its
distinctiveness, prices of comparable houses, or seller’s emotional approach to the
decision) and a warning message. The warning message advised the user from estimating
the house value around the anchor price and were shown to the user if their appraised price
was too close to the anchor price (+-10% or +-20% within the range of the anchor). The
authors investigated whether differences such as a striking message (presented in bright
red and large font) vs simple one, would have a differential effect on user’s estimated value,
however there was no difference for the messages in either format. Their intervention was
unsuccessful though, in that the provision of the warning message had a significant impact
on the number of times the users changed their appraised value, but did not influence the
value itself or its distance from the anchor (George et al., 2000).
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(Lau & Coiera, 2009) aimed to mitigate order effect (anchoring one’s judgment based on
the time and order of information presentation) - which can occur in users’ online
information search processes - in order to positively impact the outcomes of these search
(user’s conceptual understanding and confidence in their knowledge). The authors focused
on healthcare consumers’ search for medical information using a search engine, as they
had previously reported order effect during its use (Lau & Coiera, 2007). The authors noted
that after the user retrieves documents in their search, the way these records were ordered
will influence user’s perception and understanding of the concepts ingrained in them, and
thus their proposed debiasing solution constituted an interface to the search engine, which
would reorganize these records in an order counter to the initial order bias (Lau & Coiera,
2009). The rearrangement of the records was carried out by an algorithm designed to model
the initial order effect. The implementation of this debiasing DSS was partially successful,
in that the order effect was mitigated (the authors did not observe a significant order effect
among users using the interface), however it did not have any impact on the accuracy of
user’s answers to conceptual questions, or user’s confidence in those answers (Lau &
Coiera, 2009). The authors however, pointed out that the algorithm they used for debiasing
was not entirely accurate in modeling ordering bias, which could have an impact on its
effectiveness.

2.10 Risk
The very term ‘risk’ may be equivocal, as in the literature it has been defined and
approached in a variety of ways: it has been used to refer to a hazard, probability, or
ramifications of an event (Nicholson, Soane, Fenton-O’Creevy, & Willman, 2005). Despite
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these differences, the most substantial way of defining risk in the literature is the 1)
probability of an adverse outcome and 2) severity of its consequences (Sjoberg, 1999).
These two elements have been used both separately as well as combined.
Scholarship within the stream or prospect theory has so far traditionally defined risk as the
probability that a specific outcome might happen; individuals have to choose between two
options – one which provides a certain outcome, and another one, which provides an
uncertain outcome (Rothman, Bartels, Wlaschin, & Salovey, 2006).
This study focuses on subjective risk (individual’s subjective assessment of the likelihood
of an adverse outcome), whereby the perceived risk constitutes decision maker’s evaluation
of the probability of developing the illness.
2.10.1 Perceived vs. Objective Risk
Scholarship at large differentiates between objective and perceived risk, regard for each
one in literature depending fundamentally on philosophical stance and, in practice, on one’s
objective.
Positivist perspective stresses the importance of objective risk, focuses on its
conceptualization and measurement, and disregards the existence of subjective (perceived)
risk (Mitchell, 1999). Objective risk is quantitative, can be measured, computed and/ or
observed (Knight, 1921). Past occurrences and frequency of a certain event are recorded
and calculated to estimate future level of risk for the event. An objective degree of risk
exists separately from individual’s assessment of it, and signifies ‘authentic’ outcome
probabilities (Conchar, Zinkhan, Peters, & Olavarrieta, 2004).
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Relativist school of thought on the other hand concentrates on individual’s perceived risk
and views it as the main type of risk which should be measured. Both in research and
practice not all perceived risks and their conceptualizations are created equal, and are
strongly embedded (and construct definitions dependent upon) within the context of a
given phenomenon (Conchar et al., 2004). Two factors however have been recognized as
pertinent to the conceptualization of perceived risk: uncertainty and adverse consequences
(Bauer, 1960).
Uncertainty here constitutes lack of exact knowledge of a probability of a future event (in
contradistinction to objective risk which involves computation of such a probability). This
is particularly relevant to everyday situations which consumers find themselves in, where
they are able to neither foresee future events nor evaluate their probabilities (Stone &
Grønhaug, 1993). It is indeed perceived risk which may have the most substantial impact
on consumer behavior and assist the most in explaining consumer behavior (Mitchell,
1999).
Adverse consequences may be defined as ‘importance of loss’ (Taylor, 1974), and have
been distinguished as related to performance, social context, safety, financial and
psychological implications (Jacoby & Kaplan, 1972). Time also poses a level of risk to the
consumer, as product failure may be associated with time loss (e.g. required for repair) or
loss of convenience (Roselius, 1971). These elements may impact consumer’s risk
perception independently, such that when one level of risk raises, a different one may raise,
go down, or remain unchanged. Furthermore, individual in a purchase situation may face
a considerable ‘tradeoff’ across risks, for instance buying overspending on grocery supplies
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for a dinner party may decrease the host’s performance and social risk, but increase their
financial risk (Jacoby & Kaplan, 1972).
Despite the different approaches of positivism and relativism towards risk, it has been
noted that both are rather integrated in their practical approach towards risk (Mitchell,
1999). Positivism recognizes the behavioral effect and implications of perceived risk, thus
the need to measure such risk; while relativism may potentially acknowledge objective
methods considering the relativist and individual standpoint that will be measured.
2.10.1.2 Perceived risk and heuristic processing
Perceived risk is defined as decision maker’s subjective assessment of the probability of
an adverse outcome (P. Slovic, 1987; Paul Slovic, Fischhoff, & Lichtenstein, 1984).
As individuals respond to cues and external stimuli in a dual-mode fashion (Daniel
Kahneman, 2011), they may approach a risk situation: 1) in a logical, reasonable way,
analyzing the implications of choice; or 2) in an intuitive, narrative, and affective way
(Epstein, Pacini, Denes-Raj, & Heier, 1996; Paul Slovic, Finucane, Peters, & MacGregor,
2004). In practice, the majority of risk evaluation is executed spontaneously, via
experiential mode of thinking (Paul Slovic et al., 2004).
When a consumer is faced with a situation or stimuli related to an adverse outcome, he is
likely to process it heuristically, impacting his judgment of risk level and actions taken
upon it (Folkes, 1988; Keller, Siegrist, & Gutscher, 2006; Amos Tversky & Kahneman,
1973). It has been shown, for instance, that individuals exposed to media coverage,
personal past experience, or occurrence in one’s environment of an event, influences the
perceived probability of such an event occurring to the person (D. Kahneman, Slovic, &
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Tversky, 1982; Amos Tversky & Kahneman, 1973). The individual processes this
information via availability heuristic – the ease of recall of event’s exemplar instances
(Amos Tversky & Kahneman, 1973). The ease with which an event can be brought to
consumer’s mind, that is, the retrieval of that event, will guide that individual to judge the
incident’s future occurrence as probable, whereas difficulty of retrieval – as improbable
(Folkes, 1988; Schwarz et al., 1991; Amos Tversky & Kahneman, 1973). Furthermore,
remembering images associated with the event may be connected to individual’s emotion
and affect, thus providing an adaptive response to stimuli, and increasing one’s perceived
risk (Paul Slovic et al., 2004).
Literature has so far explained availability heuristic in terms of the ease of recall of
examples of an instance (Amos Tversky & Kahneman, 1973), ease of retrieval (Schwarz
et al., 1991), and memory accessibility (MacLeod & Campbell, 1992). The more easily the
event can be constructed or imagined, the higher the probability estimate the individual
will assign to it (Schwarz et al., 1991).
2.11 Health insurance purchase choices
When choosing a health insurance plan, consumers tend to pay attention to information on
plan cost and benefits included (Booske, Sainfort, & Hundt, 1999; Tumlinson,
Bottigheimer, Mahoney, Stone, & Hendricks, 1997); they tend to satisfice and their
preferences are largely influenced by their expected (perceived) needs for health services
and cost (Mechanic, 1989). Accordingly, lack of owning health insurance by a large
number of young adults can be at least partially explained by low anticipation of
prospective health services utilization (needs) (Mechanic, 1989). Since health insurance
constitutes a choice of an item which will mitigate the consequences of an adverse
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outcome, rather than a protective measure, the potential adverse outcomes tend not to be
pertinent at the moment of the decision, thus consumers frequently purchase a plan that
covers essentials and minimizes cost (Mechanic, 1989). This differs for consumers
depending on their demographics such as age or health status (Mechanic, 1989). Generally,
policy seekers apply price heuristics and lean towards less expensive plans (Ericson &
Starc, 2012).
Various sociodemographic/personal background, consumers’ cognitive and affective
responses, as well as aspects pertaining to the decision environment can affect consumer’s
choice of a health plan and the way they approach the decision.
Individual’s numeracy and cognitive reflection result in a greater Medicare enrollment
probability, thus indicating that seniors with lower numeracy skills may need to be
provided with support in enrollment (Szrek & Bundorf, 2014). Furthermore, more
numerate individuals, those exhibiting greater understanding of health insurance and those
aligning their decisions to their preferences were more likely to choose a less expensive
plan (Andrew J. Barnes et al., 2015). Personal factors affecting consumer’s overspending
on health insurance plan include individual’s age, race (non-Caucasian) and gender
(females) (Zhou & Zhang, 2012). Consumers with mental conditions were also shown to
purchase cheaper plans that those not suffering from such conditions (spending on average
$10 less per year) (Zhou & Zhang, 2012). Contextual factors such as plan characteristics
also affect overspending (for instance added generic coverage, or choosing a plan without
deductible results in higher overall overspending on policy) (Zhou & Zhang, 2012). Factors
such as gross drug spending, patient’s risk score, chronic conditions, experience did not
contribute to individual’s overspending on insurance policy (Zhou & Zhang, 2012). Task
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complexity (choice set size) and individual’s age constitute drivers of plan comprehension
errors and inconsistency in decision making (Finucane, Mertz, Slovic, & Schmidt, 2005).
They further elaborated that the impact of age may be explicated by social factors, health
profile and one’s cognitive skills such as processing speed, short-term memory, basic
numeracy skills, as well as indices of physical and emotional health (Finucane et al., 2005).
Research has also investigated whether individual’s numeracy significantly predicts his
comprehension and choice of a lower cost plan (Consumer-Directed Health Plan CDHP),
and found that, although less numerate individuals exhibited lower understanding of
CDHP, they were more likely to choose it (Greene, Peters, Mertz, & Hibbard, 2008). The
authors further examined whether format of presentation of alternatives (side-by-side vs
common/unique) could potentially improve health plan comprehension, yet showed mixed
results: a framework highlighting differences across plans improved understanding on
items associated with the framework messaged, but aggravated it on items unrelated to it
(Greene et al., 2008). Individual’s focus on price, rather than taking into consideration
various plan attributes, negatively influences his plan selection and leads to overspending
(Heiss et al., 2013).
In terms of contextual factors, research has mostly discussed the overchoice effect and how
the number of coverage plan options may influence consumer’s decision behavior.
Although literature generally agrees that a greater option set is detrimental to the person’s
choice, the dynamics of how that happens are not exactly clear. On the one hand, research
has analyzed the influence of a larger choice set on decision-making in older and younger
individuals and found that decision performance is higher with only a few options (Wood
et al., 2011). They further showed that seniors’ decision-making performance was
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substantially lower across conditions and that numeracy plays a significant role in decision
performance. Seniority of age and higher number of choices result in poorer choices of
Medicare drug plan, that is picking overly expensive plans (Hanoch, Rice, Cummings, &
Wood, 2009). Numerate individuals perform better when faced with a small set of
alternatives, but not with a large set (Szrek & Bundorf, 2014). They also showed that the
size of option set has very little impact on the performance of less numerate individuals
(Szrek & Bundorf, 2014). On the other hand research has shown that the variation in
potential financial savings across states stems from the differences in alternative sets, not
individuals’ capability to choose (little variation in terms of such characteristics as age or
gender) (Abaluck, Gruber, & NBER, 2011). Numeric price frames (as opposed to
percentage format) and choice set size negatively impact consumer’s policy choice when
decision quality is considered cost minimization (Andrew J. Barnes et al., 2012).
Interestingly, brand names of providers did not have a significant influence on choice
(Andrew J. Barnes et al., 2012). Choice set size has a negative impact on individual’s
choice of a cost minimizing plan and on time spent analyzing attributes of coverage plans
(Andrew J. Barnes et al., 2013). Information overload in the form of too many possible
alternatives may cause individual’s confusion and economically suboptimal choices
(Doonan & Katz, 2015). Consumers tend to use heuristics when purchasing a plan and
overinsure (Kettlewell, 2016). Individual’s decision quality is significantly lower when
choosing bundled products, rather than stand-alone ancillaries cover (Kettlewell, 2016).
Research has investigated different plan cost structures (higher vs lower out-of-pocket
costs for medication the individual might need), and presentation formats, and showed that
consumers make health insurance decisions consistent with expected utility theory
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(consistent choices of either of the plans), and display of information in a graphical format
further supports choice consistency (Bundorf, Mata, Schoenbaum, & Bhattacharya, 2013).
Attempts have been recently made to study presentation formats, and design features of
platforms and decision tools that could support health insurance choice and improve policy
seekers decision making. It has been posited that one of the difficulties of selecting health
insurance coverage is lack of transparency concerning total cost estimates, and investigated
whether demonstration of such information could influence consumer’s decision
performance (A. J. Barnes, Hanoch, Rice, & Long, 2016). Personalized information on
total costs can improve the quality of individual’s health insurance decision (A. J. Barnes
et al., 2016). Based on information processing model, a decision tool tailored to the user’s
preferences and needs, and with an easy to understand presentation of alternatives, has been
proposed (Politi et al., 2016). The tool - Show Me My Health Plans decreases cognitive
burden and raises comprehension through plain language and graphics, interactive
knowledge assessment, personalization of cost estimates, assessment of plan preferences,
and adoption of algorithm to demonstrate best match between user’s needs and available
plans (Politi et al., 2016). By simplifying the complexity of health insurance choices, their
tool could improve consumer’s decision quality, however the empirical evidence is still
lacking (Politi et al., 2016). Users of state health exchanges were more inclined into
choosing a high-value plan when plan information was provided in the form of a summary,
when star rating was attached adjacent to cost data, and when the plan was highlighted with
a checkmark or ribbon (Greene, Hibbard, & Sacks, 2016). The authors found that
individuals who understood quality star rating also performed better in terms of choosing
a high-value plan (Greene et al., 2016). Provision of plan recommendations as a policy tool
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supports users in selecting earnings maximizing plan (Andrew J. Barnes, Hanoch, & Rice,
2016).
2.11.1 Health insurance purchase under high perceived risk
Increased risk perception is associated with demand for insurance in a number of domains
such as natural disasters (Kunreuther, 1996; Seifert, Botzen, Kreibich, & Aerts, 2013).
Although health insurance purchase choice is often driven by legislation and during the
decision process the consumers are largely guided by the cost of the plan (Ericson & Starc,
2012), the individual health insurance market is characterized by adverse selection
(Browne, 1992) and consumers’ personal factors such as health status or medical
consumption can influence their demand for or choices of health insurance (Van de Veen
& van Praag, 1981). Anticipation of health services needs (Mechanic, 1989) and perception
of risk impact demand for coverage (for instance, consumers’ increased perceived risk for
long term care of their parents, is also associated with demand for such insurance) (ZhouRichter, Browne, & Grundl, 2010).
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3 MODEL & HYPOTHESES
3.1 Overall Research Model

Figure 2 Overall research model.

3.2 Study 1 Research Model

Figure 3 Study 1 Research model.
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3.2.2 Definitions of Constructs
Decision support tool refers to an online decision support system facilitating a user’s
decision process; constitutes one type of tool: non-compensatory.
Non-compensatory tool constitutes a list of item alternatives sorted by price in a
descending order (Price High – Low) and differentiates among three forms of output
characteristics: 1) High Price Anchor – whereby the topmost alternative included in the
choice set is asymmetrically dominated with large price increase and slight utility increase;
2) Low Price Anchor – whereby the topmost alternative included in the choice set contains
a slight price increase and slight utility increase and the option beneath it is asymmetrically
dominated; and 3) No Anchor – whereby the choice set does not include the item offered
as topmost options in the first and second choice sets and the topmost option here is
equivalent to the second from the top option in the first (with high price anchor) and second
(with low price anchor) choice sets; this choice set does not contain an asymmetrically
dominated item.
Decision Approach refers to user’s approach when evaluating the given alternatives (or
item attribute packages) and making the choice of an item (or customizing the item), and
it is differentiated as a price heuristics-driven purchase decision approach (considering the
available alternatives in terms of minimization of cost): strong vs. weak.
Decision Quality refers to user’s decision quality when making the choice, that is when
purchasing an item, measured in terms of final plan purchased by the user. Negative
decision quality is constituted by overspending (purchasing a plan with higher price and
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greater extent of coverage), and positive decision quality is constituted by not overspending
(purchasing a plan with lower price and lower extent of coverage).
3.2.3 Hypotheses
In a choice set with an asymmetrically dominated item (better in certain attributes such as
price), which serves as a decoy, the user is inclined to purchase the dominating item (higher
in value) – that is, the target item (Heath & Chatterjee, 1995; Huber et al., 1982). The item
asymmetrically dominated changes the focus of attention of the user away from itself and
other options offered in the choice set and directs it towards the item greater in value.
In a choice set with the top item asymmetrically higher in price but not in utility (substantial
increase in price but small increase in utility) (here referred to as NC Descending with a
high-price anchor), the item with a small decrease in utility but a substantial decrease in
price constitutes higher value, therefore the user will be inclined into purchasing it. In such
a case the top item offered at a much higher price shifts the focus towards the item with a
lesser extent of utility and greater decrease in price.
In a choice set including an item with a small decrease in price and small decrease in utility
compared to the top item (here referred to as NC Ascending with a low-price anchor), the
top item constitutes a higher value to the user, thus the user will be inclined into purchasing
it.
In a choice set which does not include the top item - with either a high or small – increase
in price (here referred to as NC Descending with no anchor), that is a choice set which
lacks an asymmetrically dominated option, the user will purchase an item lower in price
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and utility than if they were to choose from a choice set with a small increase in price and
utility.
H1. The effect of the usage of NC Descending tool with a low-price anchor will be negative
and the effects of usage of NC Descending tool with a high-price anchor and NC
Descending tool with no anchor on user’s decision quality will be positive, such that:
H1A. Users will purchase the health plan with greatest coverage and highest price with
NC Descending tool with a low-price anchor more frequently than with NC Descending
tool with high-price anchor.
H1B. Users will purchase the second-most expensive and second in terms of extent of
coverage – health plan using NC Descending tool with a high-price anchor more frequently
than with NC Descending with a low-price anchor.
H1C. Users will purchase the health plan with greatest coverage and highest price with
NC Descending tool with a low-price anchor more frequently than with NC Descending
with no anchor.

In situations of risk individuals engage in avoidance or precautionary behavior (Edwards,
1961; Janz & Becker, 1984; Daniel Kahneman & Tversky, 1979); unsafe environments
motivate individuals to take precautionary measures (Paul Slovic & Weber, 2002). Under
high perceived risk consumers engage in information seeking behavior (Kellens, Zaalberg,
& De Maeyer, 2012), search conciliation and exhibit greater intention to prepare for risky
events (Terpstra, 2011), and demonstrate heightened interest in purchasing insurance
policies (Kunreuther, 1996; Zhou-Richter et al., 2010). Severity of the consequences of a
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risky event is associated with individual’s perceived importance of owning precautionary
measures (such as insurance) to them (Sjoberg, 1999). The greater the seriousness of a
risky occurrence, the greater the value of having a risk mitigation measure to the consumer.
Health insurance constitutes a peculiar type of precautionary measure, in the sense that it
doesn’t carry the meaning of protection per se, but merely alleviates the possible
consequences of the adverse outcome. Consumers generally do not self-insure; and they
do exhibit a general tendency to minimize cost incurred during insurance purchase (once
the purchase transaction is taking place) (Ericson & Starc, 2012). It is therefore conceivable
that under high perceived risk, consumers will seek to purchase coverage which would
mitigate the possible consequences of an adverse outcome, while at the same time try not
to pay a high price for it. They may for example wish to buy basic coverage which would
enable them to mitigate the consequences of the adverse outcome, but they will still trade
it off against cost minimization.

Therefore, under high perceived risk, the consumer will be willing to purchase an item with
a greater level of extent of coverage to mitigate the consequences of the adverse event.

Users under low perceived risk, who don’t experience an increased subjective probability
of an adverse outcome, are likely to purchase a health plan that mitigates the consequences
of general – most frequent - health adverse outcomes (generic health services) while
minimizing cost. If the asymmetrically dominated and dominant options vary in terms of
the prices and utilities, but utilities only differ in coverage mitigating the consequences of
a specific adverse outcome, it is conceivable that those options will only be of interest to
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the users under high perceived risk. Despite the dominant option offering a high value, it
will not be of interest to the users under low perceived risk and those users will purchase
an option that meets their needs while minimizing cost incurred.
Therefore, the items purchased with NC Descending with a high-price anchor and NC
Descending with a low-price anchor will differ for users under high perceived risk. The
purchase of the most expensive item will not differ significantly across those decision tools
for users under low perceived risk.
H2. Perceived risk moderates the effect of NC Descending with a high-price anchor and
NC Descending with low-price anchor such that the effect of the usage of NC Descending
tool with a low-price anchor will be negative and the effects of NC Descending tool with a
high-price anchor will be positive on user’s decision quality under high perceived risk, but
not under low perceived risk.
Under high perceived risk the users will purchase the health plan with greatest coverage
and highest price with NC Descending tool with a low-price anchor more frequently than
with NC Descending tool with high-price anchor, but there will be no differences in this
plan purchase for users under low perceived risk.

When making a purchase decision, the user trades off the utility of available options vis-àvis the cost association with those utilities. If provided with a choice set containing an
asymmetrically dominated alternative, the user is likely to choose an option that seems of
the most value to them (Heath & Chatterjee, 1995).
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If a user, during their decision – making process, is primarily driven by price heuristics,
that is their focus is on minimizing price and they don’t pay attention to the utility of the
items, they are likely to purchase an item with the lowest price regardless of the utility and
value of the other items in the choice set. Those users will be making their decision solely
on price and the cost-utility trade-off is likely to play a lesser role (Lichtenstein et al., 1988;
Peng, Xia, Fanglin, & Bingyan, 2016). Although in most product or service purchases,
consumers, even those driven by price consciousness, are likely to search for an item that
meets their needs while minimizing cost, in the case of health insurance, it is conceivable
for users to be driven purely by price with no consideration of the coverage benefits. For
those users the effect of the HP Anchor and LP Anchor tools should not differ in terms of
the most expensive plan purchased.
Users not focusing primarily on price minimization should be engaged in cost-utility tradeoff, thus for them the effects of the tools should still hold.
H3. Decision approach moderates the effect of NC Descending with a high-price anchor
and NC Descending with low-price anchor such that the effect of the usage of NC
Descending tool with a low-price anchor will be negative and the effect of NC Descending
tool with a high-price anchor will be positive on user’s decision quality for users driven
weakly by price heuristics, but not for users driven strongly by price heuristics.
Users driven weakly by price heuristics will purchase the health plan with greatest
coverage and highest price with NC Descending tool with a low-price anchor than the item
purchased with NC Descending tool with high-price anchor, but there will be no difference
in this plan purchase for users driven strongly by price heuristics.
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3.3 Study 2 Research Model

Figure 4 Study 2 Research model.

3.3.2 Definitions of Constructs
Decision support tool refers to an online decision support system facilitating a user’s
decision process; differentiates between two types of tools: non-compensatory and
financial.
Non-compensatory (NC) tool constitutes a sorted list of item alternatives, provided in two
formats: 1) descending – whereby the options are sorted by price in descending order
(Price High-Low) and 2) ascending – whereby the options are sorted by price in ascending
order (Price Low-High); and the Financial tool constitutes a list of item attribute packages
and enabling customization of the item.
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Choice sets in non-compensatory descending and financial decision tools are characterized
by gradual decrease of price accompanied with gradual increase of utility, while choice set
in non-compensatory ascending tool is characterized by gradual increase of price
accompanied by gradual increase of utility. Choice sets in NC descending and NC
ascending are the same, and choice set in financial tool is equivalent to them in price and
utility (broken down to enable customization).
Decision Approach refers to user’s approach when evaluating the given alternatives (or
item attribute packages) and making the choice of an item (or customizing the item), and
it is differentiated as a price heuristics-driven purchase decision approach (considering the
available alternatives in terms of minimization of cost): strong vs. weak.
Decision Quality refers to user’s decision quality when making the choice, that is when
purchasing an item, measured in terms of final price paid by the user. Negative decision
quality is constituted by overspending (purchasing a plan with a higher price), and positive
decision quality is constituted by not overspending (purchasing a plan with lower price).

3.3.3 Hypotheses
Consumers institute their price judgments based on the initial price by adopting anchoringand-adjustment heuristic (Northcraft & Neale, 1987; Paul Slovic & Lichtenstein, 1971;
Amos Tversky & Kahneman, 1974). Consumers’ choices are frequently impacted by a
reference standard, as they examine available alternatives against a given point of reference
(A. Tversky & Kahneman, 1991). When they begin consideration of alternatives sorted by
price in an ascending order, they ultimately purchase a less expensive item, than if they
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were to begin the evaluation process with alternatives presented in descending price (Suk
et al., 2012).

Alternatives presented to the users in a hierarchical, price-oriented fashion can invoke
reference dependence, whereby the judgment across cost and benefits is biased by the start
point of the choice set and initiation of the evaluation of alternatives (Suk et al., 2012; A.
Tversky & Kahneman, 1991). Presentation of price in a descending vs. ascending manner,
results in consumers’ choosing a higher price in the former condition and lower in the latter
(ascending) condition (Suk et al., 2012). Thus, users making the choice using a noncompensatory tool when items are sorted by price are subject to reference dependence,
whereby the results of the effect are contingent upon whether the user makes the decision
with a choice set provided to them in an ascending or descending fashion.

When customizing the services that the consumers would like the item to include, they
effectively purchase a smaller number of services when starting from the lowest possible
number of attributes (base model) to the highest (full model) (Levin, Schreiber, Lauriola,
& Gaeth, 2002; C. W. Park et al., 2000). The base item constitutes the reference, and each
addition of an ancillary service constitutes a gain, but a loss in monetary sacrifice (Biswas
& Grau, 2008; Carmon, Wertenbroch, & Zeelenberg, 2003; C. W. Park et al., 2000). The
user ultimately purchases a smaller number of options and smaller price when considering
alternatives starting from the lowest possible number of attributes (base model) to the
highest (full model) (Levin, Schreiber, Lauriola, & Gaeth, 2002; C. W. Park et al., 2000).
The base item constitutes the reference, and each addition of an ancillary service constitutes
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a gain, but a loss in monetary sacrifice (Biswas & Grau, 2008; Carmon et al., 2003; C. W.
Park et al., 2000).
The design of an NC tool generates a list of options sorted by a given attribute (in this case,
price) thus guides the user to evaluate the alternatives starting from the top one, towards
the bottom of the list. The users making the choice with a NC tool with alternatives sorted
by price in a descending fashion are subject to reference dependence, with the top, most
expensive item as their point of reference. Starting from the top option and examining the
alternatives further down the list, the assessment of each alternative is associated with a
loss in benefit but a gain in cost they would have to incur. As losses have a greater impact
on human judgment, the user will be more inclined into purchasing a higher priced option,
not willing to incur a loss in benefit.

Conversely, when making the decision with a non-compensatory tool with options sorted
by price in an ascending fashion, the user begins their evaluation of the alternatives starting
from a low priced one, moving forward with more and more expensive plans. Every new
option being considered is associated with a gain in benefit and a loss in cost possible to
incur (W. C. Park, Jun, & Macinnis, 2000; Suk et al., 2012). As losses exert a greater
influence than possible gains, the user will be more inclined to purchasing a lower priced
option than users making the decision with a non-compensatory tool with options sorted in
a descending fashion. Thus, under high perceived risk, the price paid for the item will be
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higher for users making the decision with NC descending tool than for users making the
choice with NC ascending tool.2

The financial tool is based on customization of packages of attributes starting from the
basic package (base level) up until the full item can be constructed – in a manner equivalent
to the NC ascending tool, presented in two columns.3 As the presentation of the attribute
packages begins with the lowest attribute package, the user begins their examination of all
packages with this option. The first attribute package constitutes a reference point, thus
inducing a cost-benefit analysis with each consecutive option. Addition of each attribute
package constitutes a gain in utility but a loss in price. As losses have a greater impact on
the decision maker than prospective gains, similarly to NC ascending tool, under high
perceived risk, the price paid with the financial tool should be lower than with NC
descending tool.
Furthermore, customization of the item induces the user to consider each attribute package
more thoroughly, encourages a meticulous trade off across attributes as well the attributes
and the costs the user must incur for each one, and moves them away from a screeningdriven evaluation of the available alternatives (Tan et al., 2010). It thus makes them more

Although substantial evidence exists to show that presentation bias has been shown to affect user’s
evaluation of search results (users provided with options generated in a vertical (linear) fashion, tend to be
biased towards top alternatives) (Bar-Ilan et al., 2009), some studies show that sometimes users abandon this
bias, and examine lower ranked records (Keane et al., 2008). It remains inconclusive however, why this
happens. It is conceivable that both reference dependence as well as presentation bias play a role here,
however, as the choice set size is kept constant in this paper, the results are explained in terms of reference
dependence (A. Tversky & Kahneman, 1991; Amos Tversky & Kahneman, 1974), rather than presentation
bias (Bar-Ilan et al., 2009). However, it is conceivable that using customization-based tool would alleviate
presentation bias (as well as reference dependence) – further research adopting various choice set sizes could
test this.
2

3

The design of the Financial tool assumes the user examines the options in an F-fashion.
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involved with the information on available items and promotes a switch from heuristic
processing towards more analytical-focused processing. Active and engaged processing of
information by the decision maker is associated with less biased judgments (Hedwig &
Natter, 2005). Particularly in situations when the user predominantly concentrates on a
single parameter, such as price, it can be argued that customization encourages a shift from
focusing primarily on that particular parameter and facilitating the user to pay more
attention to utility as well, by enforcing cost-utility analysis.
Additionally, as part of financial tool design, the total price for the item which the user
customizes is presented to them on a separate page, after the user has completed the
customization process. The user is initially provided with the list of attribute packages to
choose from, they then confirm that they have completed the customization with a button
to move further, and then they are provided with a confirmation of all the attribute packages
they have chosen as well as the total price for the item. The design rationale for this feature
is that the overall price the user would have to pay is presented to them independently of
any other price points. It is therefore expected that the user would examine the total price
more objectively, and not in comparison to a different one. The tool provides the user with
prices for each individual attribute package, which further enables them to refocus their
attention from the total price to the separate additional costs the user would have to incur
while adding the options.
Last, but not least, the confirmation page with the customized item and its total price, which
follows the customization of the item, includes a warning message with a question for the
user to affirm their choice and mentions potentially lower priced options. The incorporation
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of such a prompt is designed to further encourage the user to reconsider their decision and
motivate to re-customize their item onto a less expensive one.
Thus, it is hypothesized that usage of NC Descending tool, subjecting the user to reference
dependence starting from a high priced alternative, will result in higher price paid by the
user, therefore lower decision quality; while usage of NC Ascending and Financial tools,
subjecting the user to reference dependence starting from a low price, will result in a lower
price paid and, thus higher decision quality.
H4. The effect of usage of an NC Descending tool on users’ decision quality will be
negative and the effects of usage of NC Ascending and Financial tools on user’s decision
quality will be positive, such that:
H4A. The price paid for health plan will be higher using NC Descending tool than when
using NC Ascending tool;
and H4B. The price paid for health plan will be higher using NC Descending tool than
when using Financial tool.

When provided with customizable attribute options which can constitute either essential or
tangential attributes, the price paid for chosen options and the number of tangential options
chosen for purchase are higher when beginning evaluation of alternatives from full model
than when beginning from base model (Jin, He, & Song, 2012). When considering the
essential options for purchase, there is no difference in the number of options chosen or the
price paid for them. Additionally, when presented with customizable attribute options
either starting from a full or base model, with options being important and unimportant,
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the users who customize their item starting from a full model purchase more options
considered less important than those who begin their item customization from a base model
(W. C. Park et al., 2000). There is no difference in choosing the number of important
options by users customizing either starting from full or base model (W. C. Park et al.,
2000).
Users under low perceived risk are likely to resonate with health plans including generic
benefits, thus for those users there will be no significant difference in price paid using either
of the decision tools. With a choice set including minimum 6-7/10 of the alternatives
mitigating the consequences of developing a specific medical condition, it can be argued
that such alternatives constitute tangential options for users under low perceived risk. 4
Users under low perceived risk should resonate mostly with options mitigating the
consequences of generic adverse health events – those options should be of interest to them.
Furthermore, as mentioned earlier, users who are under low perceived risk are likely to
search for a health plan that would cover general – most common – health outcomes, while
users under high perceived risk will be interested in purchasing a plan that would mitigate
the consequences of (cover the cost of health services related to) that adverse outcome. If
the output content of the decision tools contains lower priced options (5/10 covering
generic and cancer health services and of those 2/5 cover only generic health services), the
users under low perceived risk should only be interested in those plans. Users under low
perceived risk are likely to consider only among the options related to generic health
services.

4

Although Plan Bronze Plus II covers only skin cancer and specifically targets this medical condition, it can
be argued that Plan Silver, which is a level higher (as presented in NC Descending tool) covering all types
of cancers, is also relatable to users under low perceived risk – covering general, various types of cancer.
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Therefore, for users under low perceived risk examining the health plans using NC
Descending, NC Ascending tool and Financial tools will result in no difference in price
paid.
For users under high perceived risk, 6-8/10 options relate to skin cancer (7) or cancer, thus
those users should resonate with the majority of the choice set. However, since 5/10 health
plans are designed in such a way that there is a gradual increase in coverage (cash amount)
for the same benefits, the users under high perceived risk should engage in cost-utility
analysis when making the decision (at minimum for those 5 plans). Although all the options
may be of general interest to the users under high perceived risk, if the options differ in the
level of coverage purchased, they do not represent the same utility to the users (they do not
simply constitute various benefits), thus, the decision is still subject to reference
dependence.
Therefore, for the users under high perceived risk using NC Descending tool will result in
a higher price paid (thus, lower decision quality), than using NC Ascending and Financial
tools (thus, higher decision quality).

H5. Perceived risk moderates the effect of NC Descending, NC Ascending, and Financial
tools on users’ decision quality such that the effect of usage of an NC Descending tool on
users’ decision quality will be negative and the effects of usage of NC Ascending and
Financial tools on user’s decision quality will be positive under high perceived risk but not
under low perceived risk.
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Under high perceived risk:

H5A. The price paid for health plan will be higher using NC Descending tool than when
using NC Ascending tool, but there will be no differences for users under low perceived
risk;
and H5B. The price paid for health plan will be higher using NC Descending tool than
when using Financial tool, but there will be no differences for users under low perceived
risk.

When the user focuses on the ratio of utility vs. price, they tend to purchase more expensive
items when deliberating on the possible alternatives starting from the highest priced (full
model) to the lowest priced (basic model) (Peng, Xia, Fanglin, et al., 2016). This effect
however does not occur when there is lack of trade-off between utilities and costs
associated with them, for instance then the user is motivated purely by the enjoyment and
satisfaction that the purchase can provide them with (Peng, Xia, Ruan, et al., 2016). When
making a purchase choice with NC descending, NC ascending, and financial tools, the user
is subject to reference dependence and the usage of those tools affect the user’s decision
quality, if the decision approach of the user, involves a trade-off across gains and losses. If
the user is driven purely by a single factor during their decision, such as, minimization of
cost, then their manner of considering the alternatives will no longer involve a trade-off
across gains and losses, thus, the differential effects of the tools should no longer hold.
Similarly to options framing effect starting from a base model, each addition of a benefit
will be considered in terms of its utility and potential costs that the users may incur. Thus,
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users who are driven by cost-benefit analysis, will accomplish higher decision quality when
using a customization-based and NC ascending tools than such users making the choice
with NC descending tool. For those users the effect of NC descending tool will be negative.
Although when making purchase choices, consumers can take up different decision
approaches related to their motivations, and, frequently, search for products or services that
meet their needs – even if they are interested in minimizing the price they would have to
pay - the case of health insurance is somewhat different. As consumers frequently are
driven by price heuristics when buying health coverage (Ericson & Starc, 2012), they are
likely to purchase plans for a low price that meet their minimal health services needs. It is
further conceivable that some users who choose a health plan for purchase may be purely
interested in picking a plan that is offered at the lowest price possible without considering
any actual coverage benefits.
It is thus hypothesized that a user who is driven by price heuristics - defined as being driven
primarily by minimization of cost - will not be involved in cost-utility analysis when
examining the available options, and for those users, the effect of NC descending,
ascending, and financial tools will not differ in terms of decision quality attained.

H6. Decision approach moderates the effect of NC Descending, NC Ascending, and
Financial tools on users’ decision quality such that the effect of usage of an NC Descending
tool on users’ decision quality will be negative and the effects of usage of NC Ascending
and Financial tools on user’s decision quality will be positive for users driven weakly by
price heuristics but not for users driven strongly by price heuristics.
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For users driven weakly by price heuristics:

H6A. The price paid for health plan will be higher using NC Descending tool than when
using NC Ascending tool, but there will be no differences for users driven strongly by price
heuristics;
and H6B. The price paid for health plan will be higher using NC Descending tool than
when using Financial tool, but there will be no differences for users driven strongly by
price heuristics.
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4 RESEARCH METHODOLOGY
4.1 Experimental Design
4.1.1 Experimental Design, Participants, & Task
The experiment is similar to the way users evaluate product and service options for
purchase online. Subjects participating in the study have been recruited from several
different sources: a) students attending MBA and Master’s degree programs at two major
US universities in exchange for class credit b) faculty and staff at one of these universities
in exchange for advancing knowledge c) respondents registered at Amazon Mechanical
Turk (AMT) for a small financial incentive5, d) social media users (LinkedIn, Twitter and
Facebook) as a means of advancing knowledge67, and e) users registered to receive the AIS
mailing service (posted a link on AIS World)8. Not all of these segments have been
recruited during the pilots as well as the actual experiment. All data collection has been
done online.
The experiment consists of six major parts: 1) text containing basic information related to
skin cancer (to control for respondents’ knowledge) distributed to the treatment group; 2)
pre-manipulation questionnaire; 3) text containing: 3.a) frequency information, and 3.b)
scenario (combination of methods intended to induce simulation heuristic); 4) decision

5

Age limitations were set up when collecting data on AMT in order to increase the age variance in the final
dataset. US location was not set up as a restriction here.
6

Due to a lack of permission to send a request to faculty and staff to participate, an invitation to this segment
of respondents was not sent out, however, during data collection, certain respondents indicated that they
received it, which was arguably confused with an email sent from AIS mailing service.
7

US location and age above 18 were indicated as restriction for participation.

8

US location and age above 18 were indicated as restriction for participation.
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task; 5) text containing basic information related to skin cancer (to control for respondents’
knowledge) distributed to the control group; and 6) final survey.
First, the participants are randomly assigned to one of two conditions: high perceived risk
and low perceived risk (control). In the treatment group – high perceived risk – each
respondent is provided with a short text with basic information on skin cancer, its
symptoms, risk factors, and treatment options; and further, asked several questions which
function to check respondents’ level of knowledge of skin cancer, and serve as
manipulation checks.
Secondly, both the treatment and control groups are asked questions relating to their
general decision approach and major life events in the past 3 months.
Thirdly, the respondents are randomly assigned to one of two scenarios: 1) a scenario about
visiting a cousin recently diagnosed with skin cancer; or 2) a scenario about visiting a
cousin, having lunch, and hanging out together. Fourthly, each respondent is provided with
a scenario asked to purchase a health insurance plan. As part of the scenarios, the
respondents are then given instructions to purchase a health insurance plan as if they were
in a situation as described in the scenario.
Fourthly, each participant is randomly assigned to one of three websites facilitating their
choice. As part of Study 1, the websites (decision tools) include: 1) Non-compensatory
Descending with a High - Price Anchor; 2) Non-compensatory Descending with a Low Price Anchor; and 3) Non-compensatory Descending with no Anchor. As part of Study 2,
the websites (decision tools) include: 1) Non-compensatory Descending; 2) Noncompensatory Ascending; and 3) Financial (based on customization of options).
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Fifthly, the respondents in the control group are provided with the text with information on
skin cancer and asked a few questions to check their level of knowledge and serve as
manipulation checks.
Sixthly, all respondents (both in the treatment and control group) are provided with a final,
full questionnaire measuring respondent’s perceived risk, experiences with the website,
decision-related constructs, health status, and healthcare utilization.
Finally, the respondents in the treatment group are provided with a short text serving as
discomfort mitigation explaining the manipulation and encouraging them to speak to their
physician to find out their true objective risk for skin cancer.
Participants are split into groups primed by different everyday life situations which might
increase their perceived risk for developing a medical condition (in this case, skin cancer).
The context for perceived risk is constituted by skin cancer, which serves as an example of
an adverse outcome which consumers may face. The choice of skin cancer is motivated by
several reasons: with varying frequency, but it can affect all ages, all races and both genders
(Gloster & Neal, 2006; Mayer, Swetter, Fu, & Geller, 2014; Oberyszyn, 2008; Pearce,
Parker, Cotterill, Gordon, & Craft, 2003), and individuals may still have a perceived sense
of control over what they can do to minimize the occurrence.
The participants are able to make the experimental purchase of a health insurance plan
using one of three types of websites:
•

In Study 1, the tools include:
o A simple sorted list of pre-established plans arranged by price with the top
alternative having a high price (large increase in cost and small increase in utility
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from second from the top alternative to the topmost alternative) and serving as an
anchor
o A simple sorted list of pre-established plans arranged by price with the top
alternative having a price only slightly ($ 1) higher (small increase in utility and
small increase in cost from second from the top alternative to the topmost
alternative) than the second alternative and serving as an anchor
o A simple sorted list of pre-established plans arranged by price with the top
alternative constituting the alternative second from the top in the other tools –
therefore having no anchor
•

In Study 2, the tools include:
o A simple sorted list of pre-established plans arranged by price in descending order
o A simple sorted list of pre-established plans arranged by price in ascending order
o Customization tool enabling the users to pick and choose specific coverage
benefits and construct their insurance plan

Just as it is in the business realm, the health insurance plans offered include different
coverage scopes and levels with corresponding different premium prices. The choice sets
vary in the two studies, with choice sets in Study 1 increasing by price with the number of
coverage benefits, and choice sets in Study 2 increasing by price with the extent of coverage
(in terms of the extent of costs covered by the plan) for the same types of benefits in each
alternative. Prices in Study 1 involve anchors (with large or small increase in cost), while
prices in Study 2 increase – or decrease – gradually.
Both Study 1 and Study 2 are carried out as a joint data collection. An overview of the
experimental design is provided below in Figure 5. The general view – flowchart - of the
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Qualtrics survey encompassing both studies is shown in Figure 6 below and flowcharts for
Study 1 and Study 2 are presented in Figures 7 and 8.

Figure 5 General view of the experimental design.
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Figure 6 Flowchart of overall experimental platform.

68

Figure 7 Flowchart of the experimental design for Study I.
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Figure 8 Flowchart of the experimental design for Study II.
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4.1.2 Experimental Controls
Perceived credibility, reputation and trust for the website and health insurance brand are
controlled mechanically, via web and coverage plans design. The design of both: the
website and plans is done in a generic fashion, without mentioning any specific, wellknown brand names.
Family history of adverse outcome (medical condition) is controlled for mechanically, via
scenario design.
Additionally, although not controlled for, however, to account for knowledge of adverse
outcome, the experimental design includes a scenario providing basic information on the
medical condition and measures perceived comprehension of the information and
respondent’s involvement in reading the text. Prior exposure to the adverse outcome is
measured, however not controlled for.
4.1.3 Demographics measured
Demographics established based on perceived risk literature (Palm, 1999; Sjöberg, Moen,
& Rundmo, 2004), health insurance scholarship (Mathur, Paul, Prasad, & Das, 2015), and
options framing (S. Park & Kim, 2012; Peng, Xia, Fanglin, et al., 2016).
Demographics measured:
•

Gender

•

Age

•

Ethnicity

•

Skin Color
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•

Marital Status

•

Children

•

Highest Educational Level

•

Employment status

•

Occupation

•

Annual Personal Income

•

Annual Household Income

4.2 Decision Tools & Choice Sets
4.2.1 Decision Tools Specifications
4.2.1.1 Non-compensatory Decision Tool Specification
1. Non-compensatory tool constitutes a decision aid supporting the choice of an item
– health insurance plan, by presenting the options as a list pre-sorted by descending
or ascending price (premium). The top leftmost side of the page (above the list)
shows a message that reads: ‘Please browse through the following options and
choose the health insurance plan that you would like to purchase. Hover the mouse
over the benefit to read its explanation. Click the arrow on the bottom of the page
to confirm your choice.’
2. Each row of the list includes basic information pertaining to a particular health plan
(name of plan, premium, and benefits covered).
3. When the user hovers the mouse over a benefit, a pop-up window displays an
explanation of that particular benefit.
4. The leftmost side of each row contains a button enabling the user to select the plan.
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5. To confirm their choice, the user clicks an arrow on the bottom of the screen.
Afterwards, the user is transferred to a follow-up page which provides information
on which plan the user has chosen and asks the question whether the user confirms
they would like to purchase this plan or whether they would like to go back and
choose a different plan.
4.2.1.1.1 Use Case Scenario Non-compensatory Tool

Figure 9 Use case diagram for the Non-compensatory decision tool.
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4.2.1.1.1 Flowchart Non-compensatory Tool

Figure 10 Flowchart of the Non-compensatory decision tool.

4.2.1.2 Financial Tool Specification
1. Financial tool constitutes a decision aid supporting the customization of an item –
health insurance plan – based on provided attributes. The tool presents the attributes
- coverage benefits - as packages that the user can include in their customized plan,
as a list. The top leftmost side of the page (above the list) shows a message that
reads: ‘Please consider below available packages of benefits. Tick the benefit
packages which you would like to include in your customized health insurance plan.
Hover the mouse over each benefit to read its explanation. Click the arrow on the
bottom of the page to confirm your choice.’
2. The list consists of two columns where a row in each column (a cell) corresponds
to information on a specific benefits package. Each cell presents the name of the
benefits package, price per month, and which benefit or benefits the package
includes. To the left of the cell, a button to choose the benefits package is provided.
3. The benefits packages are provided starting from Basic Package and gradually
increasing. The ordering of packages and the possible combinations of customized
plans (and the number of such combinations) that the user can set up, corresponds
to the ordering and choice set in a Non-compensatory tool Ascending.
4. Depending on the ordering of the attribute as well as the limited number of
combinations, for certain benefit packages, if the user has picked out a particular
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package – or packages (depending on the possible customization combinations) –
choosing it/them would automatically open a warning message explaining which
other benefit packages must be purchased along the one(s) picked out.
5. When the user hovers the mouse over a benefit, a pop-up window displays an
explanation of that particular benefit.
6. To confirm their choice, the user clicks an arrow on the bottom of the screen.
Afterwards, the user is transferred to a follow-up page which provides information
on which benefit packages the user has chosen and informs them on the total price
that user has to incur for the customization. The user is further provided with a
question whether they confirm they would like to purchase this plan or whether
they would like to go back and choose a different plan. For plans including
Prescription Medication and above, the user is also provided with a reminder that
there are less costly plans available to customize and what those plans are.
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4.2.1.2.1 Use Case Scenario Financial Tool

Figure 11 Use case diagram for the Financial decision tool.

4.2.1.2.2 Flowchart Financial Tool

Figure 12 Flowchart of Financial decision tool.
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Choice Sets
Study 1
The choice sets for Study 1 are presented in Tables 2-4 below.
Non-compensatory Descending High-Price Anchor
Choice set adopted to study the effect of non-compensatory descending tool with high price
anchor includes 7 alternatives. The number of options of 6-7 in study 1 is chosen as the
optimal number of options that would not cause information overload.
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PLAN &
PREMIUM
COVERAGE BENEFITS
(per
month)
Plan
GOLDEN BASIC BENEFITS CANCER TREATMENT SKIN CANCER BENEFITS
PLUS
• Emergency
• Skin Cancer Integrative Care Services (Chinese
$ 449 per
• Cancer Treatment Services
Medicine, Acupuncture, Massage, Yoga)
month
ALL CANCERS
• Outpatient Care
• Supplements for Skin Cancer Patients
INCLUDING SKIN
• Inpatient Care
• Nutritional Counseling and Support for Skin Cancer
CANCER (both
• Laboratory
Patients
Outpatient
and
Inpatient
Services
• 24/7 Telecare for Skin Cancer Patients
basis)
• Prescription
• Counseling/Therapy (Individual and Relationship) for
Medication
Skin Cancer Patients
• Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) for Skin Cancer Patients
• In-Home Care for Skin Cancer Patients
• Everyday Living Expenses for Skin Cancer Patients –
Mortgage/Rent & Car Payments
• Everyday Living Expenses for Skin Cancer Patients –
Utilities & Groceries
• Travel Expenses for Skin Cancer Patients
• Travel Expenses for Caregivers of Skin Cancer Patients
• Accounting Services for Skin Cancer Patients
• Hospice Care at a Hospice Agency for Skin Cancer
Patients
• Legal Fees - Writing & Executing a Will for Skin Cancer
Patients
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•

Plan
GOLDEN
$ 239 per
month

Funeral Expenses of Deceased Skin Cancer Patients
ADDITIONAL FOR THIS PLAN:
• Grief Counseling and Bereavement Support for
Caregivers of Skin Cancer Patients
Covers all skin cancer benefits except for Grief Counseling & Bereavement Support
BASIC BENEFITS CANCER TREATMENT
• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory
Services
•Prescription
Medication

• Cancer Treatment ALL CANCERS
INCLUDING SKIN
CANCER (both
Outpatient and Inpatient
basis)

SKIN CANCER BENEFITS
•
•
•
•
•
•
•
•
•
•
•
•
•
•
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Skin Cancer Integrative Care Services (Chinese
Medicine, Acupuncture, Massage, Yoga)
Supplements for Skin Cancer Patients
Nutritional Counseling and Support for Skin Cancer
Patients
24/7 Telecare for Skin Cancer Patients
Counseling/Therapy (Individual and Relationship) for
Skin Cancer Patients
Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) for Skin Cancer Patients
In-Home Care for Skin Cancer Patients
Everyday Living Expenses for Skin Cancer Patients –
Mortgage/Rent & Car Payments
Everyday Living Expenses for Skin Cancer Patients –
Utilities & Groceries
Travel Expenses for Skin Cancer Patients
Travel Expenses for Caregivers of Skin Cancer Patients
Accounting Services for Skin Cancer Patients
Hospice Care at a Hospice Agency for Skin Cancer
Patients
Legal Fees - Writing & Executing a Will for Skin Cancer
Patients

•

Plan
SILVER
$ 185 per
month

Plan
BRONZE
PLUS II
$ 132.5
per month

BASIC BENEFITS

Funeral Expenses of Deceased Skin Cancer Patients

CANCER TREATMENT

• Emergency
Cancer Treatment ALL CANCERS INCLUDING SKIN CANCER (both Outpatient and
Services
Inpatient basis)
• Outpatient Care
• Inpatient Care
• Laboratory
Services
• Prescription
Medication
BASIC BENEFITS
CANCER TREATMENT
• Emergency
Cancer Treatment - ONLY SKIN CANCER (both Outpatient and Inpatient basis)
Services
• Outpatient Care
• Inpatient Care
• Laboratory
Services
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Plan
BRONZE
PLUS I
$ 132.5
per month

Plan
BRONZE
$ 80 per
month

Plan
BRONZE
$ 59 per
month

• Prescription
Medication
BASIC BENEFITS
CANCER TREATMENT
• Emergency
Cancer Treatment - ANY OTHER THAN SKIN CANCER (both Outpatient and
Services
Inpatient basis)
• Outpatient Care
• Inpatient Care
• Laboratory
Services
• Prescription
Medication
BASIC BENEFITS
• Emergency Services
• Outpatient Care (does not cover cancer treatment)
• Inpatient Care (does not cover cancer treatment)
• Laboratory Services
• Prescription Medication
BASIC BENEFITS
• Emergency Services
• Outpatient Care (does not cover cancer treatment)
• Inpatient Care (does not cover cancer treatment)
• Laboratory Services
Table 2 Choice set for NC Descending with High Price Anchor tool.

Non-compensatory Descending Low-Price Anchor
Choice set adopted to study the effect of non-compensatory descending tool with low price anchor includes 7 alternatives.
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PLAN &
PREMIUM
(per
month)
Plan
GOLDEN BASIC BENEFITS
PLUS
• Emergency
$ 240 per
Services
month
• Outpatient Care
• Inpatient Care
• Laboratory
Services
• Prescription
Medication

COVERAGE BENEFITS

CANCER TREATMENT SKIN CANCER BENEFITS
• Cancer Treatment ALL CANCERS
INCLUDING SKIN
CANCER (both
Outpatient and Inpatient
basis)

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
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Skin Cancer Integrative Care Services (Chinese
Medicine, Acupuncture, Massage, Yoga)
Supplements for Skin Cancer Patients
Nutritional Counseling and Support for Skin Cancer
Patients
24/7 Telecare for Skin Cancer Patients
Counseling/Therapy (Individual and Relationship) for
Skin Cancer Patients
Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) for Skin Cancer Patients
In-Home Care for Skin Cancer Patients
Everyday Living Expenses for Skin Cancer Patients –
Mortgage/Rent & Car Payments
Everyday Living Expenses for Skin Cancer Patients –
Utilities & Groceries
Travel Expenses for Skin Cancer Patients
Travel Expenses for Caregivers of Skin Cancer Patients
Accounting Services for Skin Cancer Patients
Hospice Care at a Hospice Agency for Skin Cancer
Patients
Legal Fees - Writing & Executing a Will for Skin Cancer
Patients
Funeral Expenses of Deceased Skin Cancer Patients
ADDITIONAL FOR THIS PLAN:

• Grief Counseling and Bereavement Support for
Caregivers of Skin Cancer Patients
Plan
GOLDEN
$ 239 per
month

Covers all skin cancer benefits except for Grief Counseling & Bereavement Support
BASIC BENEFITS

CANCER TREATMENT

• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory
Services
•Prescription
Medication

• Cancer Treatment ALL CANCERS
INCLUDING SKIN
CANCER (both
Outpatient and Inpatient
basis)

SKIN CANCER BENEFITS
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

BASIC BENEFITS
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Skin Cancer Integrative Care Services (Chinese
Medicine, Acupuncture, Massage, Yoga)
Supplements for Skin Cancer Patients
Nutritional Counseling and Support for Skin Cancer
Patients
24/7 Telecare for Skin Cancer Patients
Counseling/Therapy (Individual and Relationship) for
Skin Cancer Patients
Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) for Skin Cancer Patients
In-Home Care for Skin Cancer Patients
Everyday Living Expenses for Skin Cancer Patients –
Mortgage/Rent & Car Payments
Everyday Living Expenses for Skin Cancer Patients –
Utilities & Groceries
Travel Expenses for Skin Cancer Patients
Travel Expenses for Caregivers of Skin Cancer Patients
Accounting Services for Skin Cancer Patients
Hospice Care at a Hospice Agency for Skin Cancer
Patients
Legal Fees - Writing & Executing a Will for Skin Cancer
Patients
Funeral Expenses of Deceased Skin Cancer Patients
CANCER TREATMENT

Plan
SILVER
$ 185 per
month

Plan
BRONZE
PLUS II
$ 132.5
per month

Plan
BRONZE
PLUS I
$ 132.5
per month

Plan
BRONZE
$ 80 per
month

• Emergency
Cancer Treatment ALL CANCERS INCLUDING SKIN CANCER (both Outpatient
Services
and Inpatient basis)
• Outpatient Care
• Inpatient Care
• Laboratory
Services
• Prescription
Medication
BASIC BENEFITS
CANCER TREATMENT
• Emergency
Cancer Treatment - ONLY SKIN CANCER (both Outpatient and Inpatient basis)
Services
• Outpatient Care
• Inpatient Care
• Laboratory
Services
• Prescription
Medication
BASIC BENEFITS
CANCER TREATMENT
• Emergency
Cancer Treatment - ANY OTHER THAN SKIN CANCER (both Outpatient and
Services
Inpatient basis)
• Outpatient Care
• Inpatient Care
• Laboratory
Services
• Prescription
Medication
BASIC BENEFITS
• Emergency Services
• Outpatient Care (does not cover cancer treatment)
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Plan
BRONZE
$ 59 per
month

• Inpatient Care (does not cover cancer treatment)
• Laboratory Services
• Prescription Medication
BASIC BENEFITS
• Emergency Services
• Outpatient Care (does not cover cancer treatment)
• Inpatient Care (does not cover cancer treatment)
• Laboratory Services
Table 3 Choice set for NC Descending with Low Price Anchor.

Non-compensatory Descending No Anchor
Choice set adopted to study the effect of non-compensatory descending tool with no anchor includes 6 alternatives.

PLAN &
PREMIUM
(per
month)
Plan
BASIC BENEFITS
GOLDEN
$ 239 per
month
• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory
Services

COVERAGE BENEFITS
CANCER TREATMENT

• Cancer Treatment ALL CANCERS
INCLUDING SKIN
CANCER (both
Outpatient and Inpatient
basis)

SKIN CANCER BENEFITS

•
•
•
•
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Skin Cancer Integrative Care Services (Chinese
Medicine, Acupuncture, Massage, Yoga)
Supplements for Skin Cancer Patients
Nutritional Counseling and Support for Skin Cancer
Patients
24/7 Telecare for Skin Cancer Patients

•Prescription
Medication

•
•
•
•
•
•
•
•
•
•
•

Plan
SILVER
$ 185 per
month

Plan
BRONZE
PLUS II

BASIC BENEFITS
• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory
Services
• Prescription
Medication
BASIC BENEFITS
• Emergency
Services
• Outpatient Care

Counseling/Therapy (Individual and Relationship) for
Skin Cancer Patients
Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) for Skin Cancer Patients
In-Home Care for Skin Cancer Patients
Everyday Living Expenses for Skin Cancer Patients –
Mortgage/Rent & Car Payments
Everyday Living Expenses for Skin Cancer Patients –
Utilities & Groceries
Travel Expenses for Skin Cancer Patients
Travel Expenses for Caregivers of Skin Cancer Patients
Accounting Services for Skin Cancer Patients
Hospice Care at a Hospice Agency for Skin Cancer
Patients
Legal Fees - Writing & Executing a Will for Skin
Cancer Patients
Funeral Expenses of Deceased Skin Cancer Patients
CANCER TREATMENT

Cancer Treatment ALL CANCERS INCLUDING SKIN CANCER (both Outpatient
and Inpatient basis)

CANCER TREATMENT
Cancer Treatment - ONLY SKIN CANCER (both Outpatient and Inpatient basis)
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$ 132.5
per month

Plan
BRONZE
PLUS I
$ 132.5
per month

Plan
BRONZE
$ 80 per
month

Plan
BRONZE
$ 59 per
month

• Inpatient Care
• Laboratory
Services
• Prescription
Medication
BASIC BENEFITS
CANCER TREATMENT
• Emergency
Cancer Treatment - ANY OTHER THAN SKIN CANCER (both Outpatient and
Services
Inpatient basis)
• Outpatient Care
• Inpatient Care
• Laboratory
Services
• Prescription
Medication
BASIC BENEFITS
• Emergency Services
• Outpatient Care (does not cover cancer treatment)
• Inpatient Care (does not cover cancer treatment)
• Laboratory Services
• Prescription Medication
BASIC BENEFITS
• Emergency Services
• Outpatient Care (does not cover cancer treatment)
• Inpatient Care (does not cover cancer treatment)
• Laboratory Services
Table 4 Choice set for NC Descending with No Anchor.
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Study 1 Explanation of Benefits
(Exemplary benefits for Golden Plus plan and, further, two specific cancer treatment
benefits)

•

Emergency Services

Use of emergency room: ambulance transfer and medical aid in a hospital or emergency
room in acute and urgent situations; life or limb-threatening emergencies.

•

Outpatient Care (does not cover cancer treatment)

Visiting a medical facility and NOT staying overnight for examination, diagnosis,
monitoring, and/or treatment. COVERS ALL ILLNESSES AND CANCERS - EXCEPT
FOR CANCERS.

•

Inpatient Care (does not cover cancer treatment)

Covers any in-hospital care (when patient stays overnight at the hospital), nursing, room,
meals, medication and supplies. Involves staying overnight. COVERS ALL ILLNESSES
AND CANCERS - EXCEPT FOR CANCERS.

•

Laboratory Services

Covers screening and diagnostic laboratory tests when your physician orders them.
Laboratory tests include blood tests, urine tests, and tests on tissue specimens.

•

Prescription Medication
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Covers the cost of prescription drugs and medications as prescribed by your physician.

•

Cancer Treatment - ANY OTHER THAN SKIN CANCER (both Outpatient and
Inpatient basis)

Treatment of ANY CANCER OTHER THAN SKIN CANCER. Covers any needed
therapy: radiation, chemotherapy, immunotherapy, surgery, targeted therapy. Covers both
outpatient and inpatient care.

•

Cancer Treatment - ONLY SKIN CANCER (both Outpatient and Inpatient basis)

Treatment of SKIN CANCERS ONLY. Covers any needed therapy: radiation,
chemotherapy, immunotherapy, surgery, targeted therapy. Covers both outpatient and
inpatient care.

•

Cancer Treatment ALL CANCERS INCLUDING SKIN CANCER (both
Outpatient and Inpatient basis)

Treatment of ALL CANCERS INCLUDING SKIN CANCERS. Covers any needed
therapy: radiation, chemotherapy, immunotherapy, surgery, targeted therapy. Covers both
outpatient and inpatient care.

•

Skin Cancer Integrative Care Services (Chinese Medicine, Acupuncture, Massage,
Yoga)
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Covers complementary therapies to be combined with conventional medical treatment to
help fight the symptoms and side effects of skin cancer treatment. Includes traditional
Chinese medicine, acupuncture, massage therapy and yoga. Only for skin cancer patients.

•

Supplements for Skin Cancer Patients

Covers the cost of over-the-counter medicines and supplements for skin cancer patients.

•

Nutritional Counseling and Support for Skin Cancer Patients

Nutrition therapy services, including assessment and follow-up appointments to support
healthy diet management for skin cancer patients.

•

24/7 Telecare for Skin Cancer Patients

Covers the cost of 24/7 remote care with a physician or nurse provided via telephone or
videoconferencing for skin cancer patients. Care includes medical consultation, advice, and
referrals.

•

Counseling/Therapy (Individual and Relationship) for Skin Cancer Patients

Covers the cost of mental health services, and appointments with a psychiatrist, clinical
psychologist, or a counsellor for individual therapy for skin cancer patients, or relationship
counselling for skin cancer patients and their partners.

•

Cosmetic Items (e.g. wigs) and Services (e.g. scar removal) for Skin Cancer
Patients
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Covers the cost of cosmetic items (e.g. wigs) and services (e.g. reconstructive procedures,
scar removal) for skin cancer patients.">Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) for Skin Cancer Patients.

•

In-Home Care for Skin Cancer Patients

Covers the cost of home health services, including intermittent nursing care, personal care
and homemaker services. Only for skin cancer patients.

•

Everyday Living Expenses for Skin Cancer Patients – Mortgage/Rent & Car
Payments

Covers the cost of mortgage or rent, and car payments for the duration of skin cancer
treatment. Only for skin cancer patients.

•

Everyday Living Expenses for Skin Cancer Patients – Utilities & Groceries

Covers the cost of utilities (electricity, natural gas heating, water, sewage, garbage
disposal) for the duration of skin cancer treatment. Only for skin cancer patients.

•

Travel Expenses for Skin Cancer Patients

Covers travel costs of skin cancer patients. Includes costs of land and/ or air (economy or
coach fares) transport when moving temporarily out of town for skin cancer treatment,
standard accommodation – furnished room with a bathroom (if undergoing outpatient
treatment), and meals when undergoing necessary skin cancer treatment in out-of-town
medical facilities.
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•

Travel Expenses for Caregivers of Skin Cancer Patients

Covers travel costs of 1 caregiver of a skin cancer patient. Includes costs of land and/ or
air (economy or coach fares) transport when moving temporarily out of town for skin
cancer treatment, standard accommodation – furnished room with a bathroom (if
undergoing outpatient treatment), and meals when undergoing necessary skin cancer
treatment in out-of-town medical facilities.

•

Accounting Services for Skin Cancer Patients

Covers the cost of accounting services (one per year) for skin cancer patients.

•

Hospice Care at a Hospice Agency for Skin Cancer Patients

Covers hospice services if patient’s physician confirms the illness is terminal and patient
has given up treatment. Serves patient’s well-being and dignified end of life but does not
treat the illness. Includes: room and board, physician and nursing care, and medication for
symptom control or pain relief. Only for skin cancer patients.

•

Legal Fees - Writing & Executing a Will for Skin Cancer Patients

Covers the cost of legal counseling and support in writing and executing a will of a skin
cancer patient.

•

Funeral Expenses of Deceased Skin Cancer Patients

Covers funeral costs of a deceased skin cancer patient.
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•

Grief Counseling and Bereavement Support for Caregivers of Skin Cancer Patients

Covers costs of post-death grief therapy for family members of a deceased skin cancer
patient. No restrictions in terms of facilities. Covers bereavement assessment, plan of care,
and counseling (until deemed by therapist as necessary).

Study 2
The choice sets for Study 2 are presented in Tables 5-7.

Non-compensatory Descending
Choice set adopted to study the effect of non-compensatory descending tool includes 10
alternatives. The number of options of 10 in study 2 is chosen as not to cause information
overload and as the standard number of options generated by an online non-compensatory
tool on a single page is 10.
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PLAN &
PREMIUM
(per
month)
Plan
GOLDEN
PLUS IV
Premium:
$ 335 per
month

Plan
GOLDEN
PLUS III
Premium:
$ 305 per
month

COVERAGE BENEFITS

BASIC BENEFITS

CANCER TREATMENT SKIN CANCER BENEFITS

• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory
Services
• Prescription
Medication

• Cancer Treatment ALL CANCERS
INCLUDING SKIN
CANCER (both
Outpatient and Inpatient
basis)

BASIC BENEFITS

CANCER TREATMENT SKIN CANCER BENEFITS

• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory
Services

• Cancer Treatment ALL CANCERS
INCLUDING SKIN
CANCER (both
Outpatient and Inpatient
basis)
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• Integrative Care Services up to $ 25,000
• Supplements up to $ 25,000
• Nutritional Counseling and Support up to 5 consultations
per month
• Telecare up to 5 consultations per month
• Counseling/Therapy (Individual and Relationship) up to
5 consultations per month
• Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) up to $ 25,000
• In-Home Care up to 7x per week
• Travel Expenses up to $ 25,000
• Hospice Care at a Hospice Agency up to $ 25,000
• Funeral Expenses of Deceased Skin Cancer Patients up to
$ 25,000

• Integrative Care Services up to $ 20,000
• Supplements up to $ 20,000
• Nutritional Counseling and Support up to 4 consultations
per month
• Telecare up to 4 consultations per month

• Prescription
Medication

Plan
GOLDEN
PLUS II
Premium:
$ 275 per
month

• Counseling/Therapy (Individual and Relationship) up to
4 consultations per month
• Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) up to $ 20,000
• In-Home Care up to 6x per week
• Travel Expenses up to $ 20,000
• Hospice Care at a Hospice Agency up to $ 20,000
• Funeral Expenses of Deceased Skin Cancer Patients up to
$ 20,000

BASIC BENEFITS

CANCER TREATMENT

• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory
Services
• Prescription
Medication

• Cancer Treatment ALL CANCERS
INCLUDING SKIN
CANCER (both
Outpatient and Inpatient
basis)

BASIC BENEFITS

CANCER TREATMENT
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SKIN CANCER BENEFITS
• Integrative Care Services up to $ 15,000
• Supplements up to $ 15,000
• Nutritional Counseling and Support up to 3 consultations
per month
• Telecare up to 3 consultations per month
• Counseling/Therapy (Individual and Relationship) up to
3 consultations per month
• Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) up to $ 15,000
• In-Home Care up to 5x per week
• Travel Expenses up to $ 15,000
• Hospice Care at a Hospice Agency up to $ 15,000
• Funeral Expenses of Deceased Skin Cancer Patients up to
$ 15,000
SKIN CANCER BENEFITS

Plan
GOLDEN
PLUS I
Premium:
$ 245 per
month

Plan
GOLDEN
Premium:

• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory
Services
• Prescription
Medication

BASIC BENEFITS

• Cancer Treatment ALL CANCERS
INCLUDING SKIN
CANCER (both
Outpatient and Inpatient
basis)

CANCER TREATMENT
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•Integrative Care Services up to $ 10,000
•Supplements up to $ 10,000
• Nutritional Counseling and Support up to 2 consultations
per month
•Telecare up to 2 consultations per month
•Counseling/Therapy (Individual and Relationship) up to 2
consultations per month
•Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) up to $ 10,000
•In-Home Care up to 4x per week
•Travel Expenses up to $ 10,000
•Hospice Care at a Hospice Agency up to $ 10,000
•Funeral Expenses of Deceased Skin Cancer Patients up to
$ 10,000
SKIN CANCER BENEFITS

$ 215 per
month

• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory
Services
•Prescription
Medication

Plan
SILVER
$ 185 per
month

BASIC BENEFITS

Plan
BRONZE
PLUS II
$ 132.5
per month

• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory
Services
• Prescription
Medication
BASIC BENEFITS
• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory
Services

• Cancer Treatment ALL CANCERS
INCLUDING SKIN
CANCER (both
Outpatient and Inpatient
basis)

• Integrative Care Services up to $ 5,000
• Supplements up to $ 5,000
• Nutritional Counseling and Support up to 1 consultation
per month
• Telecare up to 1 consultation per month
• Counseling/Therapy (Individual and Relationship) up to
1 consultation per month
• Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) up to $ 5,000
• In-Home Care up to 3x per week
• Travel Expenses up to $ 5,000
• Hospice Care at a Hospice Agency up to $ 5,000
• Funeral Expenses of Deceased Skin Cancer Patients up to
$ 5,000
CANCER TREATMENT

Cancer Treatment ALL CANCERS INCLUDING SKIN CANCER (both Outpatient
and Inpatient basis)

CANCER TREATMENT
Cancer Treatment - ONLY SKIN CANCER (both Outpatient and Inpatient basis)
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Plan
BRONZE
PLUS I
$ 132.5
per month

Plan
BRONZE
$ 80 per
month

Plan
BRONZE
$ 59 per
month

• Prescription
Medication
BASIC BENEFITS
CANCER TREATMENT
• Emergency
Cancer Treatment - ANY OTHER THAN SKIN CANCER (both Outpatient and
Services
Inpatient basis)
• Outpatient Care
• Inpatient Care
• Laboratory
Services
• Prescription
Medication
BASIC BENEFITS
• Emergency Services
• Outpatient Care (does not cover cancer treatment)
• Inpatient Care (does not cover cancer treatment)
• Laboratory Services
• Prescription Medication
BASIC BENEFITS
• Emergency Services
• Outpatient Care (does not cover cancer treatment)
• Inpatient Care (does not cover cancer treatment)
• Laboratory Services
Table 5 Choice set for NC Descending.

Non-compensatory Ascending
Choice set adopted to study the effect of non-compensatory ascending tool includes 10 alternatives.
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PLAN &
PREMIUM
(per
month)
Plan
BRONZE
$ 59 per
month

Plan
BRONZE
$ 80 per
month

Plan
BRONZE
PLUS I
$ 132.5
per month
Plan
BRONZE
PLUS II
$ 132.5
per month

COVERAGE BENEFITS
BASIC BENEFITS
• Emergency Services
• Outpatient Care (does not cover cancer treatment)
• Inpatient Care (does not cover cancer treatment)
• Laboratory Services
BASIC BENEFITS
• Emergency Services
• Outpatient Care (does not cover cancer treatment)
• Inpatient Care (does not cover cancer treatment)
• Laboratory Services
• Prescription Medication
BASIC BENEFITS
CANCER TREATMENT
• Emergency Services
• Outpatient Care
• Inpatient Care
• Laboratory Services
• Prescription Medication
BASIC BENEFITS
• Emergency Services
• Outpatient Care
• Inpatient Care
• Laboratory Services
• Prescription Medication

Cancer Treatment - ANY OTHER THAN SKIN CANCER (both
Outpatient and Inpatient basis)

CANCER TREATMENT
Cancer Treatment - ONLY SKIN CANCER (both Outpatient and
Inpatient basis)
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Plan
SILVER
$ 185 per
month

Plan
GOLDEN
Premium:
$ 215 per
month

Plan
GOLDEN
PLUS I

BASIC BENEFITS

CANCER TREATMENT

• Emergency Services
• Outpatient Care
• Inpatient Care
• Laboratory Services
• Prescription Medication

Cancer Treatment ALL CANCERS INCLUDING SKIN CANCER
(both Outpatient and Inpatient basis)

BASIC BENEFITS

CANCER TREATMENT

SKIN CANCER BENEFITS

• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory Services
•Prescription
Medication

• Cancer Treatment ALL CANCERS
INCLUDING SKIN
CANCER (both
Outpatient and Inpatient
basis)

• Integrative Care Services up to $ 5,000
• Supplements up to $ 5,000
• Nutritional Counseling and Support up to 1 consultation
per month
• Telecare up to 1 consultation per month
• Counseling/Therapy (Individual and Relationship) up to
1 consultation per month
• Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) up to $ 5,000
• In-Home Care up to 3x per week
• Travel Expenses up to $ 5,000
• Hospice Care at a Hospice Agency up to $ 5,000
• Funeral Expenses of Deceased Skin Cancer Patients up
to $ 5,000

BASIC BENEFITS

CANCER TREATMENT

SKIN CANCER BENEFITS
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Premium:
$ 245 per
month

Plan
GOLDEN
PLUS II
Premium:
$ 275 per
month

• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory Services
• Prescription
Medication

• Cancer Treatment ALL CANCERS
INCLUDING SKIN
CANCER (both
Outpatient and Inpatient
basis)

BASIC BENEFITS

CANCER TREATMENT

SKIN CANCER BENEFITS

• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory Services
• Prescription
Medication

• Cancer Treatment ALL CANCERS
INCLUDING SKIN
CANCER (both
Outpatient and Inpatient
basis)

• Integrative Care Services up to $ 15,000
• Supplements up to $ 15,000
• Nutritional Counseling and Support up to 3 consultations
per month
• Telecare up to 3 consultations per month
• Counseling/Therapy (Individual and Relationship) up to
3 consultations per month
• Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) up to $ 15,000
• In-Home Care up to 5x per week
• Travel Expenses up to $ 15,000
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•Integrative Care Services up to $ 10,000
•Supplements up to $ 10,000
• Nutritional Counseling and Support up to 2 consultations
per month
•Telecare up to 2 consultations per month
Counseling/Therapy (Individual and Relationship) up to 2
consultations per month
•Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) up to $ 10,000
•In-Home Care up to 4x per week
•Travel Expenses up to $ 10,000
•Hospice Care at a Hospice Agency up to $ 10,000
•Funeral Expenses of Deceased Skin Cancer Patients up to
$ 10,000

• Hospice Care at a Hospice Agency up to $ 15,000
• Funeral Expenses of Deceased Skin Cancer Patients up
to $ 15,000
Plan
GOLDEN
PLUS III
Premium:
$ 305 per
month

Plan
GOLDEN
PLUS IV
Premium:
$ 335 per
month

BASIC BENEFITS

CANCER TREATMENT

SKIN CANCER BENEFITS

• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory Services
• Prescription
Medication

• Cancer Treatment ALL CANCERS
INCLUDING SKIN
CANCER (both
Outpatient and Inpatient
basis)

• Integrative Care Services up to $ 20,000
• Supplements up to $ 20,000
• Nutritional Counseling and Support up to 4 consultations
per month
• Telecare up to 4 consultations per month
• Counseling/Therapy (Individual and Relationship) up to
4 consultations per month
• Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) up to $ 20,000
• In-Home Care up to 6x per week
• Travel Expenses up to $ 20,000
• Hospice Care at a Hospice Agency up to $ 20,000
• Funeral Expenses of Deceased Skin Cancer Patients up
to $ 20,000

BASIC BENEFITS

CANCER TREATMENT

SKIN CANCER BENEFITS

• Emergency
Services
• Outpatient Care
• Inpatient Care
• Laboratory Services

• Cancer Treatment ALL CANCERS
INCLUDING SKIN
CANCER (both
Outpatient and Inpatient
basis)

• Integrative Care Services up to $ 25,000
• Supplements up to $ 25,000
• Nutritional Counseling and Support up to 5 consultations
per month
• Telecare up to 5 consultations per month
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• Prescription
Medication

• Counseling/Therapy (Individual and Relationship) up to
5 consultations per month
• Cosmetic Items (e.g. wigs) and Services (e.g. scar
removal) up to $ 25,000
• In-Home Care up to 7x per week
• Travel Expenses up to $ 25,000
• Hospice Care at a Hospice Agency up to $ 25,000
• Funeral Expenses of Deceased Skin Cancer Patients up
to $ 25,000
Table 6 Choice set for NC Ascending.
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Financial
Choice set adopted to study the effect the financial tool includes 9 attribute packages
which are possible to be customized into 10 items.

BASIC PACKAGE
$ 59 per month
•
•
•
•

ADDITIONAL BENEFITS
$ 21 per month

Emergency Services
Outpatient Care (does not cover
cancer treatment)
Inpatient Care (does not cover cancer
treatment)
Laboratory Services

•

CANCER COVERAGE
- CANCERS OTHER THAN SKIN
CANCER
$ 52.5 per month

CANCER COVERAGE
- SKIN CANCER ONLY
$ 52.5 per month
•

•

Prescription Medication

Cancer Treatment - Any Cancer
OTHER Than Skin Cancer
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Cancer Treatment - ONLY Skin
Cancer

SKIN CANCER
- MISCELLANEOUS
$ 30 per month

SKIN CANCER
- MISCELLANEOUS
$ 30 per month

(These benefits are only for Skin
Cancer Patients)

(These benefits are only for Skin
Cancer Patients)

Expense coverage & services

Additional expense coverage &
services

•
•
•
•
•
•
•
•
•
•

Integrative Care Services up to $
5,000
Supplements up to $ 5,000
Nutritional Counseling and
Support up to 1 consultation per
month
Telecare up to 1 consultation per
month
Counseling/Therapy (Individual and
Relationship) up to 1 consultation per
month
Cosmetic Items (e.g. wigs) and
Services (e.g. scar removal) up to $
5,000
In-Home Care up to 3x per week
Travel Expenses up to $ 5,000
Hospice Care at a Hospice Agency $
5,000
Funeral Expenses of Deceased Skin
Cancer Patients $ 5,000

•
•
•
•
•
•
•
•
•
•

Integrative Care Services $ 5,000
Supplements $ 5,000
Nutritional Counseling and
Support 1 consultation per month
Telecare 1 consultation per month
Counseling/Therapy (Individual and
Relationship) 1 consultation per
month
Cosmetic Items (e.g. wigs) and
Services (e.g. scar removal) $ 5,000
In-Home Care 1x per week
Travel Expenses $ 5,000
Hospice Care at a Hospice Agency $
5,000
Funeral Expenses of Deceased Skin
Cancer Patients $ 5,000

SKIN CANCER
- MISCELLANEOUS
$ 30 per month

SKIN CANCER
- MISCELLANEOUS
$ 30 per month

(These benefits are only for Skin
Cancer Patients)

(These benefits are only for Skin
Cancer Patients)

Additional expense coverage &
services

Additional expense coverage &
services

•
•
•
•
•

Integrative Care Services $ 5,000
Supplements $ 5,000
Nutritional Counseling and Support 1
consultation per month
Telecare 1 consultation per month
Counseling/Therapy (Individual and
Relationship) 1 consultation per
month
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•
•
•
•
•

Integrative Care Services $ 5,000
Supplements $ 5,000
Nutritional Counseling and
Support 1 consultation per month
Telecare 1 consultation per month
Counseling/Therapy (Individual and
Relationship) 1 consultation per
month

•
•
•
•
•

•

Cosmetic Items (e.g. wigs) and
Services (e.g. scar removal) $ 5,000
In-Home Care 1x per week
Travel Expenses $ 5,000
Hospice Care at a Hospice Agency $
5,000
Funeral Expenses of Deceased Skin
Cancer Patients $ 5,000

•
•
•
•

Cosmetic Items (e.g. wigs) and
Services (e.g. scar removal) $ 5,000
In-Home Care 1x per week
Travel Expenses $ 5,000
Hospice Care at a Hospice Agency $
5,000
Funeral Expenses of Deceased Skin
Cancer Patients $ 5,000

SKIN CANCER
- MISCELLANEOUS
$ 30 per month
(These benefits are only for Skin
Cancer Patients)
Additional expense coverage &
services
•
•
•
•
•
•
•
•
•
•

Integrative Care Services $ 5,000
Supplements $ 5,000
Nutritional Counseling and Support 1
consultation per month
Telecare 1 consultation per month
Counseling/Therapy (Individual and
Relationship) 1 consultation per
month
Cosmetic Items (e.g. wigs) and
Services (e.g. scar removal) $ 5,000
In-Home Care 1x per week
Travel Expenses $ 5,000
Hospice Care at a Hospice Agency $
5,000
Funeral Expenses of Deceased Skin
Cancer Patients $ 5,000

Table 7 Choice set and display of attribute packages in Financial tool.
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Study 2 Explanation of Benefits
(Exemplary benefits for Golden Plus IV plan and, further, two specific cancer treatment
benefits)

•

Emergency Services

Use of emergency room: ambulance transfer and medical aid in a hospital or emergency
room in acute and urgent situations; life or limb-threatening emergencies.

•

Outpatient Care (does not cover cancer treatment)

Visiting a medical facility and NOT staying overnight for examination, diagnosis,
monitoring, and/or treatment. COVERS ALL ILLNESSES EXCEPT FOR CANCERS.

•

Inpatient Care (hospitalization and hospital stay; does not cover cancer treatment)

Covers any in-hospital care (when patient stays overnight at the hospital), nursing, room,
meals, medication and supplies. Involves staying overnight. COVERS ALL ILLNESSES
EXCEPT FOR CANCER.

•

Laboratory Services

Covers screening and diagnostic laboratory tests when your physician orders them.
Laboratory tests include blood tests, urine tests, and tests on tissue specimens.

•

Prescription Medication

Covers the cost of prescription drugs and medications as prescribed by your physician.
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•

Cancer Treatment - ANY OTHER THAN SKIN CANCER (both Outpatient and
Inpatient basis)

Treatment of ANY CANCER OTHER THAN SKIN CANCER. Covers any needed
therapy: radiation, chemotherapy, immunotherapy, surgery, targeted therapy. Covers both
outpatient and inpatient care.

•

Cancer Treatment - ONLY SKIN CANCER (both Outpatient and Inpatient basis)

Treatment of SKIN CANCERS ONLY. Covers any needed therapy: radiation,
chemotherapy, immunotherapy, surgery, targeted therapy. Covers both outpatient and
inpatient care.

•

Cancer Treatment - ALL CANCERS INCLUDING SKIN CANCER (both
Outpatient and Inpatient basis)

Treatment of ALL CANCERS INCLUDING SKIN CANCER. Covers any needed therapy:
radiation, chemotherapy, immunotherapy, surgery, targeted therapy. Covers both
outpatient and inpatient care.

•

Skin Cancer Integrative Care Services (Chinese Medicine, Acupuncture, Massage,
Yoga)

Covers up to $ 25,000 of bills for complementary therapies to be combined with
conventional medical treatment to help fight the symptoms and side effects of skin cancer
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treatment. Includes traditional Chinese medicine, acupuncture, massage therapy and yoga.
Only for skin cancer patients.

•

Supplements (Nonprescription Drugs) for Skin Cancer Patients

Covers up to $ 25,000 of cost of over-the-counter medicines and supplements for skin
cancer patients.

•

Nutritional Counseling and Support for Skin Cancer Patients

Covers up to 5 consultations per month of nutrition therapy services, including assessment
and follow-up appointments to support healthy diet management for skin cancer patients.

•

Telecare for Skin Cancer Patients

Covers up to 5 consultations per month of remote care with a physician or nurse provided
via telephone or videoconferencing for skin cancer patients. Care includes medical
consultation, advice, and referrals.

•

Counseling/Therapy (Individual and Relationship) for Skin Cancer Patients

Covers up to 5 consultations per month of mental health services, and appointments with a
psychiatrist, clinical psychologist, or a counsellor for individual therapy for skin cancer
patients, or relationship counselling for skin cancer patients and their partners.

•

Cosmetic Items (e.g. wigs) and Services (e.g. scar removal) for Skin Cancer
Patients
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Covers up to $ 25,000 of bills for cosmetic items (e.g. wigs) and services (e.g.
reconstructive procedures, scar removal) for skin cancer patients.

•

In-Home Care for Skin Cancer Patients

Covers up to 7 visits per week (8 hrs each) of home health services, including intermittent
nursing care, personal care and homemaker services. Only for skin cancer patients.

•

Travel Expenses to Treatment Centers for Skin Cancer Patients (transportation,
lodging, meals)

Covers up to $ 25,000 of travel costs of skin cancer patients. Includes costs of land and/ or
air (economy or coach fares) transport when moving temporarily out of town for skin
cancer treatment, standard accommodation – furnished room with a bathroom (if
undergoing outpatient treatment), and meals when undergoing necessary skin cancer
treatment in out-of-town medical facilities."

•

Hospice Care at a Hospice Agency for Skin Cancer Patients

Covers up to $ 25,000 of bills for hospice services if patient’s physician confirms the illness
is terminal and patient has given up treatment. Serves patient’s well-being and dignified
end of life but does not treat the illness. Includes: room and board, physician and nursing
care, and medication for symptom control or pain relief. Only for skin cancer patients.

•

Funeral Expenses of Deceased Skin Cancer Patients
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Covers up to $ 25,000 of funeral costs of a deceased skin cancer patient.">Funeral
Expenses of Deceased Skin Cancer Patients up to $ 25,000.

4.3 Variables
4.3.1 Study 1
4.3.1.1 Variable Measurement
Measures for the variables examined in Study 1 are presented in Tables 8-10.
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VARIABLE
DEFINITION
MEASURE
DECISION-RELATED VARIABLES
• DECISION TOOL-RELATED VARIABLES
Decision
Online decision tool constitutes a list of item alternatives sorted by price
Support Tool supporting the
in a descending order (Price High – Low) and
decision process:
differentiates among three forms of output
non-compensatory
characteristics; output including:
with three forms of
1) High Price Anchor – topmost alternative
output
constitutes an anchor with large price increase and
characteristics
slight utility increase;
2) Low Price Anchor – topmost alternative
constitutes an anchor with slight price increase and
slight utility increase;
3) No Anchor – the choice set does not include the
item offered as anchor and the topmost option is
equivalent to the second from the top option in the
first (with high price anchor) and second (with low
price anchor) choice sets
Decision
User’s decision
Final plan: DQnegative: overspending vs. DQpositive:
Quality
quality when making not overspending
the choice, i.e. when
purchasing the item
– health insurance
plan; that is, final
plan purchase:
overspending (plan
with higher price
and great extent of
coverage) vs. not
overspending (plan
with lower price and
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SCALE

CITATION

N/A

(Ariely et al.,
2003; Kamis et
al., 2008; Tan
et al., 2010)

Frequency of
plan purchase

(Andrew J.
Barnes et al.,
2016, 2012; W.
C. Park et al.,
2000)

lower extent of
coverage)
• USER’S DECISION-RELATED VARIABLES
Decision
User’s approach
Please indicate your level of feeling and experience
Approach
when evaluating the for the following:
given alternatives
Just now, when I was choosing the health insurance
(or item attribute
plan…
packages) and
making the choice of • I relied completely on price. – I didn’t rely on
an item (or
price at all.
customizing the
• I wasn’t concerned about coverage benefits at
all. – I was only concerned with coverage
item), i.e. health
benefits.
insurance plan;
• The coverage benefits didn’t matter at all. – The
differentiated as:
coverage benefits were all that mattered.
price heuristicsdriven (considering
the available
alternatives in terms
of minimization of
cost): a) strong vs. b)
weak
RISK BEHAVIOR-RELATED VARIABLES
User’s subjective
Imagining yourself in the scenario, how likely do
Perceived
assessment of the
you think it would be that you would develop skin
Risk
probability of an
cancer?
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Likert 1-7
anchored

(Abaluck &
Gruber, 2011;
Lichtenstein et
al., 1993;
Peng, Xia,
Fanglin, et al.,
2016)

1-9
Not at all Extremely
Likely

(Kaufman,
Bollinger,
Dvoskin, &
Scott, 2012)

adverse outcome,
that is developing
skin cancer, as
imagining
themselves in the
scenario
MEASURING
User’s overall selfrated health status,
chronic conditions
Health Status
and current tobacco
use
User’s expected
needs for health care
utilization
User’s prior
experience of the
adverse outcome, i.e.
Prior
skin cancer: a)
Experience
individual; b)
with Adverse
family-related; and
Outcome
c) friend/
acquaintance related
User’s subjective
Individual
assessment of the
Perceived
probability of an
Risk
Health
Services
Utilization

In general, would you say your health is:
Poor - Fair - Good - Very Good - Excellent

5-point Likert

Do you suffer from any chronic conditions?

Nominal

Do you currently smoke cigarettes?
In the past year, how many inpatient stays or visits
to the emergency room have you had?

Ordinal
Ordinal

Have you ever suffered from skin cancer?

Nominal

Has anyone in your family ever suffered from skin
cancer?

Nominal

Have any of your friends or acquaintances ever
suffered from skin cancer?

Nominal

In your individual life, how likely do you think it
would be that you would develop skin cancer?
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1-9 Not at all
– Extremely
Likely

(Andrew J.
Barnes et al.,
2016; Kuye,
Frank, &
McWilliams,
2013)
(Andrew J.
Barnes et al.,
2016)
(Lang, GieseDavis, Patton,
& Campbell,
2017; Lykins
et al., 2008)

(Kim, PerezStable, &
Wong, 2008)

Knowledge
of Adverse
Outcome

adverse outcome,
that is developing
skin cancer and
[general] cancer as
perceived in their
individual life
User’s knowledge of
the adverse outcome,
i.e. skin cancer: its
occurrence,
manifestation, risk
factors, and possible
treatment options

In your individual life, how likely do you think it
would be that you would develop cancer?

1-9 Not at all
– Extremely
Likely

According to you, to what extent does the text
about skin cancer that you just read contain new or
known information?

1-7 Anchored
Much known
information Much new
information
1-7
Not at all –
Fully

To what extent did you understand the information
presented in the text about skin cancer that you just
read?

(Mevissen,
Meertens,
Ruiter,
Feenstra, &
Schaalma,
2009)

Table 8 Variable measurement for Study 1.

PARTICIPANT
INVOLVEMENT
CHECKS
Task Involvement

DEFINITION

MEASURE

User’s
involvement and
interest in the
experimental
purchase task

When you were choosing the health
insurance plan, to what extent were
you:
• Involved
• Interested
• Putting effort
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SCALE
5-point Likert
Not at all – Very
Not at all – Very
Not at all – A lot

CITATION
(X. Wang & Keh,
2017)

When you were choosing the health
insurance plan, to what extent were
you making the decision as if you
were really making it in real life?
Knowledge of
User’s
Adverse Outcome involvement in
control involvement the control for
knowledge of
adverse outcome

7-point Likert
Not at all Extremely

Which of the following include skin Nominal
cancer risk factors according to the
text that you just read? Tick all that
apply.

N/A

 Skin inflammation
 Exposure to certain
chemicals
 Exposure to sunlight and
use of tanning beds
 Family history of skin
cancer
 Xanthinuria Type 1
Perceived Risk
manipulation
involvement

User’s
involvement in
the manipulation
of perceived risk

What was the medical condition
that your cousin suffered from in
the scenario that you read?
o stage 4 squamos cell carcinoma
o stage 4 melanoma
o stage 2 squamos cell carcinoma
o none of the above
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Nominal

N/A

What was the email about – that
you were said to have received – in
the scenario that you read?

Nominal

o Advice on what health plans I
should purchase.
o Advice on how to prevent skin
cancer.
o My genetic predisposition for
skin cancer.
o There was no email mentioned in
the scenario.
Task
Comprehension

User’s
understanding of
experimental task

Did you understand the purchase
task you were asked to do?

Nominal

N/A

(If chose No) What confused you
about the task?

Table 9 Participant involvement checks for Study 1.

4.3.1.2 Control Variables
Variables controlled for are summarized in the table below.

VARIABLE
DEFINITION
PURCHASE-RELATED FACTORS
Perceived Credibility
User’s perceived credibility of the online
store and brand of the item
Reputation
Reputation of the online store and brand
of the item
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MEANS OF CONTROL
Experimental design
Experimental design

User’s trust in the online store and brand
of the item)
RISK-RELATED VARIABLES
Family History of Adverse
Prior occurrence of adverse outcome in
Outcome
user’s family
Knowledge of Adverse
User’s knowledge of the adverse outcome,
9
Outcome (not controlled)
i.e. skin cancer: its occurrence,
manifestation, risk factors, and possible
treatment options
Trust

Experimental design

Experimental design
Experimental design

Table 10 Control variables in Study 1.

9

Upon consultation with 3 FIU PhD students, it was decided to use a combination of time spent & correct answers given to check for Knowledge of
Adverse Outcome. The text relating to the basic information on skin cancer was rather detailed, and as one of the PhD students indicated, they wouldn’t
remember all the information. Analysis showing the results of the role of this variable in the results is indicated in the Appendix.
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4.3.2 Study 2
4.3.2.1 Variable measurement
Measures for the variables examined in Study 2 are presented below in Tables 11-13.
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VARIABLE
DEFINITION
MEASURE
• DECISION-RELATED VARIABLES
• DECISION TOOL-RELATED VARIABLES
Decision
Online decision Non-compensatory tool (sorted
Support Tool
tool supporting
list of item alternatives):
the decision
descending price and ascending
process: nonprice
compensatory and Financial tool (list of item
financial
attribute packages and enabling
customization of the item)
User’s decision
Final price: DQnegative:
quality when
overspending vs. DQpositive: not
making the
overspending
choice, i.e. when
purchasing the
item – health
insurance plan;
that is, final price
paid for the plan:
overspending vs.
not overspending
USER’S DECISION-RELATED VARIABLES
Decision
User’s approach
Please indicate your level of
Approach
feeling and experience for the
when evaluating
following:
the given
alternatives (or
Just now, when I was choosing
item attribute
the health insurance plan…
packages) and
Decision
Quality
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SCALE

CITATION

N/A

(Aksoy et al., 2006; Kamis et al.,
2008; Suk et al., 2012; Tan et al.,
2010)

Price paid

(Andrew J. Barnes et al., 2016,
2012; W. C. Park et al., 2000)

Likert 1-7
anchored

(Abaluck & Gruber, 2011;
Lichtenstein et al., 1993; Peng,
Xia, Ruan, et al., 2016)

making the choice •
of an item (or
•
customizing the
item), i.e. health
insurance plan;
differentiated as:
•
price heuristicsdriven
(considering the
available
alternatives in
terms of
minimization of
cost): a) strong vs.
b) weak

I relied completely on price.
– I didn’t rely on price at all.
I wasn’t concerned about
coverage benefits at all. – I
was only concerned with
coverage benefits.
The coverage benefits didn’t
matter at all. – The coverage
benefits were all that
mattered.

RISK BEHAVIOR-RELATED VARIABLES
Perceived
User’s subjective Imagining yourself in the
Risk
assessment of the scenario, how likely do you
probability of an think it would be that you would
adverse outcome, develop skin cancer?
that is developing
skin cancer, as
imagining
themselves in the
scenario
MEASURING
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1-9
Not at all Extremely
Likely

(Kaufman et al., 2012)

Health Status

User’s overall
self-rated health
status, chronic
conditions and
current tobacco
use

Health
Services
Utilization

User’s expected
needs for health
care utilization

Prior
Experience
with Adverse
Outcome

User’s prior
experience of the
adverse outcome,
i.e. skin cancer: a)
individual; b)
family-related;
and c) friend/
acquaintance related

In general, would you say your
health is:
Poor - Fair - Good - Very Good Excellent

5-point Likert

Do you suffer from any chronic
conditions?

Nominal

Do you currently smoke
cigarettes?

Ordinal

In the past year, how many
inpatient stays or visits to the
emergency room have you had?

Ordinal

(Andrew J. Barnes et al., 2016)

Have you ever suffered from
skin cancer?

Nominal

(Lang et al., 2017; Lykins et al.,
2008)

Has anyone in your family ever
suffered from skin cancer?

Nominal

Have any of your friends or
Nominal
acquaintances ever suffered from
skin cancer?
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(Andrew J. Barnes et al., 2016;
Kuye et al., 2013)

Individual
Perceived
Risk

Knowledge
of Adverse
Outcome

User’s subjective
assessment of the
probability of an
adverse outcome,
that is developing
skin cancer and
[general] cancer
as perceived in
their individual
life
User’s knowledge
of the adverse
outcome, i.e. skin
cancer: its
occurrence,
manifestation,
risk factors, and
possible treatment
options

In your individual life, how
likely do you think it would be
that you would develop skin
cancer?

1-9 Not at all
– Extremely
Likely

In your individual life, how
likely do you think it would be
that you would develop cancer?

1-9 Not at all
– Extremely
Likely

According to you, to what extent
does the text about skin cancer
that you just read contain new or
known information?

1-7 Anchored (Mevissen et al., 2009)
Much known
information Much new
information
1-7
Not at all –
Fully

To what extent did you
understand the information
presented in the text about skin
cancer that you just read?

(Kim, Perez-Stable, & Wong,
2008)

Table 11 Variable measurement for Study 2.

PARTICIPANT
INVOLVEMENT
CHECKS
Task Involvement

DEFINITION

MEASURE

User’s involvement
and interest in the
experimental
purchase task

When you were choosing the health
insurance plan, to what extent were
you:
• Involved
• Interested
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SCALE
5-point Likert
Not at all – Very
Not at all – Very
Not at all – A lot

CITATION
(X. Wang & Keh,
2017)

• Putting effort

Knowledge of
Adverse Outcome
control involvement

User’s involvement
in the control for
knowledge of
adverse outcome

When you were choosing the health
insurance plan, to what extent were you
making the decision as if you were
really making it in real life?

7-point Likert
Not at all - Extremely

Which of the following include skin
cancer risk factors according to the text
that you just read? Tick all that apply.

Nominal

N/A

Nominal

N/A

 Skin inflammation
 Exposure to certain chemicals
 Exposure to sunlight and use of
tanning beds
 Family history of skin cancer
 Xanthinuria Type 1
Perceived Risk
manipulation
involvement

User’s involvement
in the manipulation
of perceived risk

What was the medical condition that
your cousin suffered from in the
scenario that you read?
o stage 4 squamos cell carcinoma
o stage 4 melanoma
o stage 2 squamos cell carcinoma
o none of the above
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What was the email about – that you
were said to have received – in the
scenario that you read?

Nominal

o Advice on what health plans I should
purchase.
o Advice on how to prevent skin
cancer.
o My genetic predisposition for skin
cancer.
o There was no email mentioned in the
scenario.
Task Comprehension

User’s
understanding of
experimental task

Did you understand the purchase task
you were asked to do?

Nominal

N/A

(If chose No) What confused you about
the task?

Table 12 Participant involvement checks for Study 2.

4.3.2.2 Control Variables
Variables controlled for are summarized in the table below.
VARIABLE
DEFINITION
PURCHASE-RELATED FACTORS
Perceived Credibility
User’s perceived credibility of the online store
and brand of the item
Reputation
Reputation of the online store and brand of
the item
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MEANS OF CONTROL
Experimental design
Experimental design

Trust

User’s trust in the online store and brand of
the item)

RISK-RELATED VARIABLES
Family History of Adverse
Prior occurrence of adverse outcome in user’s
Outcome
family
Knowledge of Adverse
User’s knowledge of the adverse outcome, i.e.
Outcome10 (not controlled)
skin cancer: its occurrence, manifestation, risk
factors, and possible treatment options

Experimental design

Experimental design
Experimental design

Table 13 Control variables in Study 2.

10

Same as in Study 1. Upon consultation with 3 FIU PhD students, it was decided to use a combination of time spent & correct answers given to check
for Knowledge of Adverse Outcome. The text relating to the basic information on skin cancer was rather detailed, and as one of the PhD students indicated,
they wouldn’t remember all the information. Analysis showing the results of the role of this variable in the results is indicated in the Appendix.
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5 DATA ANALYSIS
5.1 Data cleaning & Sample
Prior to the experiment, multiple pilot testing has been carried out varying in choice set
design and scenario characteristics. Final experimental design adopted is delineated earlier,
in Chapter 4.
The data were collected from several sources: social media, FIU Masters students, College
of William and Mary Masters students, and Amazon Mechanical Turk. 198 data points
were removed as they were mostly empty with no decision tool assigned.
In both studies, to calculate the score on involvement with Knowledge of Adverse Outcome
text the correct number of answers were added; if the respondent marked all possible
answers the score was 0, and if they marked the wrong answer and at least one of the correct
answers (not all though), then correct answers were added and counted as final score. The
question was detailed therefore the correct answers were still counted even if the wrong
answer was chosen as well. To calculate the involvement with Perceived Risk scenario, the
answer to the first question – about cousin’s medical condition (correct=1, incorrect=0)
was added to the second question- about email received (correct=1, all possible answers
marked =0, incorrect + correct=0). The wrong answer was mutually exclusive from the
other answers which is why the correct answers were not taken into consideration when
the wrong possibility was chosen as well. In each study respondents who a) took less than
10 seconds to read the text pertaining to knowledge of adverse outcome and answered
wrong to the manipulation check question; OR b) took less than 15 seconds to read scenario
and answered at least one of the manipulations questions wrong, were removed.
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Responses from all data sources were investigated for duplicate participation: data points
from FIU, College of William & Mary, social media, and AIS World were examined in
terms of their demographics both within and across the data sources. No duplicates were
found in these groups. Data points from Amazon Mechanical Turk were investigated based
on the code provided (random code generated per respondent) and worker ID. Age groups
of 60-64, 65-69, 70 and above were merged as one group 60+ due to a recording issue.
For Study 1, 125 data points were removed as they constituted duplicate respondents, 1
was removed, as they indicated they were under 18 years of age despite signing the consent
form, 3 didn’t understand purchase task, 2 didn’t choose a health plan and didn’t answer
second part of the survey, and 40 were removed as they didn’t meet the criteria for time
spent reading and manipulations questions for the scenario and knowledge of adverse
outcome. The data points were further examined in terms of homogeneity of responses: if
a data point contained homogenous responses to the survey questions (by inspecting
variations in questions and responses) and did not exhibit legible and respectable responses
to open-ended questions11, it was removed. This didn’t relate to data points whose
responses were not homogenous and that didn’t provide an answer to the open-ended
questions at all. No data points were removed based on this filter. 27 more data points were
removed as they were missing 80% or above answers to the second part of the survey
(including all of the answers to decision approach items). The final sample for Study 1
included 291 data points.

11

Several open-ended questions were asked as part of the survey, and although the responses to those
questions are not a part of this analysis, they were used here as part of data cleaning to triangulate the
soundness of the dataset.
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For Study 2, 124 data points were removed as they constituted duplicate respondents, 1
indicated that they didn’t understand purchase task, 1 didn’t answer major life events
question properly (suggesting lack of involvement in experiment participation), 19 didn’t
choose a health plan and didn’t answer second part of survey, and 57 were removed as they
didn’t meet the criteria for time spent reading and manipulations questions for the scenario
and knowledge of adverse outcome. The data points were further examined in terms of
homogeneity of responses: if a data point contained homogenous responses to the survey
questions (by inspecting variations in questions and responses) or the responses to the
open-ended questions were not legible, it was removed. This didn’t relate to data points
whose responses were not homogenous and that didn’t provide an answer to the openended questions at all. 3 data points were removed this way.12 21 more data points were
removed as they were missing 80% or above answers to the second part of the survey
(including all answers to decision approach items). The final sample for Study 2 included
261 data points.
In both Study 1 and Study 2, since the respondents had a chance to change their decision,
only their final choice was taken into consideration in the analysis. In Study 1, 5 of the
alternatives in the choice set were merged, leaving Silver, Golden, and Golden Plus options
for the analysis.
The analysis was carried out using IBM SPSS® Statistics.

12

Alternative analysis was carried out using those data points and there were no differences found in terms
of the effects of decision tools, perceived risk moderation, and decision approach moderation.
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5.2 Study 1
5.2.1 Demographics
Demographic information for the sample and their involvement in the experiment for Study
1 is presented in Tables 14-16 below. The sample varied in terms of age, with most of the
respondents being 35 and above (71.6%) but had a slight majority of women (64.6 %), and,
furthermore, the participants were mostly Caucasian (66.3%). Most of the respondents
(75.9%) individually earned USD 60k or less, but the sample varied well in terms of
household income. The participants were mostly in good (39.2%) or very good (27.8%)
health, with a slight prevalence of those with no chronic conditions (56.4%), and largely
no recent major healthcare utilization (77.3 %). Most of the participants have not suffered
from skin cancer (95.5%) and were not directly exposed to it in family (59.5%) and friends
(49.5%). Around 26.5% (10.7%+15.8%) of the respondents had a medium perception for
developing skin cancer and about 30.5% of the participants reported medium perception
for developing cancer (11.3%+19.2%). 35.1% of the respondents indicated that they fully
understood the information on skin cancer provided and 40.5% - almost fully. Most of the
respondents answered correctly to the questions (or most questions) relating to the skin
cancer information: 38.5% answered all 4/4 questions correctly and 33.3% answered 3/4
questions correctly. Most of the respondents scored well on their attention reading the
perceived risk scenario: 47.8% of the participants answered both questions relating to the
perceived risk scenario correctly and 41.2% answered 1 of them correctly. Almost half
(49.1%) of the respondents indicated they were making the purchase choice extremely
similarly to how they would behave in real life and 36.8% - very similarly.
DEMOGRAPHICS
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# OF PARTICIPANTS

PERCENTAGE

0
8
12
12
47
47
43
30
41
51

0
2.7
4.1
4.1
16.2
16.2
14.8
10.3
14.1
17.5

189
102

35.1
64.6

193
18

66.3
6.2

6

2.1

36
28

12.4
9.6

1

.3

9

3.1

8
28
29
48
156
22

2.7
9.6
10.0
16.5
53.6
7.6

76

26.1

165

56.7

7
39
4

2.4
13.4
1.4

Age
Missing:
0
18-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60 and above
Gender
Missing:
1
Male
Female
Ethnicity
Missing:
0
Caucasian
African American
Native American or Alaska
Native
Asian or Pacific Islander
Latino or Hispanic
Native Hawaiian or Other
Pacific Islander
Other
Skin Color
Missing:
0
Dark brown or Black
Medium brown
Light brown
Olive
Fair
Very fair
Marital Status
Missing:
0
Single (never married)
Married (or in a domestic
partnership)
Widowed
Divorced
Separated
Children
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Missing:
0
Yes
No
Highest Educational Level
Missing:
0
High School Diploma or
GED
Some college, no degree
Associate degree (e.g. AA,
AS)
Bachelor’s degree
Master’s degree
Professional degree (e.g.
MD, DDS, DVM)
Doctorate
Employment Status
Missing:
1
Employed (part-time)
Employed (full-time)
Student
including
Student &
Working parttime
including
Student &
Working fulltime
Not employed, looking for
work
Not employed, not looking
for work
Homemaker
Retired
Unable to work
Occupation
Missing:
4
including
More than 1
occupation
Education (student)
Education, Training and
Library (excluding being a
student)
Management
Business and Financial
Operations

187
104

64.3
35.7

30

10.3

63

21.6

34

11.7

107
45

36.8
15.5

5

1.7

7

2.4

59
160
19

-

5

-

9

-

14

-

3

-

19
40
6

-

39
16

-

29

-

18

-

33

-
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Computer and
Mathematical
Architecture and
Engineering
Healthcare Practitioner and
Technical
Healthcare Support
Legal
Sales and Related
Office and Administrative
Support
Arts, Design,
Entertainment, Sports and
Media
Life, Physical and Social
Sciences
Food Preparation and
Serving-related
Transportation and Moving
Building and Grounds
Cleaning and Maintenance
Production
Other
Annual Personal Income
Missing:
0
$0-20,000
$20,001-40,000
$40,001-60,000
$60,001-80,000
$80,001-100,000
More than $100,000
Decline
Household Personal Income
Missing:
1
$0-20,000
$20,001-40,000
$40,001-60,000
$60,001-80,000
$80,001-100,000
More than $100,000
Decline

33

-

8

-

11

-

12
2
34

-

41

-

14

-

4

-

9

-

7

-

3

-

11
57

-

83
87
51
28
19
16
7

28.5
29.9
17.5
9.6
6.5
5.5
2.4

46
66
45
37
37
49
10

15.8
22.7
15.5
12.7
12.7
16.8
3.4
Table 14 Demographics for Study 1.

DEMOGRAPHICS RELATED TO HEALTH STATUS
# OF PARTICIPANTS
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PERCENTAGE

Health Status
Missing:
2
Poor
Fair
Good
Very good
Excellent
Chronic condition
Missing:
5
Yes
No
Error (both Yes & No
indicated)
Cigarette Use
Missing:
1
Regularly
Occasionally
No
Health Services Utilization
Missing:
1
0 inpatient stays or ER
visits
1 inpatient stay or ER visit
More than 1 inpatient stays
or ER visits
Individual perceived risk
for skin cancer
Mean:
5.11
Missing:
0
=0 Not likely at all
1
2
3
4
5
6
7
8
=9 Extremely likely
Individual perceived risk
for cancer
Mean:
5.70
Missing:
0
=0 Not likely at all
1

10
61
114
81
23

3.4
21.0
39.2
27.8
7.9

121
164

41.6
56.4

1

.3

44
25
221

15.1
8.6
75.9

225

77.3

47

16.2

18

99.7

23
29
36
32
31
46
37
41
8
8

7.9
10.0
12.4
11.0
10.7
15.8
12.7
14.1
2.7
2.7

17
22

5.8
7.6
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2
3
4
5
6
7
8
=9 Extremely likely
Prior exposure to skin
cancer (Self)
Missing:
1
Yes
No
Prior exposure to skin
cancer (Family)
Missing:
0
Yes
No
Don’t Know
Prior exposure to skin
cancer (Friends &
Acquaintances)
Missing:
1
Yes
No
Don’t Know

21
23
33
56
52
39
15
13

7.2
7.9
11.3
19.2
17.9
13.4
5.2
4.5

12
278

4.1
95.5

86
173
32

29.6
59.5
11.0

109
144
37

37.5
49.5
12.7

Table 15 Demographics for Study 1 related to respondent's health status.

KNOWLEDGE OF ADVERSE OUTCOME & INVOLVEMENT CHECKS
# OF PARTICIPANTS
PERCENTAGE
Knowledge of Adverse
Outcome
Missing:
1
Mean:
4.09
According to you, to what
extent does the text about
skin cancer that you just
read contain new or known
information?
=1 Much known
information
2
3
4

25

8.6

48
42
34

16.5
14.4
11.7
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5
6
= 7 Much new information
Missing:
0
Mean:
6.01
To what extent did you
understand the information
presented in the text about
skin cancer that you just
read?
=1 Not at all
2
3
4
5
6
=7 Fully
Task Involvement
Mean:
13.72
Missing:
5
When you were choosing
the health insurance plan,
to what extent were you:
• Involved
• Interested
• Putting effort
Mean:
6.25
Missing:
1
When you were choosing
the health insurance plan,
to what extent were you
making the decision as if
you were really making it
in real life?
Not at all
Very little
A little
Somewhat
Moderately
Very
Extremely
Knowledge of Adverse
Outcome control
involvement

72
41
28

24.7
14.1
9.6

1
1
5
12
52
118
102

.3
.3
1.7
4.1
17.9
40.5
35.1

-

-

3
2
1
10
24
107
143

1.0
.7
.3
3.4
8.2
36.8
49.1
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Missing:
1
Which of the following
include skin cancer risk
factors according to the
text that you just read?
0/4 Answers Correct or 5/4
1/4 Answer Correct
2/4 Answers Correct
3/4 Answers Correct
4/4 Answers Correct
Perceived Risk
manipulation involvement
Missing:
0
What was the medical
condition that your cousin
suffered from in the
scenario that you read?

22
7
52
97
112

7.6
2.4
17.9
33.3
38.5

32
120
139

11.0
41.2
47.8

What was the email about
– that you were said to
have received – in the
scenario that you read?
0/2 Answers Correct
1/2 Answer Correct
2/2 Answers Correct

Table 16 Knowledge of Adverse Outcome & Involvement checks for Study 1.

5.2.2 Manipulation checks
Table 17 below demonstrates the methods used to check whether the manipulations of decision
tools and perceived risk had a significant impact on the user: the price they paid for the health plan
and their perceived health risk.

EXPERIMENTAL
MANIPULATION
Decision
• NonTool:
compensatory
Descending
High Price
Anchor
• Noncompensatory

MANIPULATION CHECK
1) Comparison of item
purchased by users of each
of the tools.
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STATISTICAL
TEST
Mantel-Haenszel
test

Descending Low
Price Anchor
• Noncompensatory
Descending No
Anchor
High
Perceived
Risk

Comparison of average
subjective probability of
developing skin cancer as
per scenario

Kruskal-Wallis

Table 17 Methods and statistical tests used for manipulation checks in Study 1.

Mantel-Heanszel test (Linear-by-Linear Association) was carried out as a manipulation
check to test the effects of NC Descending with High Price Anchor, NC Descending with
Low Price Anchor, and NC Descending with No Anchor tools on user’s decision quality.
This test is used for datasets containing ordinal variables and for trends with contingency
tables larger than 2x2. Results for the analysis, as shown in Table 18, indicate that there is
a significant effect of the three decision tools on decision quality (plan purchased) by the
user: χ2MH = 16.237, (1 d.f., N=272) p = .00005. (Full analysis is provided further below)
Kruskal-Wallis test was carried out as a manipulation check to test the effects of the
scenarios on user’s perceived risk. Kruskal-Wallis constitutes a non-parametric test to
compare two or more independent samples. Results for the analysis, as shown in Table 19
and Figure 13, indicate that there is a significant effect of the scenarios on user’s perceived
risk: H = 77.699, (1 d.f., N=289) p = .00000. Boxplots in Figure 10 below indicates that
the perceived risk exhibited by users provided with High Perceived Risk scenario was
significantly higher than that of users provided with Low Perceived Risk scenario.
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MANIPULATION CHECK – DECISION TOOLS
MANTEL-HAENZEL RESULT
Dependent Variable: Plan purchased
Source: Decision tools
Total N
Linear-by-Linear
Degrees of Freedom
Exact Significance (2Association
sided)
272
16.237
1
.00005
Table 18 Manipulation check for decision tools - Study 1.

MANIPULATION CHECK – PERCEIVED RISK
KRUSKAL-WALLIS RESULT
Dependent Variable: Perceived Risk
Source: Scenario
Total N
Test Statistic
Degrees of Freedom Asymptotic Sig. (2sided test)
289
77.699
1
.00000
Table 19 Manipulation check for perceived risk - Study 1.

Figure 13 Boxplots of perceived risk across groups in Study1.
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5.2.3 Hypotheses Testing
5.2.3.1 CROSSTABULATION ANALYSIS FOR PLAN PURCHASED
Cross-tabulation (Mantel-Heanszel test) was carried out to examine the effects of the three
decision tools (NC Descending Anchor HP, NC Descending Anchor LP, and NC
Descending with No Anchor) on user’s decision quality.
Results of cross-tabulation analysis (shown in Table 20 below) indicate that there is a
significant impact of the usage of the three decision tools on user’s decision quality with
χ2MH = 16.237 (1 d.f., N=272), p = .00005.
Users making the purchase choice with NC Descending Anchor LP tool purchased the
Golden Plus plan (most expensive with the greatest extent of coverage) significantly more
frequently than users of the NC Descending Anchor HP tool (p<.05).
Users making the choice with NC Descending tool with HP Anchor purchased the Golden
plan (second most expensive with second highest extent of coverage significantly more
frequently than users making the decision with NC Descending Anchor LP tool (p<.05),
although not significantly more frequently than users of NC Descending tool with No
Anchor. Users purchasing the plan with NC Descending tool with No Anchor purchased
the Golden plan significantly more frequently than users of the NC Descending Anchor LP
tool (p<.05).
There was a significant difference in the frequency of the other plans in the choice set
(Silver & Others) purchased between NC Descending Anchor HP and NC Descending with
No Anchor (p<.05).
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There frequency of purchase of the remaining plans (Silver & Other) in the choice set using
NC Descending Anchor LP did not differ significantly from the other two tools.

CROSSTABULATION RESULTS: Plan Purchased * Decision Tool
NC
NC
NC
Plan
Descending Descending
Descending
Total
Purchased
Anchor HP Anchor LP
NO Anchor
Golden
Count
15a
31b
0c
46
Plus
Residual
-1.7
16.8
-15.1
Golden
Count
50a
13b
32a
95
Residual
34.6
29.3
31.1
Silver &
Count
34a
40a, b
57b
131
Other
Residual
-13.7
-.5
14.1
Each subscript letter denotes a subset of Decision Tool categories whose column
proportions do not differ significantly from each other at the .05 level
Linear-by-Linear Association (1, N=272) = 16.237, (Exact sig.) p =.00005
Phi = .468, (Exact sig.) p = .00000
Cramer’s V = .331, (Exact sig.) p = .00000
Table 20 Crosstabulation analysis for Study 1.

Figure 14 below shows the frequency of the plans purchased across the three decision
tools.
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Figure 14 Frequency of plans purchased across decision tools - Study 1.

5.2.3.2 PERCEIVED RISK MODERATION ANALYSIS
Cross-tabulation (Mantel-Heanszel test) was carried out to examine whether perceived risk
moderates the effects of the three decision tools (NC Descending Anchor HP, NC
Descending Anchor LP, and NC Descending with No Anchor) on user’s decision quality.
Results of cross-tabulation analysis (Table 21 below) indicate that there is a significant
impact of the usage of the three decision tools on user’s decision quality under high
perceived risk with χ2MH = 7.909 (1 d. f., N=146), p = .00499 as well as under low
perceived risk with χ2MH = 4.501 (1 d. f., N=126), p = .03891. However, post-hoc analysis
demonstrates that the dynamics of the effects of these decision tools on user’s decision
quality differ.
The results show that under high perceived risk the dynamics of frequency of plan purchase
was the same as in the general analysis.
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Under high perceived risk, users making the purchase choice with NC Descending Anchor
LP tool purchased the Golden Plus plan (most expensive with the greatest extent of
coverage) significantly more frequently than users of the NC Descending Anchor HP tool
(p<.05). Users making the choice with NC Descending tool with HP Anchor purchased the
Golden plan (second most expensive with second highest extent of coverage significantly
more frequently than users making the decision with NC Descending Anchor LP tool
(p<.05), although not significantly more frequently than users of NC Descending tool with
No Anchor. Users purchasing the plan with NC Descending tool with No Anchor
purchased the Golden plan significantly more frequently than users of the NC Descending
Anchor LP tool (p<.05).
Under high perceived risk, there was a significant difference in the frequency of the other
plans in the choice set (Silver & Others) purchased between NC Descending Anchor HP
and NC Descending with No Anchor (p<.05). The frequency of purchase of the remaining
plans (Silver & Other) in the choice set using NC Descending Anchor LP did not differ
significantly from the other two tools.
The dynamics of plan purchase changed though for users under low perceived risk.
Under low perceived risk, the effect of NC Descending tool with anchor LP changed: there
was no significant difference in the frequency of purchase of the Golden Plus plan across
tools with Anchor LP and Anchor HP. However, under low perceived risk, the frequency
of purchase of plan Golden remained significantly higher when making the choice with NC
Descending with Anchor HP tool than Anchor LP (p<.05). The choice of this plan didn’t
differ significantly in NC Descending tool with No Anchor from the other two tools.
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Also, under low perceived risk there were no significant differences in the purchase of the
remaining plans (Silver & Other) across all three decision tools.
CROSSTABULATION RESULTS: Plan Purchased * Decision Tool*
Perceived Risk
NC
NC
NC
Plan
Descending Descending Descending Total
Purchased
Anchor HP Anchor LP NO Anchor
High
Golden
Count
12a
20b
0c
32
Perceived Plus
Risk
Residual
-2.2
11.9
-9.6
Golden
Count
38a
7b
22a
67
Residual
8.2
-10
1.8
Silver &
Count
15a
10 a, b
22b
47
Other
Residual
-5.9
-1.9
7.8
Low
Golden
Count
3a, b
11b
0a
14
Perceived Plus
Risk
Residual
-.8
5.8
-5.0
Golden
Count
12a
6b
10a, b
28
Residual
4.4
-4.4
.0
Silver &
Count
19a
30a
35a
84
Other
Residual
-3.7
-1.3
5
Each subscript letter denotes a subset of Decision Tool categories whose
column proportions do not differ significantly from each other at the .05
level
High
Linear-by-Linear Association (1, N=146) = 7.907, (Exact sig.) p=.00499
Perceived Phi = .536, (Exact sig.) p =.00000
Risk
Cramer’s V = .379, (Exact sig.) p=.00000
Low
Linear-by-Linear Association (1, N=126) = 4.501, (Exact sig.) p=.03891
Perceived Phi = .373, (Exact sig.) p =.00124
Risk
Cramer’s V = .264, (Exact sig.) p=.00124
Table 21 Crosstabulation results for Study 1 testing perceived risk moderation.

Figures 15 and 16 below show the frequency of plans purchased across the three decision
tools under high and low perceived risk.
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Figure 15 Frequency of plans chosen across decision tools under high perceived risk.

Figure 16 Frequency of plans chosen across decision tools under low perceived risk.
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5.2.3.3 DECISION APPROACH MODERATION ANALYSIS
To compute Strong vs. Weak Price Heuristics-driven Decision Approach, the mean for
decision approach was calculated m=19.3662 (Figure 17 below), and any respondents
scoring 1-19.365 were coded as Strong Price Heuristic and participants scoring 19.3651
and above were coded as driven Weakly by Price Heuristics.
Statistics
Decision Approach
N

Valid

284

Missing

7

Mean

19.3662

Median

19.0000

Std. Deviation

4.70092

Range

24.0

Minimum

4.00

Maximum

28.00
Figure 17 Descriptive statistics for decision approach in Study 1.

Cross-tabulation (Mantel-Heanszel test) was carried out to examine whether decision
approach moderates the effects of the three decision tools (NC Descending Anchor HP,
NC Descending Anchor LP, and NC Descending with No Anchor) on user’s decision
quality.
Results of cross-tabulation analysis (Table 22) indicate that there is a significant impact of
the usage of the three decision tools on user’s decision quality for users driven strongly by
price heuristics with χ2MH = 13.742 (1 d.f., N=132) p = .00016 as well as for those driven
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weakly by price heuristics with χ2MH = 12.108 (1 d.f., N=135), p = .000497. However,
post-hoc analysis demonstrates that the dynamics of the effects of these decision tools on
user’s decision quality differ.
The results show that the dynamics of frequency of plan purchase using the three tools by
users weakly driven by price heuristic resembled the dynamics of the effects of the tools in
the general analysis.
For users driven weakly by price heuristics, users making the purchase choice with NC
Descending Anchor LP tool purchased the Golden Plus plan (most expensive with the
greatest extent of coverage) significantly more frequently than users of the NC Descending
Anchor HP tool (p<.05). Users making the choice with NC Descending tool with HP
Anchor purchased the Golden plan (second most expensive with second highest extent of
coverage significantly more frequently than users making the decision with NC
Descending Anchor LP tool (p<.05), although not significantly more frequently than users
of NC Descending tool with No Anchor. Users purchasing the plan with NC Descending
tool with No Anchor purchased the Golden plan significantly more frequently than users
of the NC Descending Anchor LP tool (p<.05).
For users driven weakly by price heuristics, there was a significant difference in the
frequency of the other plans in the choice set (Silver & Others) purchased between NC
Descending Anchor HP and NC Descending with No Anchor (p<.05). The frequency of
purchase of the remaining plans (Silver & Other) in the choice set using NC Descending
Anchor LP did not differ significantly from the other two tools.
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The dynamics of plan purchase changed though for users driven strongly by price
heuristics.
For users driven strongly by price heuristics, the effect of NC Descending tool with anchor
LP changed: there was no significant difference in the frequency of purchase of the Golden
Plus plan across tools with Anchor LP and Anchor HP. However, for those users, the
frequency of purchase of plan Golden remained significantly higher when making the
choice with NC Descending with Anchor HP tool than both: NC Descending Anchor LP
and with No Anchor (p<.05). The choice of this plan didn’t differ in NC Descending tool
Anchor LP and with No Anchor.
Also, the frequency of purchase of the remaining plans (Silver & Other) for users driven
strongly by price heuristics didn’t differ significantly across NC Descending Anchor HP
and LP. Those plans were however purchased significantly more frequently in NC
Descending tool with No Anchor than with NC descending Anchor HP (p<.05) and Anchor
LP (p<.05).

CROSSTABULATION RESULTS: Plan Purchased * Decision Tool* Decision
Approach
NC
NC
NC
Plan
Descending Descending Descending Total
Purchased
Anchor HP Anchor LP NO Anchor
Strong
Golden
Count
5a, b
7b
0a
12
Price
Plus
Heuristic
Residual
.4
3.1
-3.5
Golden
Count
21a
6b
3b
30
Residual
9.4
-3.8
-5.6
Silver &
Count
25a
30 a
35b
90
Other
Residual
-9.8
.7
9.1
Golden
Count
10a
24b
0c
34
Plus
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Weak
Price
Heuristic

Golden

Residual
Count
Residual

Silver &
Other

Count

-1.1
27a
6.5

13.9
7b
-11.7

-12.8
29a
5.2

63

7a

9a, b

22b

38

Residual
-5.4
-2.3
7.6
Each subscript letter denotes a subset of Decision Tool categories whose
column proportions do not differ significantly from each other at the .05
level
Strong
Linear-by-Linear Association (1, N=132) = 13.742, (Exact sig.)
Price
p=.00016
Heuristic Phi = .432, (Exact sig.) p =.00004
Cramer’s V = .306, (Exact sig.) p=.00004
Weak
Linear-by-Linear Association (1, N=135) = 12.108, (Exact sig.)
Price
p=.000497
Heuristic Phi = .606, (Exact sig.) p =.00000
Cramer’s V = .428, (Exact sig.) p=.00000
Table 22 Crosstabulation results for Study 1 testing decision approach moderation.

Frequency of plan purchased across the three decision tools by users driven strongly and
weakly by price heuristics is shown in Figures 18 and 19 below.

Figure 18 Frequency of plans purchased across the decision tools for users driven strongly by price heuristics.
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Figure 19 Frequency of plans purchased across the decision tools for users driven weakly by price heuristics.

Results of hypothesis testing for Study 1 are summarized in Table 23 below.
HYPOTHESIS
RESULT
H1. The effect of the usage of NC Descending tool
with a low-price anchor will be negative and the
effects of usage of NC Descending tool with a highprice anchor and NC Descending tool with no anchor
on user’s decision quality will be positive, such that:
H1A. Users will purchase the health plan with
greatest coverage and highest price with NC
Descending tool with a low-price anchor more
frequently than with NC Descending tool with
high-price anchor.
H1B. Users will purchase the second-most
expensive and second in terms of extent of
coverage – health plan using NC Descending
tool with a high-price anchor more frequently
than with NC Descending with a low-price
anchor.
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p-value

SUPPORTED

<.05

SUPPORTED

<.05

H1C. Users will purchase a health plan with
greatest coverage and highest price with NC
Descending tool with a low-price anchor more
frequently than with NC Descending with no
anchor.
H2. Perceived risk moderates the effect of NC
Descending with a high-price anchor and NC
Descending with low-price anchor such that the effect
of the usage of NC Descending tool with a low-price
anchor will be negative and the effects of NC
Descending tool with a high-price anchor will be
positive on user’s decision quality under high
perceived risk, but not under low perceived risk.

SUPPORTED

<.05

SUPPORTED

<.05

SUPPORTED

<.05

Under high perceived risk the users will purchase the
health plan with greatest coverage and highest price
with NC Descending tool with a low-price anchor
more frequently than with NC Descending tool with
high-price anchor, but there will be no differences in
this plan purchase for users under low perceived risk.
H3. Decision approach moderates the effect of NC
Descending with a high-price anchor and NC
Descending with low-price anchor such that the effect
of the usage of NC Descending tool with a low-price
anchor will be negative and the effect of NC
Descending tool with a high-price anchor will be
positive on user’s decision quality for users driven
weakly by price heuristics, but not for users driven
strongly by price heuristics.
Users driven weakly by price heuristics will purchase
the health plan with greatest coverage and highest
price with NC Descending tool with a low-price
anchor than the item purchased with NC Descending
tool with high-price anchor, but there will be no
difference in this plan purchase for users driven
strongly by price heuristics.
Table 23 Hypotheses testing for Study 1.
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5.3 Study 2
5.3.1 Demographics
Demographic information for the sample and their involvement in the experiment for Study
2 is presented in Tables 24-26 below. The nature of these demographics is characterized
by a similar pattern to the sample of Study 1. The age of the participants in the sample was
predominantly 35 and above – around 88.8% - and had a majority of women (62.5 %);
furthermore, the participants were mostly Caucasian (70.5%). Most of the participants,
circa 88.8 %, individually earned USD 80k or less, but the sample varied in terms of annual
personal and household income. The participants were mostly in good (45.2%) or very
good (26.8%) health, with a slight prevalence of those with no chronic conditions (54%),
and largely no recent major healthcare utilization (80.8 %). Most of the participants have
not suffered from skin cancer (95.8%) and were not directly exposed to it in family (62.1%)
and friends (54.8%). Around 33% (11.5%+21.5%) of the respondents had a medium
perception for developing skin cancer and about 37.2% of the participants reported medium
perception for developing cancer (11.1%+26.1%). 44.4% of the respondents indicated that
they fully understood the information on skin cancer provided and 34.5% - almost fully.
Most of the respondents answered correctly to the questions (or most questions) relating to
the skin cancer information: 36.8% answered all 4/4 questions correctly and 37.2%
answered 3/4 questions correctly. Most of the respondents scored well on their attention
reading the perceived risk scenario: 47.9% of the participants answered both questions
relating to the perceived risk scenario correctly and 39.8% answered 1 of them correctly.
42.9 % of the respondents indicated they were making the purchase choice extremely
similarly to how they would behave in real life and 30.7% - very similarly.
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DEMOGRAPHICS
Age
Missing:
1
18-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60 and above
Gender
Missing:
1
Male
Female
Ethnicity
Missing:
5
Caucasian
African American
Native American or Alaska
Native
Asian or Pacific Islander
Latino or Hispanic
Other
Skin Color
Missing:
0
Dark brown or Black
Medium brown
Light brown
Olive
Fair
Very fair
Marital Status
Missing:
0
Single (never married)
Married (or in a domestic
partnership)
Widowed
Divorced
Separated
Children
Missing:
0

# OF PARTICIPANTS

PERCENTAGE

0
2
11
15
46
40
35
40
27
44

0
.8
4.2
5.7
17.6
15.3
13.4
15.3
10.3
16.9
99.6

97
163

37.2
62.5

184
19

70.5
7.3

1

.4

25
27
5

9.6
10.3

11
22
23
33
153
19

4.2
8.4
8.8
12.8
58.6
7.3

65

24.9

148

55.9

9
35
6

3.4
13.4
2.3

153

Yes
No
Highest Educational Level
Missing:
1
High School Diploma or
GED
Some college, no degree
Associate degree (e.g. AA,
AS)
Bachelor’s degree
Master’s degree
Professional degree (e.g.
MD, DDS, DVM)
Doctorate
Employment Status
Missing:
0
Employed (part-time)
Employed (full-time)
Student
including
Student &
Working parttime
including
Student &
Working fulltime
Not employed, looking for
work
Not employed, not looking
for work
Homemaker
Retired
Unable to work
Occupation
Missing:
6
including
More than 1
occupation
Education (student)
Education, Training and
Library (excluding being a
student)
Management
Business and Financial
Operations
Computer and
Mathematical

176
85

67.4
32.6

21

8.0

55

21.1

29

11.1

97
48

37.2
18.4

6

2.3

4

1.5

50
153
19

-

5

-

9

-

11

-

1

-

15
19
10

-

28
12

-

23

-

25

-

27

-

27

-
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Architecture and
Engineering
Healthcare Practitioner and
Technical
Healthcare Support
Legal
Sales and Related
Office and Administrative
Support
Arts, Design,
Entertainment, Sports and
Media
Life, Physical and Social
Sciences
Food Preparation and
Serving-related
Transportation and Moving
Building and Grounds
Cleaning and Maintenance
Production
Other
Annual Personal Income
Missing:
0
$0-20,000
$20,001-40,000
$40,001-60,000
$60,001-80,000
$80,001-100,000
More than $100,000
Decline
Household Personal Income
Missing:
0
$0-20,000
$20,001-40,000
$40,001-60,000
$60,001-80,000
$80,001-100,000
More than $100,000
Decline

4

-

17

-

19
5
24

-

35

-

13

-

7

-

10

-

3

-

2

-

12
33

-

65
64
58
43
13
16
2

24.9
24.5
22.2
16.5
5.0
6.1
.8

36
55
48
44
28
47
3

13.8
21.1
18.4
16.9
10.7
18.0
1.1
Table 24 Demographical data for Study 2.

DEMOGRAPHICS RELATED TO HEALTH STATUS
# OF PARTICIPANTS
Health Status
155

PERCENTAGE

Missing:
1
Poor
Fair
Good
Very good
Excellent
Chronic condition
Missing:
9
Yes
No
Error (both Yes & No
indicated)
Cigarette Use
Missing:
1
Regularly
Occasionally
No
Health Services Utilization
Missing:
3
0 inpatient stays or ER
visits
1 inpatient stay or ER visit
More than 1 inpatient stays
or ER visits
Individual perceived risk
for skin cancer
Mean:
4.97
Missing:
2
=0 Not likely at all
1
2
3
4
5
6
7
8
=9 Extremely likely
Individual perceived risk
for cancer
Mean:
5.67
Missing:
4
=0 Not likely at all
1
2

4
56
119
70
12

1.5
21.5
45.2
26.8
4.6

110
141

42.1
54.0

1

4

38
13
208

14.6
5.0
79.7

211

80.8

36

13.8

11

4.2

14
26
36
36
30
56
30
15
6
10

5.4
10.0
13.8
13.8
11.5
21.5
11.5
5.7
2.3
3.8

9
16
27

3.4
6.1
10.3
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3
4
5
6
7
8
=9 Extremely likely
Prior exposure to skin
cancer (Self)
Missing:
0
Yes
No
Prior exposure to skin
cancer (Family)
Missing:
1
Yes
No
Don’t Know
Prior exposure to skin
cancer (Friends &
Acquaintances)
Missing:
0
Yes
No
Don’t Know

21
29
68
33
32
9
13

8.0
11.1
26.1
12.6
12.3
3.4
5.0

11
250

4.2
95.8

79
162

30.3
62.1

93
143
25

35.6
54.8
9.6

Table 25 Demographics for Study 2 related to respondent's health status.

KNOWLEDGE OF ADVERSE OUTCOME & INVOLVEMENT CHECKS
# OF PARTICIPANTS
PERCENTAGE
Knowledge of Adverse
Outcome
Missing:
1
Mean:
3.57
According to you, to what
extent does the text about
skin cancer that you just
read contain new or known
information?
=1 Much known
information
2
3
4

36

13.8

58
41
34

22.2
15.7
13.0
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5
6
= 7 Much new information
Missing:
1
Mean:
6.17
To what extent did you
understand the information
presented in the text about
skin cancer that you just
read?
=1 Not at all
2
3
4
5
6
=7 Fully
Task Involvement
Mean:
13.44
Missing:
1
When you were choosing
the health insurance plan,
to what extent were you:
• Involved
• Interested
• Putting effort
Mean:
6.02
Missing:
1
When you were choosing
the health insurance plan,
to what extent were you
making the decision as if
you were really making it
in real life?
Not at all
Very little
A little
Somewhat
Moderately
Very
Extremely
Knowledge of Adverse
Outcome control
involvement

46
27
18

17.6
10.3
6.9

0
1
1
13
39
90
116

.4
.4
5.0
14.9
34.5
44.4

2
3
2
18
43
80
112

.8
1.1
.8
6.9
16.5
30.7
42.9
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Missing:
0
Which of the following
include skin cancer risk
factors according to the
text that you just read?
0/4 Answers Correct or 5/4
1/4 Answer Correct
2/4 Answers Correct
3/4 Answers Correct
4/4 Answers Correct
Perceived Risk
manipulation involvement
Missing:
0
What was the medical
condition that your cousin
suffered from in the
scenario that you read?

14
10
44
97
96

5.4
3.8
16.9
37.2
36.8

32
104
125

12.3
39.8
47.9

What was the email about
– that you were said to
have received – in the
scenario that you read?
0/2 Answers Correct
1/2 Answer Correct
2/2 Answers Correct

Table 26 Knowledge of Adverse Outcome & Involvement checks for Study 2.

5.3.2 Manipulation checks
Table 27 below demonstrates the methods used to check whether the manipulations of
decision tools and perceived risk had a significant impact on the user: the price they paid
for the health plan and their perceived health risk.
EXPERIMENTAL
MANIPULATION
• NonDecision
compensatory
Tool:
Descending

MANIPULATION CHECK
Comparison of average
price paid for item by users
of each of the tools.
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STATISTICAL
TEST
ANOVA

High
Perceived
Risk

• Noncompensatory
Ascending
• Financial
Comparison of
average subjective
probability of
developing skin
cancer as per
scenario

Comparison of average
subjective probability of
developing skin cancer as
per scenario

ANOVA

Table 27 Methods and statistical tests used for manipulation checks in Study 2.

One-way ANOVA was carried out as a manipulation check to test the effects of NC
Descending, NC Ascending, and Financial tools on user’s decision quality. ANOVA tests
differences among group means and assumes homogeneity of variance of the groups.
Results for the analysis, as shown in Table 28, indicate that there is a significant effect of
the three decision tools on decision quality (price paid) by the user: F (2,257) = 42.106,
p = .00000. (Full analysis with post-hoc is provided below)
One-way ANOVA was carried out as a manipulation check to test the effects of the
scenarios on user’s perceived risk. Results for the analysis, as shown in Table 29, indicate
that there is a significant effect of the scenarios on user’s perceived risk: F (1,257) = 66.818,
p = .00000. Means plot in Figure 20 below indicates that the perceived risk exhibited by
users provided with High Perceived Risk scenario was significantly higher than that of
users provided with Low Perceived Risk scenario.
MANIPULATION CHECK – DECISION TOOLS
ANOVA RESULT
Dependent Variable: Price paid for the item
Source: Decision Tool
Type III Sum
df
Mean Square
F
of Squares
Between
459369.663
2
229684.831
42.106
Groups
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Sig.
.00000

Within
Groups
Total

1401909.079

257

1861278.741

259

5454.899
Table 28 Manipulation check for Decision tools - Study 2.

MANIPULATION CHECK – PERCEIVED RISK
ANOVA RESULT
Dependent Variable: Perceived Risk
Source: Scenario
Type III
df
Mean
F
Sum of
Square
Squares
Between Groups
307.740
1
307.740
66.818
Within Groups
1183.650
257
4.606
Total
1491.390
258

Sig.

.00000

Table 29 Manipulation check for Perceived risk - Study 2.

Figure 20 Means plot for perceived risk - Study 2.

5.3.3 Hypotheses testing
5.3.3.1 ANOVA ANALYSIS FOR PRICE PAID
One-way ANOVA was carried out to test the effects of NC Descending, NC Ascending,
and Financial tools on user’s decision quality. Results for the analysis, as shown in Table
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20, indicate that there is a significant effect of the three decision tools on decision quality
(price paid) by the user: F (2,257) = 42.106, p = .00000. η2 = .2468 indicates that the usage
of the three decision tools explain around 24.7% of the variance in price paid by the user
for a health plan.
Fully analysis is provided in Tables 30-35. Figure 21 below demonstrates the differences
in mean prices paid across the decision tools.

162

Descriptives
Price Paid
95% Confidence
Interval for Mean
N
NC Descending
91
NC Ascending
90
Financial
79
Total
260
Model Fixed
Effects
Random
Effects

Mean

Std.
Deviation

Std.
Error

Lower
Bound

Upper
Bound

246.8132
204.9667
142.8671
200.7442

69.53723
77.88084
73.98006
84.77266

7.28948
8.20936
8.32341
5.25738

232.3314
188.6548
126.2965
190.3916

261.2950
221.2785
159.4377
211.0969

73.85729

4.58043

191.7243 209.7642

Minimum Maximum

80.00
59.00
59.00
59.00

Between
Component
Variance

335.00
335.00
335.00
335.00

2592.3688
29.80778

72.4917

328.9967
Table 30 Descriptives for ANOVA in Study 2.
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Test of Homogeneity of Variances
Levene Statistic
Price Paid
Based on
.360
Mean
Based on
.900
Median
Based on
Median and
.900
with
adjusted df
Based on
trimmed
.838
mean

df1

df2

Sig.

2

257

.698

2

257

.408

2

226.702

.408

2

257

.434

Table 31 Homogeneity of variances test in Study 2.

ANOVA RESULTS (DV: Price Paid)
Source
Type III Sum
df
Mean Square
of Squares
Between
Groups
Within
Groups
Total

459369.663

2

229684.831

1401909.079

257

5454.899

1861278.741

F

Sig.

Eta
Squared

42.106

.00000

.24680

259
Table 32 ANOVA result: effects of decision tools on decision quality for Study 2.

Robust Tests of Equality of Means
Price Paid
Statistica
Welch
44.013
Brown-Forsythe
42.071
a. Asymptotically F distributed

df1
2
2

df2
169.117
252.276

Sig.
.000
.000

Table 33 Equality of means tests for Study 2.
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Multiple Comparisons
Dependent Variable: Price Paid
95% Confidence Interval
(I)
Decision
Tool

(J)
Mean
Decision
Difference
Tool
(I-J)
Tukey
NC
41.84652*
NC
HSD
Ascending
Descending
Financial
103.9461*
NC
-41.84652*
NC
Descending
Ascending
Financial
62.09958*
NC
-103.946*
Descending
Financial
NC
-62.09958*
Ascending
Scheffe
NC
41.84652*
NC
Ascending
Descending
Financial
103.9461*
NC
-41.84652*
NC
Descending
Ascending
Financial
62.09958*
NC
-103.946*
Descending
Financial
NC
-62.09958*
Ascending
* The main difference is significant at the .05 level

Std. Error

Sig.

Lower Bound

Upper Bound

10.97971

.00050651

15.9632

67.7298

11.35752

.00000001

77.1722

130.7200

10.97971

.00050651

-67.7298

-15.9632

11.38681

.00000035

35.2566

88.9425

11.35752

.00000001

-130.7200

-77.1722

11.38681

.00000035

-88.9425

-35.2566

10.97971

.00085447

14.8136

68.8795

11.35752

.00000000

75.9829

131.9093

10.97971

.00085447

-68.8795

-14.8136

11.38681

.00000077

34.0643

90.1348

11.35752

.00000000

-131.9093

-75.9829

11.38681

.00000077

-90.1348

-34.0643

Table 34 Multiple comparisons across decision tools in Study 2.
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Price Paid
Subset for alpha = .05
Decision
Tool
Tukey
HSDa,b

Financial

N
79

NC
Ascending

90

NC
Descending

91

Sig.
Scheffea,b

Financial

1

3

142.8671

204.9667

246.8132

1.000
79

2

1.000

1.000

142.8671

NC
90
204.9667
Ascending
NC
91
246.8132
Descending
Sig.
1.000
1.000
1.000
Means for groups in homogenous subsets are displayed.
a. Uses Harmonic Mean Sample Size = 86.310.
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I
error levels are not guaranteed.
Table 35 Homogeneous subsets in Study 2.
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Means of Price Paid across Decision Tools

Mean of Price Paid

300

250

246.8132

204.9667
200

142.8671

150
100
50
0
NC Descending

NC Ascending

Financial

Decision Tools
Figure 21 Means of price paid across the decision tools in Study 2.

5.3.3.2 PERCEIVED RISK MODERATION ANALYSIS
ANCOVA was carried out to test whether perceived risk moderates the effects of NC
Descending, NC Ascending, and Financial tools on user’s decision quality. Results for the
analysis, as shown in Table 36 below, indicate that there is a significant interaction between
the decision tools and user’s perceived risk: F (3, 256) = 42.448, p = .00000. R2 = .332
indicates that the usage of the three decision tools and user’s perceived risk explain about
33.2 % of the variance in price paid by the user for a health plan.
The interaction plot shown in Figure 23 further below, indicates that prices paid are higher
when making purchase choices with the three decision tools when users are under high
perceived risk than when they are under low perceived risk. Post hoc analysis further below
delineates these results in detail.
Full analysis is provided below in Tables 36-44 and Figure 22.

167

ANCOVA RESULTS (DV: Price Paid)
Source
Type III
df
Mean
Sum of
Square
Squares
Corrected
Model
Intercept
Decision
Tool *
Perceived
Risk
Error
Total
Corrected
Total

618302.832

F

a

3

206100.944

42.448

2251528.47
7

1

2251528.47
7

463.71
9

618302.832

3

206100.944

42.448

1242975.90
9
12338822.7
5
1861278.74
1

25
6
26
0
25
9

Sig.

.0000
0
.0000
0
.0000
0

Partial
Eta
Square
d

Observe
d Powerb

.332

1.000

.644

1.000

.332

1.000

4855.375

a

R2 = .332 (Adjusted R2 = .324)
b
Computed using alpha = .05
Table 36 ANCOVA results for Study 2 with perceived risk moderation.

Between-Subjects Factors
Decision Tool

4.00
5.00
6.00

Value Label
NC Descending
NC Ascending
Financial

N
91
90
79

Table 37 Between-subjects factors for ANCOVA with perceived risk.

Descriptives
Price Paid
Decision Tool
NC Descending
NC Ascending
Financial
Total

Mean
246.8132
204.9667
142.8671
200.7442

Std. Deviation
69.53723
77.88084
73.98006
84.77266

N
91
90
79
260

Table 38 Descriptives for ANCOVA with perceived risk.
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Levene’s Test of Equality of Error Variancesa
Dependent Variable: Price Paid
F
df1
df2
Sig.
.546
2
257
.580
Tests the null hypothesis that the error variance of the dependent variable is equal
across groups.
a. Design: Intercept + Decision Tool*Perceived Risk
Table 39 Levene's test for ANCOVA with perceived risk.

White Test for Heteroskedasticitya,b,c
Chi-Square
df
Sig.
2.698
3
.441
a. Dependent variable: Price Paid
b. Tests the null hypothesis that the variance of the errors does not depend on the
values of the independent variables.
c. Design: Intercept + Decision Tool*Perceived Risk
Table 40 White test for heteroskedaticity for ANCOVA with perceived risk.

F Test for Heteroskedasticitya,b,c
F
df1
df2
Sig.
.895
3
256
.444
a. Dependent variable: Price Paid
b. Tests the null hypothesis that the variance of the errors does not depend on the
values of the independent variables.
c. Design: Intercept + Decision Tool*Perceived Risk
Table 41 F test for heteroskedasticity for ANCOVA with perceived risk.

Estimates
Dependent Variable: Price Paid
95% Confidence
Interval
Decision Tool
Mean
Std. Error
Lower
Upper
Bound
Bound
NC Descending
239.159a
7.154
225.071 253.248
NC Ascending
205.674a
7.018
191.853 219.495
a
Financial
151.722
7.555
136.844 166.601
a. Covariates appearing in the model are evaluated at the following values: Perceived
Risk = 1.4923
Table 42 Estimates for ANCOVA with perceived risk.
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Pairwise Comparisons
Dependent Variable:
Price Paid
95% Confidence
Intervalb
(I) Decision
Tool

(J)
Mean
Std.
Lower
Upper
Decision
Difference
Sig.b
Error
Bound
Bound
Tool
(I-J)
NC Descending
NC
33.486*
9.839 .00077213 14.110
52.861
Ascending
Financial
87.437*
10.249 .00000000 67.253 107.620
NC Ascending
NC
-33.486*
9.839 .00077213 -52.861 -14.110
Descending
Financial
53.951*
10.100 .00000020 34.062
73.841
Financial
NC
-87.437* 10.249 .00000000
-67.253
Descending
107.620
NC
-53.951* 10.100 .00000020 -73.841 -34.062
Ascending
Based on estimated marginal means
* The main difference is significant at the .05 level.
b. Adjustment for multiple comparisons: Least Significant Difference (equivalent to no
adjustments).
Table 43 Pairwise comparisons for ANCOVA with perceived risk.
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Univariate Tests
Dependent Variable: Price Paid
Sum of
Squares

df

Mean
Square

F

Sig.

Contrast

Partial
Eta
Square
d

Noncen
t.
Parame
ter
73.670

Observed
Powera

357696
.0000
1.000
2
178848.44
36.835
.223
.88
0000
Error
124297
256
4855.375
5.9
The F tests the effect of Decision Tool. This test is based on the linearly independent pairwise
comparisons among the estimated marginal means.
a. Computed using alpha = .05
Table 44 Univariate tests for ANCOVA with perceived risk.
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Estimated Marginal Means

Estimated Marginal Means of Price Paid across Decision Tools
with Perceived Risk moderation
300
250
200
150
100
50
0

239.159
205.674
151.722

NC Descending

NC Ascending

Financial

Decision Tools
Covariates appering in the model are evaluated at the following
values: Perceived Risk = 1.4923
Figure 22 Estimated marginal means of price paid for ANCOVA with perceived risk.

Figure 23 Interaction plot for decision tools and user's perceived risk.
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POST HOC ANALYSIS FOR PERCEIVED RISK
After carrying out ANCOVA to test the moderating effect of perceived risk on user’s
decision quality, the dataset was split by perceived risk and ANOVA was carried out in
each subset as post-hoc to examine the effect of the decision tools for each level of
perceived risk.
Post-hoc analysis shows that means of prices paid are higher under high than under low
perceived risk (significantly higher for NC Descending p=.00000 and NC Ascending tools
p=.00010).
For each group, there are significant differences for price paid across the decision tools
under high perceived risk and there is no significant difference across price paid between
NC Descending and Ascending under low perceived risk.
HIGH PERCEIVED RISK
One-way ANOVA was carried out to test the effects of NC Descending, NC Ascending,
and Financial tools on user’s decision quality for users under high perceived risk. Results
for the analysis, as shown in Table 47, indicate that there is a significant effect of the three
decision tools on decision quality (price paid) of the user: F (2,129) = 32.940, p = .00000.
η2 = .338 indicates that the usage of the three decision tools explain around 33.8 % of the
variance in price paid for a health plan by the user when in circumstances of high perceived
risk.
Under high perceived risk, the price paid for a health plan by the users when making the
purchase choice with NC Descending tool is significantly higher from price paid when
making the decision with NC Ascending tool: M = 281.276 vs. M = 238.93, p = .00984.
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The price paid with NC Descending tool is also significantly higher from price paid using Financial tool: M = 281.276 vs. M =
163.9250, p = .00000.
Furthermore, under high perceived risk, the price paid for a health plan by the users, when making the purchase choice with NC
Ascending tool, is significantly higher from price paid when making the choice with the Financial tool: M = 238.9302 vs. M =
163.9250, p = .00001. Full analysis is provided in Tables 45-50 and Figure 24 below.
Descriptives
Price Paid
95% Confidence
Interval for Mean
N
NC Descending
49
NC Ascending
43
Financial
40
Total
132
Model Fixed
Effects
Random
Effects

Mean

Std.
Deviation

Std.
Error

Lower
Bound

Upper
Bound

281.2755
238.9302
163.9250
231.9205

56.69298
71.68454
76.77586
83.18084

8.09900
10.93179
12.13933
7.23996

264.9914
216.8690
139.3709
217.5981

297.5596
260.9915
188.4791
246.2428

68.19873

5.93594

220.1761 243.6649

Minimum Maximum

132.50
59.00
59.00
59.00

Between
Component
Variance

335.00
335.00
335.00
335.00

3388.4583
34.24747

84.5655

379.2754
Table 45 Descriptives in high perceived risk condition.
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Test of Homogeneity of Variances
Levene Statistic
Price Paid
Based on
1.987
Mean
Based on
.674
Median
Based on
Median and
.674
with
adjusted df
Based on
trimmed
1.937
mean

df1

df2

Sig.

2

129

.141

2

129

.511

2

113.100

.512

2

129

.148

Table 46 Homogeneity of variance test in high perceived risk condition.

ANOVA RESULTS (DV: Price Paid)
Source
Sum of
df
Mean Square
Squares
Between
Groups
Within
Groups
Total

306408.318

2

153204.159

599987.596

129

4651.067

906395.915

131

F

Sig.

Eta
Squared

32.940

.00000

.338

Table 47 ANOVA result for users under high perceived risk.

Robust Tests of Equality of Means
Price Paid
Statistica
Welch
32.183
Brown-Forsythe
31.937
a. Asymptotically F distributed

df1
2
2

df2
80.433
114.529

Sig.
.00000000
.00000000

Table 48 Equality of means tests for ANOVA in high perceived risk condition.
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Multiple Comparisons
Dependent Variable: Price Paid
95% Confidence Interval
(I)
Decision
Tool

(J)
Mean
Decision
Difference (ITool
J)
Tukey
NC
42.34528*
NC
HSD
Ascending
Descending
Financial
117.3505*
NC
-42.34528*
NC
Descending
Ascending
Financial
75.00523*
NC
-117.351*
Descending
Financial
NC
-75.00523*
Ascending
Scheffe
NC
42.34528*
NC
Ascending
Descending
Financial
117.3505*
NC
-42.34528*
NC
Descending
Ascending
Financial
75.00523*
NC
-117.351*
Descending
Financial
NC
-75.00523*
Ascending
* The main difference is significant at the .05 level

Std. Error

Sig.

Lower Bound

Upper Bound

14.25076

.00983500

8.5557

76.1349

14.53260

.00000001

82.8926

151.8084

14.25076

.00983500

-76.1349

-8.5557

14.98136

.00000531

39.4833

110.5271

14.53260

.00000001

-151.8084

-82.8926

14.98136

.00000531

-110.5271

-39.4833

14.25076

.01397893

7.0541

77.6365

14.53260

.00000000

81.3613

153.3397

14.25076

.01397893

-77.6365

-7.0541

14.98136

.00001062

37.9047

112.1057

14.53260

.00000000

-153.3397

-81.3613

14.98136

.00001062

-112.1057

-37.9047

Table 49 Multiple comparisons for ANOVA in high perceived risk condition.
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Price Paid
Subset for alpha = .05

Tukey
HSDa,b

Decision
Tool

N

1

Financial

40

163.9250

NC
Ascending

43

NC
Descending

49

Sig.
Scheffea,b

Financial

3

238.9302

281.2755

1.000
40

2

1.000

1.000

163.9250

NC
43
238.9302
Ascending
NC
49
281.2755
Descending
Sig.
1.000
1.000
1.000
Means for groups in homogenous subsets are displayed.
a. Uses Harmonic Mean Sample Size = 43.691.
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I
error levels are not guaranteed.
Table 50 Homogenous subsets for ANOVA in high perceived risk condition.
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Means of Price Paid across Decision Tools
under High Perceived Risk

Mean of Price Paid

300

281.2755

238.9302

250
200

163.9250

150
100
50
0
NC Descending

NC Ascending

Financial

Decision Tools
Figure 24 Means of price paid across decision tools in high perceived risk condition.

LOW PERCEIVED RISK
One-way ANOVA was carried out to test the effects of NC Descending, NC Ascending,
and Financial tools on user’s decision quality for users under low perceived risk. Results
for the analysis, as shown in Table 53, indicate that there is a significant effect of the three
decision tools on decision quality (price paid) of the user: F (2,125) = 17.130, p = .00000.
η2 = .215 indicates that the usage of the three decision tools explain around 21.5 % of the
variance in price paid for a health plan by the user when in circumstances of low perceived
risk.
The price paid with NC Descending tool is significantly higher from price paid using
Financial tool: M = 206.6071 vs. M = 173.8936, p = .00000. Furthermore, under low
perceived risk, the price paid for a health plan by the users, when making the purchase
choice with NC Ascending tool, is significantly higher from price paid when making the
choice with the Financial tool: M = 173.8936 vs. M = 121.2692, p = .00100.
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However, under low perceived risk, the price paid for a health plan by the users when making the purchase choice with NC
Descending tool is not significantly higher from price paid when making the decision with NC Ascending tool: M = 206.6071
vs. M = 173.8936, p = .054898.
Full analysis is provided below in Tables 51-56 and Figure 25.
Descriptives
Price Paid
95% Confidence
Interval for Mean
N
NC Descending
42
NC Ascending
47
Financial
39
Total
128
Model Fixed
Effects
Random
Effects

Mean

Std.
Deviation

Std.
Error

Lower
Bound

Upper
Bound

206.6071
173.8936
121.2692
168.5938

61.45051
70.55941
65.10749
73.93745

9.48202
10.29215
10.42554
6.53521

187.4578
153.1766
100.1638
155.6618

225.7565
194.6106
142.3746
181.5257

66.02552

5.83589

157.0438

180.1437

Minimum

Maximum

80.00
59.000
59.00
59.00

335.00
335.00
335.00
335.00

Between
Component
Variance

1653.0333
24.25623

64.2276

272.9599
Table 51 Descriptives in low perceived risk condition.
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Test of Homogeneity of Variances
Levene Statistic
Price Paid
Based on
.900
Mean
Based on
.431
Median
Based on
Median and
.431
with
adjusted df
Based on
trimmed
1.004
mean

df1

df2

Sig.

2

125

.409

2

125

.651

2

115.475

.651

2

125

.369

Table 52 Homogeneity of variance test in low perceived risk condition.

ANOVA RESULTS (DV: Price Paid)
Source
Sum of
df
Squares
Between
Groups
Within
Groups
Total

Mean
Square

F

Sig.

Eta
Squared

17.130

.00000

.215

149355.716

2

74677.858

544921.159

125

4359.369

694276.875

127
Table 53 ANOVA result for users under low perceived risk.

Robust Tests of Equality of Means
Price Paid
Statistica
Welch
18.300
Brown-Forsythe
17.296
a. Asymptotically F distributed

df1
2
2

df2
82.652
123.987

Sig.
.00000026
.00000024

Table 54 Equality of means test for ANOVA in low perceived risk condition.
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Multiple Comparisons
Dependent Variable: Price Paid
95% Confidence Interval
(I)
Decision
Tool

(J)
Mean
Decision
Difference
Tool
(I-J)
Tukey
NC
32.71353
NC
HSD
Ascending
Descending
Financial
85.33791*
NC
-32.71353
NC
Descending
Ascending
Financial
52.62439*
NC
-85.33791*
Descending
Financial
NC
-52.62439*
Ascending
Scheffe
NC
32.71353
NC
Ascending
Descending
Financial
85.33791*
NC
-32.71353
NC
Descending
Ascending
Financial
52.62439*
NC
-85.33791*
Descending
Financial
NC
-52.62439*
Ascending
* The main difference is significant at the .05 level

Std. Error

Sig.

Lower Bound

Upper Bound

14.01952

.05489839

-.5402

65.9673

14.68241

.00000015

50.5118

120.1640

14.01952

.05489839

-65.9673

.5402

14.30144

.00100198

18.7020

86.5468

14.68241

.00000015

-120.1640

-50.5118

14.30144

.00100198

-86.5468

-18.7020

14.01952

.06961235

-2.0181

67.4451

14.68241

.00000032

48.9641

121.7117

14.01952

.06961235

-67.4451

2.0181

14.30144

.00161604

17.1944

88.0544

14.68241

.00000032

-121.7117

-48.9641

14.30144

.00161604

-88.0544

-17.1944

Table 55 Multiple comparisons for ANOVA in low perceived risk condition.
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Price Paid
Subset for alpha = .05

Tukey
HSDa,b

Decision
Tool

N

1

Financial

39

121.2692

NC
Ascending

47

173.8936

NC
Descending

42

206.6071

Sig.
Scheffea,b

Financial

1.00
39

2

3

.062

121.2692

NC
47
173.8936
Ascending
NC
42
206.6071
Descending
Sig.
1.000
.078
Means for groups in homogenous subsets are displayed.
a. Uses Harmonic Mean Sample Size = 42.417.
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I
error levels are not guaranteed.
Table 56 Homogeneous subsets in low perceived risk condition.
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Means of Price Paid across Decision Tools
under Low Perceived Risk

Mean of Price Paid

250
206.6071
200

173.8936

150

121.2692

100

50
0
NC Descending

NC Ascending

Financial

Decision Tools
Figure 25 Means of prices paid across decision tools in low perceived risk condition.

DECISION TOOLS AND PERCEIVED RISK
An additional analysis was executed to examine the differences across prices paid using
the three decision tools and perceived risk. The data were recoded to account for both
decision tool and perceived risk group assignment and ANOVA was carried out to check
price mean differences across the groups.
Results for the analysis, as shown in Table 59 below, indicate that there is a significant
interaction between the decision tools and user’s perceived risk: F (5, 254) = 31.786, p =
.00000.
Prices paid using the three decision tools by users under high perceived risk were higher
than prices paid by users under low perceived risk.
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The price paid using NC Descending tool was significantly higher under high than under
low perceived risk (NC Descending HPR vs LPR p=.00000).
The price paid using NC Ascending tool was also significantly higher under high than
under low perceived risk (NC Ascending HPR vs LPR p =.00010).
There was no significant difference across price paid using the Financial tool under high
vs. under low perceived risk.
Interestingly, there was no significant difference across prices paid using NC Descending
and under low perceived risk vs. NC Ascending tools and users under high perceived risk.
Full analysis is provided in tables 57-62 and Figure 26 below.
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Descriptives
Price Paid
95% Confidence
Interval for Mean
N
NC Descending
49
& HPR
NC Descending
42
& LPR
NC Ascending
43
& HPR
NC Ascending
47
& LPR
Financial &
40
HPR
Financial & LPR 39
Total
260
Model Fixed
Effects
Random
Effects

Mean

Std.
Deviation

Std.
Error

Lower
Bound

Upper
Bound

281.2755

56.69298

8.09900

264.9914 297.5596

206.6071

61.45051

9.48202

187.4578 225.7565

238.9302

71.68454

10.93179 216.8690 260.9915

173.8936

70.55941

10.29215 153.1766 194.6106

163.9250

76.77586

12.13933 139.3709 188.4791

121.2692
200.7442

65.10749
84.77266

10.42554 100.1638 142.3746
5.25738 190.3916 211.0969

67.13803

4.16372

Minimum Maximum

132.50

335.00

80.00

335.00

59.00

335.00

59.00

335.00

59.00

335.00

59.00
59.00

335.00
335.00

Between
Component
Variance

192.5444 208.9440
3206.7055

23.56811 140.1605 261.3280
Table 57 Descriptives for data grouped by decision tool * perceived risk.
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Test of Homogeneity of Variances
Levene Statistic
Price Paid
Based on
1.493
Mean
Based on
.601
Median
Based on
Median and
.601
with
adjusted df
Based on
trimmed
1.487
mean

df1

df2

Sig.

5

254

.192

5

254

.699

5

228.260

.699

5

254

.194

Table 58 Homogeneity of variance test for ANOVA - data grouped by decision tool * perceived risk.

ANOVA RESULTS (DV: Price Paid)
Source
Sum of Squares
df

Mean Square

F

Sig.

Between
Groups

31.786

.00000

Within Groups
Total

716369.986

5

143273.997

1144908.755

254

4507.515

1861278.741

259
Table 59 ANOVA result for data grouped by decision tool * perceived risk.

Robust Tests of Equality of Means
Price Paid
Statistica
Welch
35.821
Brown-Forsythe
31.513
a. Asymptotically F distributed

df1
5
5

df2
116.687
238.659

Sig.
.00000000
.00000000

Table 60 Equality of means tests - data grouped by decision tool * perceived risk.
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Multiple Comparisons
Dependent Variable: Price Paid
95% Confidence Interval
(I)
Decision
Tool

(J)
Decision
Tool
Scheffe
NC
Descending
& LPR
NC
Ascending
& HPR
NC
Descending
NC
& HPR
Ascending
& LPR
Financial
& HPR
Financial
& LPR
NC
Descending
& HPR
NC
NC
Descending Ascending
& LPR
& HPR
NC
Ascending
& LPR

Mean
Difference
(I-J)

Std. Error

Sig.

Lower Bound

Upper Bound

74.66837*

14.11779

.0000654780

27.3205

122.0163

42.34528

14.02911

.1089186917

-4.7052

89.3958

107.38189*

13.70747

.0000000001

61.4101

153.3537

117.35051*

14.30657

.0000000000

69.3695

165.3315

160.00628*

14.40720

.0000000000

111.6878

208.3248

-74.66837*

14.11779

.0000654780

-122.0163

-27.3205

-32.32309

14.56529

.4274167184

-81.1718

16.5256

32.71353

14.25575

.3869800078

-15.0971

80.5241
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NC
Ascending
& HPR

NC
Ascending
& LPR

Financial
42.68214
& HPR
Financial
85.33791*
& LPR
NC
Descending -42.34528
& HPR
NC
Descending 32.32309
& LPR
NC
Ascending 65.03662*
& LPR
Financial
75.00523*
& HPR
Financial
117.66100*
& LPR
NC
Descending
107.38189*
& HPR
NC
Descending -32.71353
& LPR
NC
Ascending -65.03662*
& HPR
Financial
9.96862
& HPR
Financial
52.62439*
& LPR

14.83272

.1457509343

-7.0635

92.4278

14.92981

.0000097390

35.2667

135.4091

14.02911

.1089186917

-89.3958

4.7052

14.56529

.4274167184

-16.5256

81.1718

14.16794

.0010686621

17.5205

112.5527

14.74835

.0001540371

25.5426

124.4679

14.84598

.0000000001

67.8709

167.4511

13.70747

.0000000001

-153.3537

-61.4101

14.25575

.3869800078

-80.5241

15.0971

14.16794

.0010686621

-112.5527

-17.5205

14.44273

.9928804826

-38.4691

58.4063

14.54242

.0248913241

3.8524

101.3964
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NC
Descending
117.35051*
& HPR
NC
Descending -42.68214
& LPR
Financial
NC
& HPR
Ascending -75.00523*
& HPR
NC
Ascending
-9.96862
& LPR
Financial
42.65577
& LPR
NC
Descending
160.00628*
& HPR
NC
Descending -85.33791*
& LPR
Financial
NC
& LPR
Ascending
117.66100*
& HPR
NC
Ascending -52.62439*
& LPR
Financial
-42.65577
& HPR
* The main difference is significant at the .05 level

14.30657

.0000000000

-165.3315

-69.3695

14.83272

.1457509343

-92.4278

7.0635

14.74835

.0001540371

-124.4679

-25.5426

14.44273

.9928804826

-58.4063

38.4691

15.10845

.1621372683

-8.0146

93.3261

14.40720

.0000000000

-208.3248

-111.6878

14.92981

.0000097390

-135.4091

-35.2667

14.84598

.0000000001

-167.4511

-67.8709

14.54242

.0248913241

-101.3964

-3.8524

15.10845

.1621372683

-93.3261

8.0146

Table 61 Multiple comparisons for ANOVA for data grouped by decision tool * perceived risk.
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Price Paid
Subset for alpha = .05

Tukey
HSDa,b

Decision
Tool

N

1

Financial
& LPR

39

121.2692

Financial
& HPR

40

NC
Ascending
& LPR

2

3

4

5

163.9250
173.8936

47

173.8936

NC
238.9302 206.6071
Descending 42
& LPR
NC
238.9302
Ascending 43
& HPR
NC
Descending 49
281.2755
& HPR
Sig.
1.000
.983
.214
.226
1.000
Means for groups in homogenous subsets are displayed.
a. Uses Harmonic Mean Sample Size = 43.044.
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I
error levels are not guaranteed.
Table 62 Homogeneous subsets for data grouped by decision tool * perceived risk.
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Figure 26 Means of prices paid across groups differentiating decision tool used and perceived risk condition.

5.3.3.3 DECISION APPROACH MODERATION ANALYSIS
ANCOVA was carried out to test whether decision approach (being driven primarily by
price heuristics or not) moderates the effects of NC Descending, NC Ascending, and
Financial tools on user’s decision quality. Results for the analysis, as shown in Table 63
below, indicate that there is a significant interaction between the decision tools and user’s
decision approach: F (3, 251) = 61.344, p = .00000. R2 = .423 indicates that the usage of
the three decision tools and user’s decision approach explain about 42.3 % of the variance
in price paid by the user for a health plan.
The interaction plot shown in Figure 28 demonstrates that for users driven strongly by price
heuristics, the prices paid for the health plans are lower using the three decision tools than
for users driven weakly by price heuristics in their decision approach. These findings are
examined in detail and delineated further below in post-hoc analysis.
Full results are demonstrated in tables 63-71 and Figures 27 and 28.
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ANCOVA RESULTS (DV: Price Paid)
Source
Type III
df
Mean
Sum of
Square
Squares
Corrected
769180.122a
3
256393.374
Model
Intercept
41876.513
1
41876.513
Decision
Tool*
769180.122
3
256393.374
Decision
Approach
Error
1049075.707 251
4179.584
Total
12092791.50 255
Corrected
1818255.829 254
Total

F

Sig.

Partial Observed
Eta
Powerb
Squared

61.344

.00000

.423

1.000

10.019

.00174

.038

.884

61.344

.00000

.423

1.000

a

R2 = .423 (Adjusted R2 = .416)
b
Computed using alpha = .05
Table 63 ANCOVA results for Study 2 with decision approach moderation.

Between-Subjects Factors
Decision Tool

4.00
5.00
6.00

Value Label
NC Descending
NC Ascending
Financial

N
89
89
77

Table 64 Between-subjects factors for ANCOVA with decision approach.

Descriptives
Price Paid
Decision Tool
NC Descending
NC Ascending
Financial
Total

Mean
245.5056
206.3708
142.4545
200.7294

Std. Deviation
69.61458
77.16797
74.78056
84.60785

N
89
89
77
255

Table 65 Descriptives for ANCOVA with decision approach.

Levene’s Test of Equality of Error Variancesa
Dependent Variable: Price Paid
F
df1
df2
Sig.
.274
2
252
.760
Tests the null hypothesis that the error variance of the dependent variable is equal
across groups.
a. Design: Intercept + Decision Tool*Decision Approach
Table 66 Levene's Test for ANCOVA with decision approach.
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White Test for Heteroskedasticitya,b,c
Chi-Square
df
Sig.
3.441
3
.328
a. Dependent variable: Price Paid
b. Tests the null hypothesis that the variance of the errors does not depend on the
values of the independent variables.
c. Design: Intercept + Decision Tool*Decision Approach
Table 67 White test for heteroskedasticity for ANCOVA with decision approach.

F Test for Heteroskedasticitya,b,c
F
df1
df2
Sig.
1.145
3
251
.332
a. Dependent variable: Price Paid
b. Tests the null hypothesis that the variance of the errors does not depend on the
values of the independent variables.
c. Design: Intercept + Decision Tool*Decision Approach
Table 68 F Test for heteroskedasticity for ANCOVA with decision approach.

Estimates
Dependent Variable: Price Paid
95% Confidence
Interval
Decision Tool
Mean
Std. Error
Lower
Upper
Bound
Bound
NC Descending
243.058a
6.729
229.805 256.311
NC Ascending
209.743a
6.761
196.427 223.060
a
Financial
141.955
7.172
127.831 156.079
a. Covariates appearing in the model are evaluated at the following values: Perceived
Risk = 18.6588
Table 69 Estimates for ANCOVA with decision approach.

Pairwise Comparisons
Dependent Variable:
Price Paid
95% Confidence
Intervalb
(I) Decision
Tool
NC Descending

(J)
Decision
Tool
NC
Ascending
Financial

Mean
Difference
(I-J)

Std.
Error

Sig.b

Lower
Bound

Upper
Bound

33.315*

9.467

.00051381

14.671

51.959

101.103*

9.713

.00000000

81.973

120.233
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NC Ascending

NC
-33.315*
9.467 .00051381 -51.959 -14.671
Descending
Financial
67.789*
9.761 .00000000 48.565
87.012
Financial
NC
-101.103* 9.713 .00000000
-81.973
Descending
120.233
NC
-67.789*
9.761 .00000000 -87.012 -48.565
Ascending
Based on estimated marginal means
* The main difference is significant at the .05 level.
b. Adjustment for multiple comparisons: Least Significant Difference (equivalent to no
adjustments).
Table 70 Pairwise comparisons for ANCOVA with decision approach.
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Univariate Tests
Dependent Variable: Price Paid
Sum of
Squares

df

Mean
Square

F

Sig.

Partial
Eta
Square
d

Noncent.
Parameter

Observed
Powera

Contrast

465092
.0000
111.277
1.000
2
232546.18
55.639
.307
.36
0000
Error
104907
251
4179.584
5.7
The F tests the effect of Decision Tool. This test is based on the linearly independent pairwise comparisons
among the estimated marginal means.
a. Computed using alpha = .05
Table 71 Univariate tests for ANCOVA with decision approach.
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Figure 27 Estimated marginal means of prices paid for ANCOVA with decision approach.
.

Figure 28 Interaction plot for decision tools and decision approach.
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POSTHOC ANALYSIS FOR PRICE HEURISTIC
To compute Strong vs. Weak Price Heuristics-driven Decision Approach, the mean for
decision approach was calculated m=18.6602 (Table 72 below), and any respondents
scoring 1-18.65 were coded as Strong Price Heuristic and participants scoring 18.651 and
above were coded as driven Weakly by Price Heuristics. The data was then split by decision
approach.
Post-hoc analysis shows that means of prices paid are higher for users weakly driven by
price heuristics (significantly higher for NC Descending p=.00021 and NC Ascending
p=.00000). There is no significant difference in price paid using the Financial tool for users
driven by strong vs weak price heuristics.
For each group there are significant differences for price paid across the decision tools
strongly driven by price heuristics and there is no significant difference across price paid
between NC Descending and Ascending for users driven weakly by price heuristics.
STRONG PRICE HEURISTIC
One-way ANOVA was carried out to test the effects of NC Descending, NC Ascending,
and Financial tools on user’s decision quality for users strongly driven by price heuristics.
Results for the analysis, as shown in Table 75, indicate that there is a significant effect of
the three decision tools on decision quality (price paid) of the user: F (2,137) = 24.594, p
= .00000. η2 = .264 indicates that the usage of the three decision tools explain around 22.3
% of the variance in price paid for a health plan by the user driven strongly by price
heuristics.
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For users driven strongly by price heuristics, the price paid for a health plan by the users
when making the purchase choice with NC Descending tool is significantly higher from
price paid when making the decision with NC Ascending tool: M = 217.6020 vs. M =
169.7941, p = .00072. The price paid with NC Descending tool is also significantly higher
from price paid using Financial tool: M = 217.6020 vs. M = 122.9000, p = .00000.
Furthermore, for users driven strongly by price heuristics, the price paid for a health plan
by the users, when making the purchase choice with NC Ascending tool, is significantly
higher from price paid when making the choice with the Financial tool: M = 169.7941 vs.
M = 122.9000, p = .00183.
Full analysis of ANOVA is provided below in tables 73-78 and Figure 29.

Statistics
Decision Approach
N

Valid

256

Missing

5

Mean

18.6602

Median

18.0000

Std. Deviation

4.60410

Range

24.00

Minimum

4.00

Maximum

28.00
Table 72 Descriptive statistics for decision approach in Study 2.

198

Descriptives
Price Paid
95% Confidence
Interval for Mean
N
NC Descending
49
NC Ascending
51
Financial
40
Total
140
Model Fixed
Effects
Random
Effects

Mean

Std.
Deviation

Std.
Error

Lower
Bound

Upper
Bound

217.6020
169.7941
122.9000
173.1286

62.29123
65.22915
62.75667
73.50374

8.89875
9.13391
9.92270
6.21220

199.7099
151.4481
102.8294
160.8459

235.4942
188.1401
142.9706
185.4112

63.50982

5.36756

162.5146 183.7426

Minimum Maximum

80.00
59.00
59.00
59.00

Between
Component
Variance

335.00
305.00
335.00
335.00

2050.0555
26.50982

57.7288

288.5283
Table 73 Descriptives for Strong Price Heuristic group.
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Test of Homogeneity of Variances
Levene Statistic
Price Paid
Based on
.577
Mean
Based on
.212
Median
Based on
Median and
.212
with
adjusted df
Based on
trimmed
.523
mean

df1

df2

Sig.

2

137

.563

2

137

.809

2

133.659

.809

2

137

.594

Table 74 Homogeneity of variances test for Strong Price Heuristic group.

ANOVA RESULTS (DV: Price Paid)
Source
Sum of
df
Mean Square
Squares
Between
198400.008
2
99200.004
Groups
Within
552589.178
137
4033.498
Groups
Total
750989.186
139

F

Sig.

Eta sq.

24.594

.00000

.264

Table 75 ANOVA for the effects of decision tools for users strongly driven by price heuristics.

Robust Tests of Equality of Means
Price Paid
Statistica
Welch
25.177
Brown-Forsythe
24.676
a. Asymptotically F distributed

df1
2
2

df2
89.228
134.181

Sig.
.00000000
.00000000

Table 76 Equality of means tests for users driven strongly by price heuristics.
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Multiple Comparisons
Dependent Variable: Price Paid
95% Confidence Interval
(I)
Decision
Tool

(J)
Mean
Decision
Difference
Tool
(I-J)
Tukey
NC
47.80792*
NC
HSD
Ascending
Descending
Financial 94.70204*
NC
NC
Descending 47.80792*
Ascending
Financial 46.89412*
NC
Descending 94.70204*
Financial
NC
Ascending 46.89412*
Scheffe
NC
47.80792*
NC
Ascending
Descending
Financial 94.70204*
NC
NC
Descending 47.80792*
Ascending
Financial 46.89412*
NC
Descending 94.70204*
Financial
NC
Ascending 46.89412*
* The main difference is significant at the .05 level

Std. Error

Sig.

Lower Bound

Upper Bound

12.70451

.00072168

17.7051

77.9108

13.53343

.00000001

62.6351

126.7690

12.70451

.00072168

-77.9108

-17.7051

13.41364

.00183258

15.1110

78.6772

13.53343

.00000001

-126.7690

-62.6351

13.41364

.00183258

-78.6772

-15.1110

12.70451

.00118522

16.3674

79.2485

13.53343

.00000000

61.2101

128.1940

12.70451

.00118522

-79.2485

-16.3674

13.41364

.00286946

13.6987

80.0896

13.53343

.00000000

-128.1940

-61.2101

13.41364

.00286946

-80.0896

-13.6987

Table 77 Multiple comparisons for users driven strongly by price heuristics.

201

Price Paid
Subset for alpha = .05

Tukey
HSDa,b

Decision
Tool

N

1

Financial

40

122.9000

NC
Ascending

51

NC
Descending

49

Sig.
Scheffea,b

Financial

3

169.7941

217.6020

1.000
40

2

1.000

1.000

122.9000

NC
51
169.7941
Ascending
NC
49
217.6020
Descending
Sig.
1.000
1.000
1.000
Means for groups in homogenous subsets are displayed.
a. Uses Harmonic Mean Sample Size = 46.142.
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I
error levels are not guaranteed.
Table 78 Homogeneous subsets for users driven strongly by price heuristics.
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Means of Price Paid across Decision Tools
for Users driven Strongly by Price Heuristics

Mean of Price Paid

250.0000

217.6020

200.0000

169.7941

150.0000

122.9000

100.0000

50.0000
0.0000
NC Descending

NC Ascending

Financial

Decision Tools
Figure 29 Means of prices paid across decision tools by users driven strongly by price heuristics.

WEAK PRICE HEURISTIC
One-way ANOVA was carried out to test the effects of NC Descending, NC Ascending,
and Financial tools on user’s decision quality for users strongly driven by price heuristics.
Results for the analysis, as shown in Table 81, indicate that there is a significant effect of
the three decision tools on decision quality (price paid) of the user: F (2,117) = 30.027, p
= .00000. η2 = .339 indicates that the usage of the three decision tools explain around 33.9
% of the variance in price paid for a health plan by the user driven weakly by price
heuristics.
For users driven weakly by price heuristics, the price paid for a health plan by the users
when making the purchase choice with NC Ascending tool is significantly higher from
price paid when making the choice with the Financial tool: M = 250.9615 vs. M =
163.3462, p = .00000. The price paid with NC Descending tool is also significantly higher
from price paid using Financial tool: M = 280.8929 vs. M = 163.3462, p = .00000.
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The price paid for a health plan by the users weakly driven by price heuristics when making
the purchase choice with NC Descending tool is not significantly higher from price paid
when making the decision with NC Ascending tool: M = 280.8929 vs. M = 250.9615, p =
.14028.
Full analysis is displayed in tables 79-86 and Figure 30 below.
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Descriptives
Price Paid
95% Confidence
Interval for Mean
N
NC Descending
42
NC Ascending
39
Financial
39
Total
120
Model Fixed
Effects
Random
Effects

Mean

Std.
Deviation

Std.
Error

Lower
Bound

Upper
Bound

280.8929
250.9615
163.3462
232.9625

62.14612
69.10760
79.63677
85.94312

9.58936
11.06607
12.75209
7.84550

261.5268
228.5594
137.5309
217.4276

300.2590
273.3636
189.1614
248.4974

70.45803

6.43191

220.2244 245.7006

Minimum Maximum

132.50
132.50
59.00
59.00

Between
Component
Variance

335.00
335.00
335.00
335.00

3604.8077
35.27710

81.1774

384.7476
Table 79 Descriptives for users driven weakly by price heuristics.
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Test of Homogeneity of Variances
Levene Statistic
Price Paid
Based on
1.161
Mean
Based on
.492
Median
Based on
Median and
.492
with
adjusted df
Based on
trimmed
1.096
mean

df1

df2

Sig.

2

117

.317

2

117

.613

2

94.122

.613

2

117

.338

Table 80 Homogeneity of variances test for users driven weakly by price heuristics.

ANOVA RESULTS (DV: Price Paid)
Source
Sum of
df
Mean Square
Squares
Between
298133.044
2
149066.522
Groups
Within
580827.037
117
4964.334
Groups
Total
878960.081
119

F

Sig.

Eta sq.

30.027

.00000

.339

Table 81 ANOVA for the effects of decision tools for users weakly driven by price heuristic.

Robust Tests of Equality of Means
Price Paid
Statistica
Welch
27.333
Brown-Forsythe
29.769
a. Asymptotically F distributet

df1
2
2

df2
76.338
110.286

Sig.
.00000000
.00000000

Table 82 Equality of means tests for users driven weakly by price heuristics.
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Multiple Comparisons
Dependent Variable: Price Paid
95% Confidence Interval
(I)
Decision
Tool

(J)
Mean
Decision
Difference (ITool
J)
Tukey
NC
29.93132
NC
HSD
Ascending
Descending
Financial
117.5467*
NC
-29.93132
NC
Descending
Ascending
Financial
87.61538*
NC
-117.547*
Descending
Financial
NC
-87.61538*
Ascending
Scheffe
NC
29.93132
NC
Ascending
Descending
Financial
117.5467*
NC
-29.93132
NC
Descending
Ascending
Financial
87.61538*
NC
-117.547*
Descending
Financial
NC
-87.61538*
Ascending
* The main difference is significant at the .05 level

Std. Error

Sig.

Lower
Bound

Upper Bound

15.66809

.14028044

-7.2633

67.1260

15.66809

.00000001

80.3520

154.7414

15.66809

.14028044

-67.1260

7.2633

15.95560

.00000071

49.7382

125.4926

15.66809

.00000001

-154.7414

-80.3520

15.95560

.00000071

-125.4926

-49.7382

15.66809

.16582650

-8.9165

68.7791

15.66809

.00000000

78.6989

156.3945

15.66809

.16582650

-68.7791

8.9165

15.95560

.00000149

48.0547

127.1760

15.66809

.00000000

-156.3945

-78.6989

15.95560

.00000149

-127.1760

-48.0547

Table 83 Multiple comparisons for users driven weakly by price heuristics.
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Price Paid
Subset for alpha = .05

Tukey
HSDa,b

Decision
Tool

N

1

Financial

39

163.3462

NC
Ascending

39

250.9615

NC
Descending

42

280.8929

Sig.
Scheffea,b

Financial

1.000
39

2

.144

163.3462

NC
39
250.9615
Ascending
NC
42
280.8929
Descending
Sig.
1.000
.169
Means for groups in homogenous subsets are displayed.
a. Uses Harmonic Mean Sample Size = 39.951.
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I
error levels are not guaranteed.
Table 84 Homogeneous subsets for users driven weakly by price heuristics.
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Means of Price Paid across Decision Tools
for Users driven Weakly by Price Heuristics

Mean of Price Paid

300.0000

280.8929
250.9615

250.0000
200.0000

163.3462

150.0000
100.0000
50.0000
0.0000
NC Descending

NC Ascending

Financial

Decision Tools
Figure 30 Means of prices paid across decision tools for users driven weakly by price heuristics.

ADDITIONAL ANALYSIS FOR DECISION APPROACH
An additional analysis was done to examine the differences across prices paid using the
three decision tools and decision approach. The data were recoded to account for both
decision tool and decision approach and ANOVA was carried out to check price mean
differences across the groups.
Results for the analysis, as shown in Table 87 below, indicate that there is a significant
interaction between the decision tools and user’s perceived risk: F (5, 249) = 32.265, p =
.00005.
Price paid using NC Descending tool was significantly lower for users driven strongly by
price heuristics than users driven weakly by price heuristics (NC Descending Strong PH
vs Weak PH p=.00021).
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Price paid using NC Ascending tool was significantly lower for users driven strongly by
price heuristics than users driven weakly by price heuristics (Strong PH vs Weak PH
p=.00000).
There was no significant difference found for price paid using the Financial tool for users
driven by strong vs weak price heuristics.
Interestingly, there was no significant difference in price paid for users driven strongly by
price heuristics and making the decision using NC Descending tool vs users driven weakly
by price heuristics and making the decision using NC Ascending tool.
Full results are shown in tables 85-90 below and Figure 31.
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Descriptives
Price Paid
95% Confidence
Interval for Mean
N
NC Descending
47
& Strong PH
NC Descending
42
& Weak PH
NC Ascending
50
& Strong PH
NC Ascending
39
& Weak PH
Financial &
38
Strong PH
Financial &
39
Weak PH
Total
255
Model Fixed
Effects
Random
Effects

Mean

Std.
Deviation

Std.
Error

Lower
Bound

Upper
Bound

213.8830

60.52714

8.82879

196.1115

231.6544

280.8929

62.14612

9.58936

261.5288

300.2590

171.5900

64.60521

9.13656

153.2294

189.9506

250.9615

69.10760

11.06607 228.5594

273.3636

121.0132

63.56817

10.31212 100.1188

141.9075

163.3462

79.63677

12.75209 137.5309

189.1614

200.7294

84.60785

5.29835

190.2951

211.1637

66.56763

4.16863

192.5191

208.9397

Minimum

Maximum

80.00

335.00

132.50

335.00

59.00

305.00

132.50

335.00

59.00

335.00

59.00

335.00

59.00

335.00

Between
Component
Variance

3267.1768
23.83300 139.4647

261.9941

Table 85 Descriptives for data grouped by decision tool * decision approach.
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Test of Homogeneity of Variances
Levene Statistic
Price Paid
Based on
1.974
Mean
Based on
1.121
Median
Based on
Median and
1.121
with
adjusted df
Based on
trimmed
1.837
mean

df1

df2

Sig.

5

249

.083

5

249

.350

5

218.407

.350

5

249

.106

Table 86 Homogeneity of variances test - data grouped by decision tool * decision approach.

ANOVA RESULTS (DV: Price Paid)
Source
Sum of Squares
df
Between
Groups
Within
Groups
Total

Mean Square

F

Sig.

32.265

.00000

714874.598

5

142974.920

1103381.232

249

4431.250

1818255.829

254

Table 87 ANOVA result for data grouped by decision tool * decision approach.

Robust Tests of Equality of Means
Price Paid
Statistica
Welch
33.413
Brown-Forsythe
31.877
a. Asymptotically F distributed

df1
5
5

df2
113.797
229.914

Sig.
.00000000
.00000000

Table 88 Equality of means tests - data grouped by decision tool * decision approach.
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Multiple Comparisons
Dependent Variable: Price Paid
95% Confidence Interval
(I)
Decision
Tool
Scheffe

NC
Descending
& Strong
PH

NC
Descending
& Weak
PH

NC
Ascending

(J) Decision Tool
NC Descending
& Weak PH
NC Ascending &
Strong PH
NC Ascending &
Weak PH
Financial &
Strong PH
Financial &
Weak PH
NC Descending
& Strong PH
NC Ascending &
Strong PH
NC Ascending &
Weak PH
Financial &
Strong PH
Financial &
Weak PH
NC Descending
& Strong PH

Mean
Difference
(I-J)

Std. Error

Sig.

Lower Bound

Upper Bound

-67.00988*

14.13463

.0006110698

-114.4218

-19.5979

42.29298

13.52431

.0857953401

-3.0718

87.6577

-37.07856

14.41887

.2550002929

-85.4439

11.2868

92.86982*

14.52218

.0000003619

44.1579

141.5817

50.53682*

14.41887

.0339379245

2.1715

98.9022

67.00988*

14.13463

.0006110698

19.5979

114.4218

109.30286*

13.93309

.0000000001

62.5669

156.0388

29.93132

14.80296

.5380210472

-19.7224

79.5851

159.87970*

14.90362

.0000000000

109.8883

209.8711

117.54670*

14.80296

.0000000001

67.8930

167.2004

-42.29298

13.52431

.0857953401

-87.6577

3.0718
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& Strong
PH

NC
Ascending
& Weak
PH

Financial
& Strong
PH

NC Descending
-109.30286*
& Weak PH
NC Ascending &
-79.37154*
Weak PH
Financial &
50.57684*
Strong PH
Financial &
8.24385
Weak PH
NC Descending
37.07856
& Strong PH
NC Descending
-29.93132
& Weak PH
NC Ascending &
79.37154*
Strong PH
Financial &
129.94838*
Strong PH
Financial &
87.61538*
Weak PH
NC Descending
-92.86982*
& Strong PH
NC Descending
-159.87970*
& Weak PH
NC Ascending &
-50.57684*
Strong PH
NC Ascending &
-129.94838*
Weak PH
Financial &
-42.33300
Weak PH
NC Descending
-50.53682*
& Strong PH

13.93309

.0000000001

-156.0388

-62.5669

14.22135

.0000182948

-127.0744

-31.6687

14.32609

.0317105475

2.5227

98.6310

14.22135

.9968706615

-39.4590

55.9467

14.41887

.2550002929

-11.2868

85.4439

14.80296

.5380210472

-79.5851

19.7224

14.22135

.0000182948

31.6687

127.0744

15.17345

.0000000000

79.0519

180.8449

15.07460

.0000063159

37.0505

138.1803

14.52218

.0000003619

-141.5817

-44.1579

14.90362

.0000000000

-209.8711

-109.8883

14.32609

.0317105475

-98.6310

-2.5227

15.17345

.0000000000

-180.8449

-79.0519

15.17345

.1729276329

-93.2295

8.5635

14.41887

.0339379245

-98.9022

-2.1715
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NC Descending
-117.54670*
& Weak PH
NC Ascending &
-8.24385
Financial
Strong PH
& Weak
NC Ascending &
PH
-87.61538*
Weak PH
Financial &
42.33300
Strong PH
* The main difference is significant at the .05 level

14.80296

.0000000001

-167.2004

-67.8930

14.22135

.9968706615

-55.9467

39.4590

15.07460

.0000063159

-138.1803

-37.0505

15.17345

.1729276329

-8.5635

93.2295

Table 89 Multiple comparisons - data grouped by decision tool * decision approach.
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Price Paid
Subset for alpha = .05
Decision
N
1
2
3
4
Tool
Tukey
Financial
a,b
HSD
& Strong
38
121.0132
PH
Financial
& Weak
39
163.3462
PH
NC
Ascending
50
171.5900
& Strong
PH
NC
Descending
47
213.8830
& Strong
PH
NC
Ascending
39
250.9615
250.9615
& Weak
PH
NC
Descending
42
280.8929
& Weak
PH
Sig.
1.000
.993
.113
.311
Means for groups in homogenous subsets are displayed.
a. Uses Harmonic Mean Sample Size = 42.051.
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I
error levels are not guaranteed.
Table 90 Homogeneous subsets - data grouped by decision tool * decision approach.
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Means of Price Paid across Decision Tools
and Decision Approaches

Mean of Price Paid

300.0000

280.8929

250.0000

250.9615

213.8830

200.0000

171.5900

163.3462

150.0000

121.0132

100.0000
50.0000
0.0000
NC Descending NC Descending NC Ascending NC Ascending
&
&
&
&
Strong Price
Weak Price
Strong Price
Weak Price
Heuristic
Heuristic
Heuristic
Heuristic

Financial
&
Strong Price
Heuristic

Financial
&
Weak Price
Heuristic

Decision Tools & Decision Approaches
Figure 31 Means of prices paid across conditions grouped by decision tool * decision approach.

Results of hypothesis testing for Study 2 are summarized in Table 91 below.
HYPOTHESIS

RESULT

p-value

H4. The effect of usage of an NC Descending tool
on users’ decision quality will be negative and the
effects of usage of NC Ascending and Financial
tools on user’s decision quality will be positive,
such that:
H4A. The price paid for health plan will be
higher using NC Descending tool than when
SUPPORTED
using NC Ascending tool;
and H4B. The price paid for health plan will
be higher using NC Descending tool than
SUPPORTED
when using Financial tool.
H5. Perceived risk moderates the effect of NC
Descending, NC Ascending, and Financial tools
on users’ decision quality such that the effect of
usage of an NC Descending tool on users’
decision quality will be negative and the effects of
usage of NC Ascending and Financial tools on
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p =.000

p =.000

user’s decision quality will be positive under high
perceived risk but not under low perceived risk.
Under high perceived risk:
H5A. The price paid for health plan will be
higher using NC Descending tool than when
using NC Ascending tool, but there will be no
SUPPORTED
differences for users under low perceived
risk;
and H5B. The price paid for health plan will
be higher using NC Descending tool than
when using Financial tool, but there will be
no differences for users under low perceived
risk.

p=.01398

NOT
SUPPORTED

H6. Decision approach moderates the effect of
NC Descending, NC Ascending, and Financial
tools on users’ decision quality such that the effect
of usage of an NC Descending tool on users’
decision quality will be negative and the effects of
usage of NC Ascending and Financial tools on
user’s decision quality will be positive for users
driven weakly by price heuristics but not for users
driven strongly by price heuristics.
For users driven weakly by price heuristics:
H6A. The price paid for health plan will be
higher using NC Descending tool than when
using NC Ascending tool, but there will be no
differences for users driven strongly by price
heuristics;
and H6B. The price paid for health plan will
be higher using NC Descending tool than
when using Financial tool, but there will be
no differences for users driven strongly by
price heuristics.

NOT
SUPPORTED

NOT
SUPPORTED

Table 91 Hypotheses testing for Study 2.
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6 DISCUSSION
6.1 Study 1: Discussion
As demonstrated by the results of Study 1 and confirming findings from prior literature,
choice sets with asymmetrically dominated alternatives can change user’s purchase
decision: there was a clear switch between the options in NC Descending Anchor HP and
Anchor LP tools. Increasing the utility of the available alternative with an incremental
increase in the cost associated with it, drives the user to purchase a less expensive option
than when the choice set offers an alternative with the same utility change but a minor
change in cost. NC Descending with Low Price Anchor yielded the lowest decision quality
with plan purchased containing the largest extent in coverage and highest price.
As far as the differences in plans purchased across NC Descending with High Price Anchor
and Low Price Anchor versus with No Anchor the results may seem natural at first hand.
As much as if an alternative is not offered, it will not be chosen by the user, however, the
dynamic of differences across these decision tools demonstrates that choices, and thus,
decision quality, are frequently not a manifestation of one’s preferences, but can be easily
impacted by the characteristics of the output.
The circumstances of the user altered the dynamics of the effects of the tools only for users
under low perceived risk. As hypothesized, those users had a smaller inclination to
purchase the top plans whose coverage differed in terms of additional skin cancer benefits.
Interestingly, the effect of NC Descending with Anchor HP tool remained robust for those
users also – only the effect of LP Anchor tool changed the decision quality of the users
under low perceived risk.
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Furthermore, as hypothesized, the effects of the tools differed when the users were less
likely to be engaged in cost-utility trade-off and were primarily interested in minimizing
the cost of the plan. Similarly to the moderating effect of perceived risk, the effect of the
tool with a High Price Anchor remained robust, while the effect of Low Price Anchor
dissipated for users whose decision approach was strongly driven by price heuristics.
6.2 Study 2: Discussion
The results of Study 2 indicate that there is a significant difference in price paid for health
plans across the NC Descending, NC Ascending, and Financial tools. As expected, the
highest price is paid using NC Descending tool, it is lower when making the choice using
NC Ascending tool, and further lower using Financial tool. This latter result of the price
paid being significantly lower using Financial tool was not anticipated (it was only
anticipated that there would be a difference in NC Descending>NC Ascending and NC
Descending>Financial). This result shows that customization and breaking down the health
plans constituted added value and further mitigated overspending effect.
Although perceived risk didn’t fully moderate the effects of the decision tools on user’s
decision quality, although as the additional analysis demonstrated, the prices paid by users
under high perceived risk were significantly higher than prices paid by users under low
perceived risk using NC Descending and NC Ascending tools. This finding is interesting
in the sense that users under high perceived risk will pay higher prices using NC tools, but
not significantly higher than users under low perceived risk when making the decision
using the Financial tool. Additionally, being under high perceived risk does not guarantee
paying higher prices regardless of the tool, as reference dependence the users were subject
to still held.
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Using the Financial tool significantly lowered the price paid for users under low perceived
risk, further supporting the notion that customization can potentially mitigate
overspending.
Decision approach also didn’t fully moderate the effects of the decision tools on user’s
decision quality, but the prices paid were significantly lower for users driven strongly by
price heuristics when making the decision using NC Descending and NC Ascending tool
than for users driven weakly by price heuristics and making the decision with those tools.
This result indicates that users focused solely on price will pay lower prices than other
users when making the choice with non-compensatory tools. There was no significant
difference in price paid using the Financial tool for users driven strongly or weakly by price
heuristics.
Users driven strongly by price heuristics paid significantly different prices using the three
tools, thus were still subject to reference dependence; while users driven weakly by price
heuristics paid similar prices using non-compensatory tools but further lower prices using
the Financial tool. This result indicates that the Financial tool reduced price paid even when
NC Ascending tool didn’t.
Furthermore, as per the suggestions proposed by Novemsky & Kahneman (2005), being
under low perceived risk has been argued here to constitute an environment in which users
should seek generic health coverage (rather than specialized kind) at lower prices. The
findings here support this argument, thus add to the extant empirical evidence on decision
makers’ intention reducing loss aversion. However, the moderating effect of decision
approach has not been supported here and reference dependence remained robust for users
driven both weakly as well as strongly by price heuristics.
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6.3 Study 1 & 2: Collective Discussion
6.3.1 The role of output format in decision quality
Considering that the choice sets may include different levels of price and utility changes –
whether they are gradual or more extreme – the nature of the format of the output can affect
user’s decision-making and their ultimate choice. Users tend to be subject to reference
dependence based on the option they begin their consideration of options with and such
reference dependence will thus have an effect on their purchase decision: for instance when
the alternatives are displayed by the highest price on top of the list and decreasing the price
as the user evaluates the options further down the list, the user gains in cost while losing in
utility, subject to loss aversion, the user eventually pays a higher price than when the
options are displayed starting from the least expensive item.
6.3.2 The role of output characteristics in decision quality
The findings indicate that the purchase choice of the user is not only a result of their
preferences, their own characteristics, or even their circumstances (which can affect their
needs perceptions), but also are affected by the characteristics of the alternatives provided
by the tool. These characteristics may occur randomly (not predetermined by the vendor)
or purposely (if offered by the same vendor). As shown in Study 1, a large – or alternatively
very small - price difference across two options can change user’s choice of an item. In any
case, the decision the user makes is not entirely a representation of their preferences but
also is affected by the consideration of the other alternatives in the choice set, and,
particularly, the different aspects they may have.
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6.3.3 The role of decision tool design in the impact of online decision tool usage
As shown by the results of Study 2, when making the choice with a customization-based
tool with a choice set akin to a choice set as displayed in a Price Low-High output format,
the price paid by the user is further lower than when making the choice with NC Ascending
tool. This finding (price paid with Financial tool is significantly lower than NC Ascending
tool) was not initially expected (only a difference between NC Descending and Financial
tools was anticipated); however, it indicates that a combination of output format, content,
and tool design, can further minimize spending effect evoked by reference dependence.
The Financial tool exhibits a combination of all those elements: 1) it is based on
customization, thus enabling the user to pick the attribute packages they are interested in
instead of browsing through a list of items, 2) it displays the attribute packages in two
columns13 starting from a package akin to the NC Ascending tool – starting from the lowest
price package14, and 3) it breaks down the costs and coverage benefits of the different plans
characterizing them. Arguably, the customization feature and the breakdown of costs and
utilities, further enforces cost-utility analysis, and, since the reference point in this tool
constitutes the lowest price (and the lowest attribute package), every new attribute package
added is associated with a loss of cost and gain in utility. It is also believed here that the
customization-based tool reduces heuristic processing which the users are involved in when
making the choice when options are displayed as a sorted list. Interestingly, (Biswas, 2009)
showed that options framing holds under rational but not under experiential processing
modes and (Peng, Xia, Fanglin, et al., 2016) demonstrated that options framing held when
13

It is assumed here the users evaluate the attribute packages in an F-fashion.

14

Starting from the lowest price package and increasing the utility as in NC Ascending tool with price
increasing accordingly.
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participants were focusing on cost-utility analysis but not when they were focusing on their
enjoyment out of the purchase; in this experiment the customization-based tool further
lowered price paid thus extending prior findings.

These findings indicate that tool design can further affect decision outcome in combination
with the way information is delivered to the user.

Furthermore, in addition to the discussion pertaining to output format, if the design of the
decision tool yields a certain method of displaying the options, then the dynamics of the
output format will also hold. However, this may not always be the case – a noncompensatory tool may also display its output in several columns (or in other ways, such
as side by side), not necessarily as single sorted list.

The results of this study support and extends the findings of (Song et al., 2007) showing
inferiority of non-compensatory tools and further extends (Tan et al., 2010) indicating
user’s higher decision quality when number of attributes is low, by looking at the
phenomenon in detail, taking into consideration the interaction between the user, the tool
and information delivery characteristics.
6.3.4 The role of decision context in the impact of online decision tool usage
The situational factors that the user finds themselves in, such as the level of perceived risk
can affect their perception of anticipated need for health services, thus driving them to
purchase more coverage and/or pay a higher price (such as pay a higher premium in
exchange for lower deductible). If intention moderates loss aversion (Novemsky &
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Kahneman, 2005), users under high perceived risk should be inclined to purchasing
different alternatives than users under low perceived risk, thus altering the effect of the
characteristics and the format of the output – if the effect of the output is a result of
reference dependence. As shown by the findings here, there is a tendency to moderate the
effect of the decision tools, although not fully – since, for instance, NC Descending with
HP Anchor tool remained robust for users both under high as well as low perceived risk.
6.3.5 The role of user’s decision approach in the impact of online decision tool usage
Similarly to decision context, if decision approach of the user is associated with their
primary interest/ objective, it is also likely to change the decision outcome regardless of
how information is delivered by the tool. As presented in the findings of this study, if
information delivery subjects the user to reference dependence – and the consideration of
the available alternatives is associated with cost-utility trade-off – such effect is diminished
when the user is focused on one particular element during their decision, for instance cost
minimization. For users who rely on price of the available options and don’t pay attention
to the coverage benefits of the health plan, the choice will be different (lower price paid)
than for those who take both aspects (price and benefits) into consideration. However, as
shown by findings of Study 1, these effects are not entirely eradicated, as the effect of NC
Descending Anchor HP tool still had an influence on their decision.
6.3.5 Research Questions Answered
1. How can the design of an online decision tool affect user’s purchase decision?
The design of an online decision tool can have varying effects on user’s decision quality –
potentially decreasing or improving it, depending on the specific features and how it is
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used. As the decision tool design constitutes only one aspect of an online decision - making
process, the effect of usage of an online decision aid should be considered in the light of
both how the alternatives are generated by the tool as well as how they are presented to the
user.
The decision quality obtained by the user may be lower, that is the user may spend more
on a health plan, using different types of decision tools – this however depends on how the
available health insurance plans are displayed to the user and how they are characterized.
If the price of the alternatives is the focus of the decision tools and the choice sets, these
overspending effects may be evoked by decoy effect or price order effect.
2. How can such an effect be mitigated?
Indeed, a particular decision tool design in combination with information delivery, can
reduce price paid for a health plan if the overspending effect is evoked by reference
dependence.
3. Which consumers are particularly vulnerable to this effect?
Particularly vulnerable to overspend are users not driven by price heuristics or users in
circumstances driving the need to purchase more (or pay a higher price), such as users
under high perceived risk.
4. What is the effect of non-compensatory online decision tool usage on buyer’s
decision quality?
The use of a non-compensatory online decision tool on buyer’s decision quality is lower
(higher price paid) when the alternatives are presented as a sorted list by price in a
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descending fashion, it is higher (lower price paid) when the options are displayed as a
sorted list by price in an ascending fashion.
User’s decision quality may also be lower when the choice set contains an asymmetrically
dominated alternative focusing user’s attention to a particular option. Although this is not
only pertinent to a non-compensatory tool, it needs to be mentioned here, if the focus is on
single attribute-based decision tools.
5. What is the effect of a customization-based online decision tool usage on buyer’s
decision quality?
The effect of a customization-based online decision tool increases user’s decision quality
as the price paid by those users is lower than when making the choice with noncompensatory tools.
6. How will these effects vary for consumers under different levels of perceived risk
and who differ in the decision approach they undertake?
For users under high perceived risk, the effects of non-compensatory tools may exacerbate
overspending effect, as risk perception places the user in a position of greater anticipated
need of health services, thus driving them to purchase more. For users who are primarily
driven by price heuristics spending will be lower than for users weakly driven by price
heuristics, as those users are less engaged in cost-utility analysis across the available
options and are focused on cost minimization regardless of information delivery.
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6.3.6 Generalizability
Although the studies carried out here adopt price anchoring and price order effect (with
assumptions relating to price and utility drops or increases), which may not always occur
in outputs generated by non-compensatory tools, the dynamics of the effect of a noncompensatory tool enabling price sorting is largely generalizable. Reference dependence
and loss aversion, both effects which price anchoring and price order effect stem from,
have been demonstrated to be robust across conditions and contexts (Ariely, Huber, &
Wertenbroch, 2005; Jin et al., 2012; Levin, Schreiber, Lauriola, & Gath, 2002; Suk et al.,
2012). Varying levels of anchors in pricing and presence of decoys differentially affect
consumer choices (Ariely et al., 2005; Heath & Chatterjee, 1995) thus different price
anchors as well as the non-existence of an anchor is examined in this study.
It is therefore reasoned that the findings related to the effects of non-compensatory and
customization-based tool designs as well as output characteristics and format should apply
not only to the specifics outlined in the choice sets adopted here. Indeed, by focusing the
study on simple individual features of online decision tools, the findings can apply to
different contexts and other tools adopting these design and information delivery features
– as long as the user is subject to reference dependence. For instance, (Cai & Xu, 2008)
who studied item sorting in e-commerce for products with positive correlation between
price and quality whereby the items were sorted by descending and ascending quality as
well as random ordering of quality; they showed that users include items of higher quality
in their consideration sets when provided with a descending list.
Furthermore, although the decision adopted in this study – purchase of a health insurance
plan under high perceived risk - is specific, it generalizes to other settings and
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circumstances in which the user makes a purchase choice. At minimum, it generalizes to
products and services of precautionary nature, although since relative pricing has been
studied in a number of contexts and has been shown to be robust, it can be argued that the
focus on health insurance here does not limit the findings to this item. Furthermore,
decision under perceived risk, taking into account its idiosyncrasies, can also arguably
constitute an exemplary context where the user might be willing to pay a higher price or
purchase an item of greater utility than otherwise.
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7 CONCLUSIONS
7.1 Contribution
This study contributes to IS literature by considering the effectiveness of online decision
tools in the setting of the contextual mechanisms of the decision scenario and exploring the
dynamics of the fit between decision tool design, output characteristics, the user’s
situational environment, and the user’s cognition. It serves as an illustration of a decision
process supported by two types of online decision tools within the more comprehensive
context of decision scenario; DSS literature mostly discusses the effectiveness of tools in
terms of their capacity to handle cognitive overload, little is known about the mechanisms
of decision tools and their effectiveness in the light of a decision process, such as a purchase
choice process. It also demonstrates how characteristics of information delivery can subject
the user to reference dependence and evoke biased processing.
This study answers a call for research raised by (Xiao & Benbasat, 2007, 2014) to examine
decision tool- and user- related factors that impact the effect of usage of online
recommendation agents on decision outcomes. Specifically, it investigates the role of
design features of a non-compensatory and customization-based tools and their output
characteristics in user’s choice, and the effect of these features on user’s decision quality.
It shows that for users making their decision with a non-compensatory tool when the search
results are sorted by price, their decision quality – the price they pay – can differ depending
on whether the items are sorted in a descending or ascending fashion, and, the situational
context of the user. Furthermore, the decision quality will differ for various tool designs
and information delivery methods – whether the design of the tool facilitates cost-utility
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analysis, or when the display of the alternatives facilitates heuristic processing (such as in
a sorted list).
It also extends the research by (Xiao & Benbasat, 2007, 2014) whose propositions
regarding output content only referred to utility scores or predicted ratings; as well as
whose propositions regarding output format discussed the number of generated alternatives
and potential improvement in decision quality of sorted options by evoking heuristic
processing.
Drawing from relative pricing literature, this study also extends decision support research
to detailed dynamics which can be evoked by the characteristics of the output and the
format of the output of online decision tools.
This study also extends prior decision support systems research which has so far largely
focused on product-related purchases (Xiao & Benbasat, 2007, 2014) to service purchase
tasks. It shows the dynamics of complex service purchase choices being made with
standard online decision tools – specifically common design features of such tools- and the
interaction between the peculiar environmental contexts that the user is at while making
such decisions and the decision tool.
This study extends research investigating the decoy effect by demonstrating the differences
in options chosen when asymmetrically dominated alternatives differ in terms of the price
increase with the same change in utility. It further extends this research by showing the
moderating effects of perceived risk and decision approach and how this moderation is
bounded by different levels of change in price in the anchor options.

231

It extends options framing and price order effect to comparisons of choice sets presented
as lists of full items vs. customizable options and it shows that option framing and price
order effect will differ even if in both conditions the alternatives begin with the lowest
price. Furthermore, it extends research concerning the moderating effect of option
importance to conditions where the options available may be of interest to the user, yet
reference dependence remains robust. It also demonstrates the moderating effects of
perceived risk and decision approach on reference dependence that the consumer is subject
to. It shows that reference dependence may still hold even for users in specific conditions
and with clear decision approaches – although their ultimate decisions may still differ.
Furthermore, prior research has argued that price order effect should only occur with choice
sets assuming price-quality relationship (Diehl et al., 2003; Suk et al., 2012). In this study,
neither of the choice sets assumes such a relationship, however it does assume price-utility
association, which also significantly impacts user’s decision.
The study extends research concerning the boundaries of loss aversion research by
examining the moderating effect of decision context on decoy effect, price order effect,
and options framing as well as the moderating impact of decision approach on loss
aversion. It extends the findings of (Novemsky & Kahneman, 2005) indicating that
intention moderates loss aversion, to conditions influencing preference creation and
decision approach which the decision maker undertakes when making the choice. It further
contributes to the research of (Koszegi & Rabin, 2006) who posited that the reference point
may not be current endowment (thus the transaction would not entail loss aversion) but
expected endowment.
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Furthermore, it contributes to scholarship concerning consumer behavior under perceived
risk, specifically health insurance choices under risk, by furthering our understanding of
the decisions which consumers make in the online environment under low and under high
perceived risk. It extends extant research by examining the distinct choices for healthcare
coverage the consumers make and the prices they pay when choosing from a set of options,
or, alternatively, when customizing the plan, online.
At a practical level the study informs consumers about the potential consequences of the
choices they make while purchasing items online. It educates the public of possible
ramifications to the quality of decisions they make with the support of online tools in
different circumstances, they may find themselves in, in their everyday lives. Particularly,
it demonstrates that a consumer purchasing an item such as health insurance with the
support of a non-compensatory online decision tool under high perceived risk, may
overspend. It is advisable that - for users wishing to minimize the price they pay - the
purchases done in situations of increased perceived risk should be carried out with
customization-based decision tools, as the price paid for health plans with those types of
tools is lower. It is further conceivable that providers attempting to stimulate their sales,
may potentially misuse the design and output characteristics of non-compensatory tools
and leave consumers vulnerable. The negative impact that of the design of noncompensatory tools and their output characteristics – whether unintentional (embedded
naturally in the tool) or deliberate – calls for a reconsideration of decision tool design and
possible standardization of such tools in certain domains and industries.
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7.2 Limitations
Study 1 and study 2 and the findings they have uncovered are both subject to several
limitations.
Firstly, the choice sets adopted in the studies have specific characteristics in terms of the
way they are priced and their respective utilities, which may not always be the case in
outputs generated by non-compensatory tools online. In study 1 the topmost alternative is
established purposely as an anchor and in study 2 the alternatives increase gradually in
terms of both the prices and utilities. In the online setting the characteristics of the output
(in terms of changes and gaps across prices and the extent and characteristics of the utilities
offered) will vary across websites and available inventory at hand by the merchants. The
case of pricing will also differ depending on whether the website is provided and managed
by the supplier or vendor. Arguably, alternatives offered directly by the supplier may be
associated with one another in terms of pricing; while the pricing of options aggregated
from various suppliers may be rather unrelated and, thus, generated as a single output of a
non-compensatory tool, provided by a vendor, may be more unsystematic. Although this
study has adopted robust effects of anchoring, price order effect, and options framing to
explain the dynamics of price sort in a non-compensatory tool and the characteristics of
their output, further research is required for us to fully understand these mechanisms.
Moreover, the choice sets are focused around a single health condition which, although
necessary to examine the effects under study (to show users’ choices with regards to the
coverage while under high perceived risk for a particular adverse outcome), are not entirely
reflective of actual health plans offered in the industry.
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Furthermore, the customization tool also examines the choice set as precisely equivalent to
the non-compensatory ascending tool. Although this is necessary to demonstrate the
effectiveness of the tool to mitigate the negative impact of the non-compensatory tool on
user’s decision quality, the industry may not always offer such alternatives. The
effectiveness of the customization tool in terms of mitigating overspending, may be
therefore limited to the choice set characteristics.
Secondly, the choice set size was fixed in both studies, although possible number of options
generated by online decision tools and offered by providers can easily go beyond that.
Consumers facing a vast number of alternatives are subject to information overload and
adopt heuristic processing to manage the options. On the one hand, it can be argued that in
such circumstances the effect of anchors and price sort in non-compensatory and
customization tools on user choices will hold. On the other hand, it is conceivable that users
in different situations, driven by specific motivations, for instance highly involved in the
purchase activity, should be more inclined into thoroughly considering further options in
the choice set. In this case the effect of anchors could potentially dissipate, as with
deliberation of more options, the user may be more likely to choose one of the options
further down from the anchor. The effect of purchase task involvement might possibly
amplify the effect of cost-utility analysis in non-compensatory and customization tools, as
the user would be more committed into this manner of considering the options. The effect
of anchors, non-compensatory and customization tools might also differ for users with
clearly established preferences or set budgets. Those users might be less susceptible to
heuristics and may not examine the options in terms of their costs and respective utilities,
but rather search for options that fit with their individual objectives.
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Thirdly, by focusing on output characteristics, this study tests non-compensatory tools in a
given, pre-established format. The non-compensatory tool is studied in two conditions:
descending and ascending price order; and the customization tool is studied in a single
condition, whereby the attribute packages are listed in an equivalent manner to the noncompensatory ascending tool (starting with the lowest level of attributes). The study does
not take into account the motivations to utilize different tools available and how to use
them – for instance, users may differ in their choices to use a non-compensatory tool and
sort by price either in descending or ascending fashion, and, therefore, obtain different
formats of the output.
Fourthly, the decision tools examined here are simplified – the functionality embedded in
the non-compensatory tool enables the user not only just to sort but also to sort only price,
while the customization tool only lets the user pick and choose packages to customize one
out of possible 10 alternatives. Neither the non-compensatory nor the customization tool
studied here has any other functionalities which would facilitate the decision-making
process for the user, such as filtering or sorting by any other factors. This simplification
has been chosen for the purpose of the study to focus on those specific design features and
output characteristics, however in the online environment greater complexity of tools is
available, which could change the dynamics and the result of the choice.
Fifthly, the customization-based tool offered here as an alternative to the noncompensatory tool mitigates the effect of overspending which occurs when using the latter
tool, however, it needs to be shown that it is not entirely behaviorally-neutral.
Customization of the alternative out of attribute packages presented beginning from the
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package with utility equivalent to the lowest option in the ascending tool also subjects the
user to reference dependence, similarly to the non-compensatory tool.
Finally, the experimental design adopted for the purpose of the study involved a scenario
which also sets limitations to the interpretation of the findings. The participants during the
experiment were instructed to imagine themselves in a situation as per the scenario and to
make their purchase choice as if they were in such circumstances. This raises a question to
what extent were the participants able to imagine themselves in such a situation and to what
extent was their choice indeed reflective of the choice they would make in their lives.
Furthermore, the participants during the experiments were not given a budget to keep in
mind while making the purchase choice- there was no mention of budget or income in the
instructions. In their everyday lives, consumers are likely to be impacted by their incomes,
which could, in turns affect their decisions even when presented with options in such a way
that evoke reference dependence.
7.3 Further research recommendations
This study represents one of minority of studies examining at a detailed level the effect of
online decision tool usage on user’s decision quality within the contextual setting of the
decision scenario and the interaction between the tool and the user at the cognitive level. It
constitutes a necessary step in our understanding of the dynamics of online decision tools
and, particularly, the differential impact that information delivery embedded in decision
tool design and output characteristics can have on user’s choices. The study also constitutes
one of a minority of studies specifically focusing on non-compensatory designs. Further
research is needed, however, to examine this phenomenon in order for us to fully
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understand the interaction between the user and the decision tool, so that we can provide
effective decision tool designs.
Future research should investigate the conditions that can amplify or diminish the effects
of anchoring and reference dependence and change the impact of the tool on user’s decision
quality. User’s personal characteristics such as task commitment or item involvement may
be investigated as possible elements that can change the way the user cross-examines the
alternatives and, ultimately, influence their decision. Different environmental/situational
factors may also be studied, with varying levels of uncertainty of user’s preferences. There
is also a need for further studies that would attempt to offer further tool designs which
could mitigate the negative effect of reference dependence on user’s decision quality. It is
imperative that decision tool design takes into consideration user’s individual and
environmental factors and is maximally tailored to the user’s purchase task in order to
support less biased decision making.
Accordingly, additional studies are needed which would examine the role of user’s
heuristics and biases in their interaction with the decision tool, and, how such cognitive
limitations can be evoked by different forms of decision tool design or user’s information
processing. Interesting phenomena can include user’s heuristic processing when making
the choice with non-compensatory tools, framing effects, which can be induced by
information presentation, or selection bias possible to occur when examining the choice
set.
There is a need for additional research that would inspect not only the impact of the tool
on user’s decision outcomes, but also research of how the decision tool is appropriated by
the user. With increasing level of functionality of decision tools and a number of
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capabilities for the user to choose from and how to use them, it is crucial that scholarship
examines how such functions (such as how the user sorts – and/or by which factor) are
utilized by the user, as those elements then influence output characteristics, and, possibly,
the decision-making process. An interesting phenomenon would be self-framing (X. T.
Wang, 2004) and possibly extending it in the decision tool design domain: for instance,
users in different circumstances will use such design features differentially, for instance,
users with higher income or, potentially, users who are motivated (for any reason) to pay a
higher price for an item, may be more inclined to sort by price in descending fashion, or
users who lack trust with online vendors, may be more inclined to sort by customer reviews.
7.4 Conclusion
This study investigates the role of output format, output content, decision tool design,
decision context, and user’s decision approach in user’s decision quality. As the context of
the purchase decision examined here is health insurance, for which consumers frequently
adopt price heuristics, the element that this paper focuses on is price – aspects of
information delivery and tool design related to the price of the alternatives. It shows that
the different factors pertinent to an online purchase using non-compensatory and
customization-based tools, can on the one hand, yield higher price paid or more extensive
items purchased by the users, and on the other hand, mitigate such overspending effects.
The findings of this study indicate that the effectiveness of online decision tools is
influenced not only by tool design but also by the item search output characteristics, user’s
cognition, as well as the individual circumstances in which the user is at. Drawing from
relative pricing literature, this study shows that non-compensatory tools which enable the
user to sort by price, may subject the user to reference dependence, thus, having a negative
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impact on their decision quality. Users making their purchase choice with a noncompensatory tool sorting by price in a descending fashion pays a higher price than users
making their decision when the alternatives are sorted in an ascending manner. Usage of a
customization-based tool further positively impacts the user’s decision quality by
mitigating this overspending effect. In conclusion, decision tools can have a substantial
effect on users’ choices which can result in different prices paid and varying items being
purchased. Decision tool design, which has so far been very extensively discussed in the
information systems literature, is not the only element which can affect decision quality.
Users’ online choices are impacted by the components of the decision tool supporting the
different stages of the decision-making process as well as by the user and their
circumstances.
Furthermore, the decision approach the user takes up when making the choice can further
amplify the effect of the non-compensatory tool enabling the user to sort by price, by
moderating the reference dependence embedded in it.
Output characteristics of online decision tools, which depend on the tool design and/or the
specifics of the choice set itself, can also impact purchase choices that the user makes.
Last, but not least, this study shows the complexity of moderating the effects of reference
dependence, which a consumer can be subject to, for instance in the online environment.
As much as the circumstances of the user can contribute to their preference creation, and
in such situations (when considering a choice set with limited number of relatable
alternatives), reference dependence can be reduced. Additionally, the results of this study
showed a significant moderation of reference dependence by the user’s decision approach
– being weakly driven by price heuristics, contrary to the hypothesized argument.
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APPENDICES
APPENDIX 1 STUDY 1 DECISION APPROACH FACTOR ANALYSIS
Results of factor analysis for decision approach in Study 1 are presented in Tables 92-97
and Figure 32 below.
KMO and Bartlett’s Test
Kaiser-Meyer-Olkin
Measure of Sampling
Adequacy
Bartlett’s Test of
Sphericity

.688

Approx. Chi-Square

506.631

df
Sig.

6
.00000000

Table 92 KMO and Bartlett's test - decision approach in Study 1.

Correlation Matrix

Correlation

Sig.
(1-tailed)

I relied
completely on
price.
All that
mattered was
minimizing
cost I would
incur.
I wasn’t
concerned
about
coverage
benefits at all.
The coverage
benefits didn’t
matter at all.
I relied
completely on
price.

I relied
completely on
price.

All that
mattered
was
minimizing
cost I would
incur.

I wasn’t
concerned
about
coverage
benefits at
all.

The
coverage
benefits
didn’t
matter at
all.

1.000

.659

.564

.542

.659

1.000

.355

.430

.564

.355

1.000

.732

.542

.430

.732

1.000

.000

.000

.000
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All that
mattered was
minimizing
cost I would
incur.
I wasn’t
concerned
about
coverage
benefits at all.
The coverage
benefits didn’t
matter at all.

.000

.000

.000

.000

.000

.000

.000

.000

.000

Table 93 Correlation matrix for decision approach in Study 1.

Communalities
Initial
1.000

I relied completely on price.
All that mattered was minimizing cost I
1.000
would incur.
I wasn’t concerned about coverage
1.000
benefits at all.
The coverage benefits didn’t matter at all.
1.000
Extraction Method: Principal Component Analysis.

Extraction
.726
.543
.677
.702

Table 94 Communalities for decision approach in Study 1.

Total Variance Explained
Initial Eigenvalues
Component

% of
Cumulative
Variance
%
1
2.648
66.201
66.201
2
.779
19.473
85.674
3
.334
8.357
94.030
4
.239
5.970
100.000
Extraction Method: Principal Component Analysis.
Total

Extraction Sums of Squared
Loadings
% of
Cumulative
Total
Variance
%
2.648
66.201
66.201

Table 95 Total variance explained for decision approach in Study 1.
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Figure 32 Scree plot for decision approach in Study 1.

Component Matrixa

I relied completely on price.
All that mattered was minimizing cost I would incur.
I wasn’t concerned about coverage benefits at all.
The coverage benefits didn’t matter at all.
Extraction Method: Principal Component Analysis.
a. 1 components extracted.

Component
1
.852
.737
.823
.838

Table 96 Component matrix for decision approach in Study 1.

Reliability Statistics
Cronbach’s Alpha
.825

N of Items
4
Table 97 Cronbach's alpha for decision approach in Study 1.

KMO for all the items was .688 and Bartlett’s Test of Sphericity was 506.631, p=.00000.
Cronbach’s Alpha for the measure reached a satisfactory .825 indicating the measure is
internally consistent (Haif, Ringle, & Sarstedt, 2011).
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To measure price heuristics driven decision approach, four items (as indicated in the
analysis above) were used:
Just now, when I was choosing the health plan:
I relied completely on price. – I didn’t rely on price at all.
All that mattered was minimizing cost I would incur. - minimizing cost I would incur
didn’t matter at all.
I wasn’t concerned about coverage benefits at all. – I was only concerned with coverage
benefits.
The coverage benefits didn’t matter at all. – The coverage benefits were all that mattered.
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APPENDIX 2 STUDY 1 EXPERIMENTAL TASK INVOLVEMENT &
MANIPULATIONS
It was examined whether there was any difference in terms of plan purchased across the
respondents who varied in their involvement with reading the Perceived Risk scenario
(measured as correct answers provided). No significant difference was found. Results are
shown below in tables 98-99.

CROSSTABULATION RESULTS: Plan Purchased * Perceived Risk Scenario
Involvement
Perceived Risk Scenario Involvement
0/2
Plan
1/2 Answer 2/2 Answers
Answers
Total
Purchased
Correct
Correct
Correct
Golden
Count
6a
13a
27a
46
Plus
Residual
.6
-4.8
4.2
Golden
Count
10a
37a
48a
95
Residual
-1.2
.3
.8
Silver &
Count
16a
55a
60a
131
Other
Residual
.6
4.4
-5.0
Each subscript letter denotes a subset of Perceived Risk Scenario Involvement
categories whose column proportions do not differ significantly from each other at the
.05 level
Linear-by-Linear Association (1, N=272) = 1.188, (Exact sig.) p =.287
Table 98 Crosstabulation of plans chosen across scenario involvement in Study 1.

It was examined whether there was any difference in terms of plan purchased across the
respondents who varied in their involvement with reading the informational text pertaining
to skin cancer – Knowledge of Adverse Outcome text (measured as correct answers
provided). No significant difference was found. Results are shown below in tables 100101.
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CROSSTABULATION RESULTS: Plan Purchased * Knowledge of Adverse Outcome
Involvement
Knowledge of Adverse Outcome Involvement
0/4
3/4
4/4
1/4
2/4
Plan
Answers
Answers Answers
Answer Answers
Total
Purchased
Correct
Correct
Correct
Correct Correct
or 5/4
Golden
10a
22a
Count
2a
3a
9a
46
Plus
Residual
-1.7
1.8
.7
-5.2
4.4
Golden
Count
6a
2a
14a
37a
36a
95
Residual
-1.7
-.4
-3.1
5.6
-.3
Silver &
43a
46a
Count
14a
2a
26a
272
Other
Residual
3.4
-1.4
2.4
-.3
-4.1
Each subscript letter denotes a subset of Perceived Risk Scenario Involvement
categories whose column proportions do not differ significantly from each other at the
.05 level
Linear-by-Linear Association (1, N=272) = 1.761, (Exact sig.) p =.190
Table 99 Crosstabulation - plans chosen across Knowledge of Adverse Outcome Involvement Study 1.

It was examined whether there was any difference in terms of perceived risk across the
respondents who varied in their involvement with reading the Perceived Risk scenario
(measured as correct answers provided). No significant difference was found. Results are
shown below in tables 102-103.

Test of Homogeneity of Variances
Levene Statistic
Perceived
Based on
2.614
Risk
Mean
Based on
2.078
Median
Based on
Median and
2.078
with
adjusted df
Based on
trimmed
2.901
mean

df1

df2

Sig.

2

286

.075

2

286

.127

2

276.441

.127

2

286

.057

Table 100 Homogeneity of variances test of perceived risk across scenario involvement Study 1.
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ANOVA RESULTS (DV: Perceived Risk)
Source
Type III Sum of
df
Mean Square
Squares
Between
35.285
2
17.642
Groups
Within
1907.317
286
6.669
Groups
Total
1942.602
288

F

Sig.

2.645

.073

Table 101 ANOVA for perceived risk across Scenario Involvement in Study 1.

It was examined whether there was any difference in terms of perceived risk across the
respondents who varied in their involvement with reading the informational text pertaining
to skin cancer – Knowledge of Adverse Outcome text (measured as correct answers
provided). No significant difference was found. Results are shown below in tables 104105.
Test of Homogeneity of Variances
Levene Statistic
Perceived
Based on
1.374
Risk
Mean
Based on
1.023
Median
Based on
Median and
1.023
with
adjusted df
Based on
trimmed
1.367
mean

df1

df2

Sig.

4

283

.243

4

283

.396

4

275.504

.396

4

283

.245

Table 102 Homogeneity of variances test for perceived risk across Knowledge of Adverse Outcome Involvement in
Study 1.

ANOVA RESULTS (DV: Perceived Risk)
Source
Type III Sum of
df
Mean Square
Squares
Between
28.700
4
7.175
Groups
Within
1899.018
283
6.710
Groups
Total
1927.719
287

F

Sig.

1.069

.372

Table 103 ANOVA for perceived risk across Knowledge of Adverse Outcome Involvement in Study 1.
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APPENDIX 3 STUDY 1 EXPERIMENTAL MANIPULATIONS ACROSS DATA
SOURCES
It was examined whether there was any difference in terms of perceived risk (tables 106107) and plan purchased (108-109) across the respondents joining the experiment from
different locations. There was a significant difference p=.003 across the data sources in
terms of perceived risk, however there was no significant difference in terms of price paid.
The pair of data sources significantly different from each other by perceived risk include
Students at FIU and respondents from AMT (also largest groups).

Kruskal-Wallis test for perceived risk.

Independent-Samples
Kruskal-Wallis Test Summary (DV: Perceived Risk)
Total N
289
Test Statistic
15.876a
Degree of
4
Freedom
Asymptotic Sig.
.003
(2-sided test)
a. The test statistic is adjusted for ties.
Table 104 Kruskal-Wallis result for perceived risk across data sources in Study 1.

Pairwise Comparisons of Data Sources
Dependent Variable:
Perceived Risk
Test
Sample 1
Sample 2
Statistic
AIS World
University
62.319
1
AIS World
Amazon
Mechanical 112.673
Turk
AIS World
Social
133.500
Media
262

Std.
Error

Std. Test
Statistic

Sig.

Adj.
Sig.a

60.270

1.034

.301

1.000

58.899

1.913

.056

.557

82.962

1.609

.108

1.000

AIS World

University
180.500 101.607
1.776
.076
.757
2
University 1
Amazon
Mechanical -50.354
14.797
-3.403
.001
.007
Turk
University 1
Social
-71.181
60.270
-1.181
.238
1.000
Media
University 1
University
-118.181 84.106
-1.405
.160
1.000
2
AMT
Social
-20.827
58.899
-.354
.724
1.000
Media
AMT
University
67.827
83.129
.816
.415
1.000
2
Social Media
University
47.000
101.607
.463
.644
1.000
2
Each row tests the null hypothesis that the Sample 1 and Sample 2 distributions are the
same.
Asymptotic significances (2-sided tests) are displayed. The significance level is .05.
a. Significance values have been adjusted by the Bonferroni correction for multiple
tests.
Table 105 Pairwise comparisons for perceived risk across data sources in Study 1.

Crosstabs analysis for plan purchased.

CROSSTABULATION RESULTS: Plan Purchased * Data Source
Data Source
Amazon
Plan
University University
Social
AIS
Mechanical
Purchased
1
2
Media World
Turk
Golden
Count
5a
0a
40a
1a
0a
Plus
Residual
Golden
Count
12a
0a
82a
1a
0a
Residual
Silver &
Count
15a
1a
113a
1a
1a
Other
Residual
Each subscript letter denotes a subset of Data Source categories whose column
proportions do not differ significantly from each other at the .05 level
Linear-by-Linear Association (1, N=272) = .006, (Exact sig.) p =.967

Total
46
95
131

Table 106 Crosstabulation for plan purchased across data sources in Study 1.
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APPENDIX 4 STUDY 2 DECISION APPROACH FACTOR ANALYSIS
Results of factor analysis for decision approach in Study 2 are presented below in tables
110-115 and Figure 33.

KMO and Bartlett’s Test
Kaiser-Meyer-Olkin
Measure of Sampling
Adequacy
Bartlett’s Test of
Sphericity

.674

Approx. Chi-Square

473.978

df
Sig.

6
.00000000

Table 107 KMO and Bartlett's test - decision approach in Study 2.

Correlation Matrix

Correlation

Sig. (1tailed)

I relied
completely
on price.
All that
mattered was
minimizing
cost I would
incur.
I wasn’t
concerned
about
coverage
benefits at
all.
The coverage
benefits
didn’t matter
at all.
I relied
completely
on price.

I relied
completely on
price.

All that
mattered
was
minimizing
cost I would
incur.

I wasn’t
concerned
about
coverage
benefits at
all.

The
coverage
benefits
didn’t
matter at
all.

1.000

.607

.537

.517

.607

1.000

.338

.338

.537

.338

1.000

.805

.517

.338

.805

1.000

.000

.000

.000
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All that
mattered was
minimizing
cost I would
incur.
I wasn’t
concerned
about
coverage
benefits at
all.
The coverage
benefits
didn’t matter
at all.

.000

.000

.000

.000

.000

.000

.000

.000

.000

Table 108 Correlation matrix for decision approach in Study 2.

Communalities
Initial
1.000

I relied completely on price.
All that mattered was minimizing cost I
1.000
would incur.
I wasn’t concerned about coverage
1.000
benefits at all.
The coverage benefits didn’t matter at all.
1.000
Extraction Method: Principal Component Analysis.

Extraction
.680
.460
.729
.717

Table 109 Communalities for decision approach in Study 2.

Total Variance Explained
Initial Eigenvalues
Component

% of
Cumulative
Variance
%
1
2.586
64.650
64.650
2
.868
21.695
86.345
3
.352
8.800
95.145
4
.194
4.855
100.00
Extraction Method: Principal Component Analysis.
Total

Extraction Sums of Squared
Loadings
% of
Cumulative
Total
Variance
%
2.586
64.650
64.650

Table 110 Total variance explained - decision approach in Study 2.
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Figure 33 Scree plot for decision approach in Study 2.

Component Matrixa

I relied completely on price.
All that mattered was minimizing cost I would incur.
I wasn’t concerned about coverage benefits at all.
The coverage benefits didn’t matter at all.
Extraction Method: Principal Component Analysis.
a. 1 components extracted.

Component
1
.825
.678
.854
.847

Table 111 Component matrix for decision approach in Study 2.

Reliability Statistics
Cronbach’s Alpha
.811

N of Items
4
Table 112 Cronbach's alpha for decision approach in Study 2.

KMO for all the items was .674 and Bartlett’s Test of Sphericity was 473.978, p=.00000.
Cronbach’s Alpha for the measure reached a satisfactory .811 indicating the measure is
internally consistent (Haif et al., 2011).
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To measure price heuristics driven decision approach, four items were used (as indicated
in the analysis above):
Just now, when I was choosing the health plan:
I relied completely on price. – I didn’t rely on price at all.
All that mattered was minimizing cost I would incur. - minimizing cost I would incur
didn’t matter at all.
I wasn’t concerned about coverage benefits at all. – I was only concerned with coverage
benefits.
The coverage benefits didn’t matter at all. – The coverage benefits were all that mattered.
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APPENDIX 5 STUDY 2 EXPERIMENTAL TASK INVOLVEMENT &
MANIPULATIONS

It was examined whether there was any difference in terms of price paid across the
respondents who varied in their involvement with reading the Perceived Risk scenario
(measured as correct answers provided). No significant difference was found. Results are
shown below in tables 116-117.

Test of Homogeneity of Variances
Levene Statistic
Perceived
Based on
1.422
Risk
Mean
Based on
1.495
Median
Based on
Median and
1.495
with
adjusted df
Based on
trimmed
1.444
mean

df1

df2

Sig.

2

257

.243

2

257

.226

2

256.820

.226

2

257

.238

Table 113 Homogeneity of variances test - price paid across scenario involvement in Study 2.

ANOVA RESULTS (DV: Price Paid)
Source
Type III Sum of
df
Squares
Between
17196.449
2
Groups
Within
1844082.292
257
Groups
Total
1861278.741
259

Mean Square

F

Sig.

8598.225

1.198

.303

7175.417

Table 114 ANOVA result for price paid across scenario involvement in Study 2.

It was examined whether there was any difference in terms of price paid across the
respondents who varied in their involvement with reading the informational text pertaining
to skin cancer – Knowledge of Adverse Outcome text (measured as correct answers
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provided). No significant difference was found. Results are shown below in tables 118119.

Test of Homogeneity of Variances
Levene Statistic
Perceived
Based on
.273
Risk
Mean
Based on
.168
Median
Based on
Median and
.168
with
adjusted df
Based on
trimmed
.272
mean

df1

df2

Sig.

4

255

.896

4

255

.954

4

248.500

.954

4

255

.896

Table 115 Homogeneity of variances test - price paid across Knowledge of Adverse Outcome Involvement in Study 2.

ANOVA RESULTS (DV: Price Paid)
Source
Type III Sum of
df
Squares
Between
52500.955
4
Groups
Within
180.08777.786
255
Groups
Total
1861278.741
259

Mean Square

F

Sig.

13125.329

1.850

.120

7093.246

Table 116 ANOVA result for prices paid across Knowledge of Adverse Outcome Involvement in Study 2.

It was examined whether there was any difference in terms of perceived risk (tables 120121) across the respondents who varied in their involvement with reading the informational
text pertaining to skin cancer – Knowledge of Adverse Outcome text (measured as correct
answers provided). There was a significant difference, however, adjusted significance
values did not show any significant differences (significance level differences were found
between 1/4 and 3/4 and 1/4/ and 4/4).
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Independent-Samples
Kruskal-Wallis Test Summary (DV: Perceived Risk)
Total N
259
Test Statistic
9.945
Degree of
4
Freedom
Asymptotic
Sig. (2-sided
.041
test)
a. The test statistic is adjusted for ties.
Table 117 Kruskal-Wallis result for perceived risk across Knowledge of Adverse Outcome Involvement in Study 2.

Pairwise Comparisons of Knowledge of Adverse Outcome Involvement
Dependent Variable:
Perceived Risk
Test
Std.
Std. Test
Sample 1
Sample 2
Sig.
Statistic
Error
Statistic
1/4 Answer
0/4
Correct
Answers
41.336
30.766
1.344
.179
Correct or
5/4
1/4 Answer
2/4
Correct
Answers
-50.230
26.087
-1.925
.054
Correct
1/4 Answer
3/4
Correct
Answers
-65.764
24.691
-2.663
.008
Correct
1/4 Answer
4/4
Correct
Answers
-68.394
24.691
-2.770
.006
Correct
0/4 Answers
2/4
Correct or 5/4
Answers
-8.895
22.865
-.389
.697
Correct
0/4 Answers
3/4
Correct or 5/4
Answers
-24.428
21.258
-1.149
.251
Correct
0/4 Answers
4/4
Correct or 5/4
Answers
-27.058
21.258
-1.273
.203
Correct
2/4 Answers
3/4
Correct
Answers
-15.533
13.635
-1.139
.255
Correct
2/4 Answers
4/4
Correct
Answers
-181.64
13.635
-1.332
.183
Correct
270

Adj.
Sig.a
1.000

.542

.077

.056

1.000

1.000

1.000

1.000

1.000

3/4 Answers
Correct

4/4
Answers
-2.630
10.725
-.245
.806
1.000
Correct
Each row tests the null hypothesis that the Sample 1 and Sample 2 distributions are the
same.
Asymptotic significances (2-sided tests) are displayed. The significance level is .05.
a. Significance values have been adjusted by the Bonferroni correction for multiple
tests.
Table 118 Pairwise comparisons for perceived risk across Knowledge of Adverse Outcome Involvement in Study 2.

It was examined whether there was any difference in terms of perceived risk across the
respondents who varied in their involvement with reading the Perceived Risk scenario
(measured as correct answers provided). No significant difference was found. Results are
shown below in tables 122-123.

Test of Homogeneity of Variances
Levene Statistic
Perceived
Based on
.576
Risk
Mean
Based on
.662
Median
Based on
Median and
.662
with
adjusted df
Based on
trimmed
.618
mean

df1

df2

Sig.

2

256

.563

2

256

.517

2

251.335

.517

2

256

.540

Table 119 Homogeneity of variances test for ANOVA for perceived risk across scenario involvement.

ANOVA RESULTS (DV: Perceived Risk)
Source
Type III Sum of
df
Mean Square
Squares
Between
23.377
2
11.688
Groups
Within
1468.013
256
5.734
Groups
Total
1491.390
258

F

Sig.

2.038

.132

Table 120 ANOVA result for perceived risk across scenario involvement.
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APPENDIX 6 STUDY 2 EXPERIMENTAL MANIPULATIONS ACROSS DATA
SOURCES
It was examined whether there was any difference in terms of price paid across the
respondents joining the experiment from different locations. No significant difference was
found. Results are shown in tables 124-125 below.

Test of Homogeneity of Variances
Levene Statistic
Perceived
Based on
1.202
Risk
Mean
Based on
.905
Median
Based on
Median and
.905
with
adjusted df
Based on
trimmed
1.211
mean

df1

df2

Sig.

2

254

.302

2

254

.406

2

252.839

.406

2

254

.300

Table 121 Homogeneity of variances test - price paid across data sources in Study 2.

ANOVA RESULTS (DV: Price Paid)
Source
Type III Sum of
df
Squares
Between
54862.605
5
Groups
Within
1806416.1
254
Groups
Total
1861278.7
259

Mean Square

F

Sig.

10972.521

1.543

.177

7111.875

Table 122 ANOVA result for price paid across data sources in Study 2.

It was examined whether there was any difference in terms of perceived risk across the
respondents joining the experiment from different locations (Tables 126-127). No
significant difference was found.

Test of Homogeneity of Variances
Levene Statistic
272

df1

df2

Sig.

Perceived
Risk

Based on
Mean
Based on
Median
Based on
Median and
with
adjusted df
Based on
trimmed
mean

.170

2

253

.843

.115

2

253

.891

.115

2

249.445

.891

.159

2

253

.854

Table 123 Homogeneity of variances test - perceived risk across data sources Study 2.

ANOVA RESULTS (DV: Perceived Risk)
Source
Type III Sum of
df
Mean Square
Squares
Between
55.834
5
11.167
Groups
Within
1435.556
253
5.674
Groups
Total
1491.390
258

F

Sig.

1.968

.084

Table 124 ANOVA result for perceived risk across data sources in Study 2.
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